[
  {
    "id": 144953,
    "drug": {
      "current_status": "MARKETED",
      "id": 12884,
      "drug_code": 72016,
      "updated_date": "2025-05-15T02:31:27-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8254719,
          "ingredient": {
            "id": 916,
            "ingredient_code": 1395,
            "en_name": "FAMOTIDINE",
            "fr_name": "Famotidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02247735",
      "brand_name": "FAMOTIDINE OMEGA -(WITHOUT PRESERVATIVE)",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0118722003"
    },
    "created_date": "2021-09-01T15:10:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247735",
    "company_name": "OMEGA LABORATORIES LTD",
    "atc_number": "A02BA",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2021-10-31T00:00:00-04:00",
    "actual_start_date": "2021-10-04T00:00:00-04:00",
    "actual_end_date": "2021-10-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-26T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "On Allocation.",
    "en_drug_brand_name": "FAMOTIDINE OMEGA  -(WITHOUT PRESERVATIVE)",
    "en_drug_common_name": "Famotidine injection",
    "fr_drug_brand_name": "Famotidine Injection",
    "fr_drug_common_name": "Famotidine Injection",
    "en_ingredients": "FAMOTIDINE",
    "fr_ingredients": "Famotidine",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 x 2mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 144965,
    "drug": {
      "current_status": "MARKETED",
      "id": 14304,
      "drug_code": 74388,
      "updated_date": "2025-05-15T02:31:38-04:00",
      "company": {
        "id": 16952,
        "created_date": "2020-09-03T01:00:04-04:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 17643,
        "mfr_code": "",
        "name": "ELVIUM LIFE SCIENCES",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255153,
          "ingredient": {
            "id": 1476,
            "ingredient_code": 11163,
            "en_name": "TIMOLOL",
            "fr_name": "Timolol (Maléate de timolol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8255152,
          "ingredient": {
            "id": 1624,
            "ingredient_code": 11213,
            "en_name": "DORZOLAMIDE",
            "fr_name": "Dorzolamide (Chlorhydrate de dorzolamide)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02258692",
      "brand_name": "COSOPT PRESERVATIVE-FREE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0237301001"
    },
    "created_date": "2021-09-01T18:53:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02258692",
    "company_name": "ELVIUM LIFE SCIENCES",
    "atc_number": "S01ED",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "anticipated_start_date": "2021-09-01T00:00:00-04:00",
    "estimated_end_date": "2021-09-10T00:00:00-04:00",
    "actual_start_date": "2021-09-01T00:00:00-04:00",
    "actual_end_date": "2021-09-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-09-10T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "COSOPT",
    "en_drug_common_name": "Dorzolamide and timolol ophthalmic solution",
    "fr_drug_brand_name": "COSOPT",
    "fr_drug_common_name": "collyre de dorzolamide et timolol",
    "en_ingredients": "TIMOLOL\r\nDORZOLAMIDE",
    "fr_ingredients": "sous forme de chlorhydrate de dorzolamide et de maléate de timolol",
    "drug_strength": "5MG\r\n20MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "0.2ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145004,
    "drug": {
      "current_status": "MARKETED",
      "id": 63434,
      "drug_code": 97222,
      "updated_date": "2025-05-15T02:36:54-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8263643,
          "ingredient": {
            "id": 2138,
            "ingredient_code": 11104,
            "en_name": "ONDANSETRON",
            "fr_name": "Ondansétron"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02481731",
      "brand_name": "ONDANSETRON ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131120001"
    },
    "created_date": "2021-09-02T15:43:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02481731",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A04AA",
    "atc_description": "ANTIEMETICS AND ANTINAUSEANTS",
    "estimated_end_date": "2021-10-15T00:00:00-04:00",
    "actual_start_date": "2021-08-30T00:00:00-04:00",
    "actual_end_date": "2021-10-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-20T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ONDANSETRON ODT",
    "en_drug_common_name": "ONDANSETRON ODT",
    "fr_drug_brand_name": "ONDANSETRON ODT",
    "fr_drug_common_name": "ONDANSETRON ODT",
    "en_ingredients": "ONDANSETRON",
    "fr_ingredients": "Ondansétron",
    "drug_strength": "8MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "10 ODT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145007,
    "drug": {
      "current_status": "MARKETED",
      "id": 19932,
      "drug_code": 81245,
      "updated_date": "2025-05-15T02:32:25-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256968,
          "ingredient": {
            "id": 670,
            "ingredient_code": 10075,
            "en_name": "FENTANYL",
            "fr_name": "Fentanyl (Citrate de fentanyl)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "37",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02327139",
      "brand_name": "SANDOZ FENTANYL PATCH",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123302016"
    },
    "created_date": "2021-09-02T15:45:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02327139",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N02AB",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2021-09-10T00:00:00-04:00",
    "actual_start_date": "2021-08-30T00:00:00-04:00",
    "actual_end_date": "2021-09-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-09-09T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ FENTANYL PATCH",
    "en_drug_common_name": "FENTANYL PATCH",
    "fr_drug_brand_name": "SANDOZ\tFENTANYL PATCH",
    "fr_drug_common_name": "FENTANYL PATCH",
    "en_ingredients": "FENTANYL",
    "fr_ingredients": "Fentanyl",
    "drug_strength": "37MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "5 PATCHES",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145010,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 30754,
      "drug_code": 92802,
      "updated_date": "2025-05-15T04:24:00-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8355994,
          "ingredient": {
            "id": 292,
            "ingredient_code": 8565,
            "en_name": "TOBRAMYCIN",
            "fr_name": "Tobramycine (Sulfate de tobramycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": true
        }
      ],
      "din": "02443368",
      "brand_name": "TOBRAMYCIN INHALATION SOLUTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0110230004"
    },
    "created_date": "2021-09-02T15:49:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02443368",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "J01GB",
    "atc_description": "AMINOGLYCOSIDE ANTIBACTERIALS",
    "actual_start_date": "2021-08-30T00:00:00-04:00",
    "actual_end_date": "2021-08-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-09-14T15:37:02-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "TOBRAMYCIN INHALATION SOLUTION",
    "en_drug_common_name": "TOBRAMYCIN INH",
    "fr_drug_brand_name": "TOBRAMYCIN INHALATION SOLUTION",
    "fr_drug_common_name": "TOBRAMYCIN INH",
    "en_ingredients": "TOBRAMYCIN",
    "fr_ingredients": "Tobramycine",
    "drug_strength": "300MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "56 LIN",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145015,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 30754,
      "drug_code": 92802,
      "updated_date": "2025-05-15T04:24:00-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8355994,
          "ingredient": {
            "id": 292,
            "ingredient_code": 8565,
            "en_name": "TOBRAMYCIN",
            "fr_name": "Tobramycine (Sulfate de tobramycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": true
        }
      ],
      "din": "02443368",
      "brand_name": "TOBRAMYCIN INHALATION SOLUTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0110230004"
    },
    "created_date": "2021-09-02T15:53:56-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02443368",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "J01GB",
    "atc_description": "AMINOGLYCOSIDE ANTIBACTERIALS",
    "discontinuation_date": "2021-08-31T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-09-02T15:54:47-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TOBRAMYCIN INHALATION SOLUTION",
    "en_drug_common_name": "TOBRAMYCIN INH",
    "fr_drug_brand_name": "TOBRAMYCIN INHALATION SOLUTION",
    "fr_drug_common_name": "TOBRAMYCIN INH",
    "en_ingredients": "TOBRAMYCIN",
    "fr_ingredients": "Tobramycine",
    "drug_strength": "300MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "56 LIIN",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145053,
    "drug": {
      "current_status": "MARKETED",
      "id": 19638,
      "drug_code": 810,
      "updated_date": "2025-12-03T00:30:19-05:00",
      "company": {
        "id": 3128,
        "created_date": "2017-08-17T01:15:06-04:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 16816,
        "mfr_code": "",
        "name": "KNIGHT THERAPEUTICS INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "100 ALEXIS-NIHON BLVD., SUITE 600",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4M 2P2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250193,
          "ingredient": {
            "id": 48,
            "ingredient_code": 7532,
            "en_name": "HYDROCORTISONE",
            "fr_name": "Hydrocortisone (Extrait corticosurrénalien)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        },
        {
          "id": 8250192,
          "ingredient": {
            "id": 2662,
            "ingredient_code": 9081,
            "en_name": "CLIOQUINOL",
            "fr_name": "Clioquinol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "00074500",
      "brand_name": "VIOFORM HYDROCORTISONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "30001",
      "number_of_ais": "2",
      "ai_group_no": "0204581001"
    },
    "created_date": "2021-09-02T19:10:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00074500",
    "company_name": "PALADIN LABS INC.",
    "atc_number": "D07CA",
    "atc_description": "CORTICOSTEROIDS, COMB WITH ANTIBIOTICS",
    "anticipated_start_date": "2021-09-02T00:00:00-04:00",
    "estimated_end_date": "2021-11-01T00:00:00-04:00",
    "actual_start_date": "2021-09-02T00:00:00-04:00",
    "actual_end_date": "2021-11-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-11-03T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "VIOFORM HYDROCORTISONE",
    "en_drug_common_name": "Vioform Hydrocortisone 3% 1% CR 30g",
    "fr_drug_brand_name": "Vioform Hydrocortisone",
    "fr_drug_common_name": "Vioform Hydrocortisone 3% 1% CR 30g",
    "en_ingredients": "HYDROCORTISONE\r\nCLIOQUINOL",
    "fr_ingredients": "Hydrocortisone\r\nClioquinol",
    "drug_strength": "1%\r\n3%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "30g tube",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145106,
    "drug": {
      "current_status": "MARKETED",
      "id": 64614,
      "drug_code": 94374,
      "updated_date": "2025-05-15T02:35:29-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262060,
          "ingredient": {
            "id": 3432,
            "ingredient_code": 20171,
            "en_name": "DULOXETINE",
            "fr_name": "Duloxétine (Chlorhydrate de duloxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02456753",
      "brand_name": "TEVA-DULOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152350001"
    },
    "created_date": "2021-09-02T19:49:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02456753",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2021-11-30T00:00:00-05:00",
    "actual_start_date": "2021-09-01T00:00:00-04:00",
    "actual_end_date": "2021-11-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-12-02T20:25:22-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-DULOXETINE",
    "en_drug_common_name": "DULOXETINE HCL 30MG CAPS",
    "fr_drug_brand_name": "TEVA-DULOXETINE HCL 30MG CAPS",
    "fr_drug_common_name": "DULOXETINE HCL 30MG CAPS",
    "en_ingredients": "DULOXETINE",
    "fr_ingredients": "DULOXETINE HCL",
    "drug_strength": "30MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145109,
    "drug": {
      "current_status": "MARKETED",
      "id": 58,
      "drug_code": 10117,
      "updated_date": "2025-05-15T02:30:49-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251292,
          "ingredient": {
            "id": 24,
            "ingredient_code": 8642,
            "en_name": "DOXYCYCLINE",
            "fr_name": "Doxycycline (Hyclate de doxycycline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00725250",
      "brand_name": "TEVA-DOXYCYCLINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "69798",
      "number_of_ais": "1",
      "ai_group_no": "0105569001"
    },
    "created_date": "2021-09-02T19:50:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00725250",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01AA",
    "atc_description": "TETRACYCLINES",
    "estimated_end_date": "2021-09-30T00:00:00-04:00",
    "actual_start_date": "2021-09-01T00:00:00-04:00",
    "actual_end_date": "2021-09-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-09-09T19:42:18-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-DOXYCYCLINE",
    "en_drug_common_name": "DOXYCYCLINE 100MG CAPS",
    "fr_drug_brand_name": "TEVA-DOXYCYCLINE 100MG CAPS",
    "fr_drug_common_name": "DOXYCYCLINE 100MG CAPS",
    "en_ingredients": "DOXYCYCLINE",
    "fr_ingredients": "Doxycycline",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145112,
    "drug": {
      "current_status": "MARKETED",
      "id": 1696,
      "drug_code": 13654,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251795,
          "ingredient": {
            "id": 916,
            "ingredient_code": 1395,
            "en_name": "FAMOTIDINE",
            "fr_name": "Famotidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02022133",
      "brand_name": "TEVA-FAMOTIDINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "75087",
      "number_of_ais": "1",
      "ai_group_no": "0118722001"
    },
    "created_date": "2021-09-02T19:51:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02022133",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "A02BA",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2021-09-30T00:00:00-04:00",
    "actual_start_date": "2021-09-01T00:00:00-04:00",
    "actual_end_date": "2021-09-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-09-23T17:41:14-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-FAMOTIDINE",
    "en_drug_common_name": "FAMOTIDINE 20MG FC TAB",
    "fr_drug_brand_name": "FAMOTIDINE 20MG FC TAB",
    "fr_drug_common_name": "TEVA-FAMOTIDINE 20MG FC TAB",
    "en_ingredients": "FAMOTIDINE",
    "fr_ingredients": "Famotidine",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145115,
    "drug": {
      "current_status": "MARKETED",
      "id": 18386,
      "drug_code": 79654,
      "updated_date": "2025-05-15T02:32:10-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256442,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02310929",
      "brand_name": "TEVA-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055004"
    },
    "created_date": "2021-09-02T19:52:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02310929",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2021-10-31T00:00:00-04:00",
    "actual_start_date": "2021-09-01T00:00:00-04:00",
    "actual_end_date": "2021-11-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-12-01T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-ATORVASTATIN",
    "en_drug_common_name": "ATORVASTATIN 80MG FC TAB",
    "fr_drug_brand_name": "TEVA-ATORVASTATIN 80MG FC TAB",
    "fr_drug_common_name": "ATORVASTATIN 80MG FC TAB",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "ATORVASTATIN",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145118,
    "drug": {
      "current_status": "MARKETED",
      "id": 6078,
      "drug_code": 4255,
      "updated_date": "2025-05-15T02:30:30-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250614,
          "ingredient": {
            "id": 1222,
            "ingredient_code": 10127,
            "en_name": "PROPRANOLOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de propranolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00496499",
      "brand_name": "TEVA-PROPRANOLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "57111",
      "number_of_ais": "1",
      "ai_group_no": "0101831004"
    },
    "created_date": "2021-09-02T19:53:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00496499",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C07AA",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2021-09-30T00:00:00-04:00",
    "actual_start_date": "2021-09-01T00:00:00-04:00",
    "actual_end_date": "2021-09-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-09-23T17:41:35-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-PROPRANOLOL",
    "en_drug_common_name": "PROPRANOLOL 40MG TAB",
    "fr_drug_brand_name": "TEVA-PROPRANOLOL 40MG TAB",
    "fr_drug_common_name": "PROPRANOLOL 40MG TAB",
    "en_ingredients": "PROPRANOLOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de propanolol",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1000",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145121,
    "drug": {
      "current_status": "MARKETED",
      "id": 18170,
      "drug_code": 79435,
      "updated_date": "2025-05-15T02:32:08-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256371,
          "ingredient": {
            "id": 2670,
            "ingredient_code": 11854,
            "en_name": "SILDENAFIL",
            "fr_name": "Sildénafil (Citrate de sildénafil)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02308738",
      "brand_name": "TEVA-SILDENAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136261001"
    },
    "created_date": "2021-09-02T19:54:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02308738",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "G04BE",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "estimated_end_date": "2021-09-30T00:00:00-04:00",
    "actual_start_date": "2021-09-01T00:00:00-04:00",
    "actual_end_date": "2021-09-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-09-23T17:42:00-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-SILDENAFIL",
    "en_drug_common_name": "TEVA-SILDENAFIL 25MG TAB",
    "fr_drug_brand_name": "TEVA-SILDENAFIL 25MG TAB",
    "fr_drug_common_name": "SILDENAFIL 25MG TAB",
    "en_ingredients": "SILDENAFIL",
    "fr_ingredients": "SILDENAFIL",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "PP4",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145124,
    "drug": {
      "current_status": "MARKETED",
      "id": 16866,
      "drug_code": 77854,
      "updated_date": "2025-05-15T02:31:55-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255956,
          "ingredient": {
            "id": 2616,
            "ingredient_code": 11795,
            "en_name": "CLOPIDOGREL",
            "fr_name": "Clopidogrel (Bisulfate de clopidogrel)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02293161",
      "brand_name": "TEVA-CLOPIDOGREL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134440001"
    },
    "created_date": "2021-09-02T19:55:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02293161",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "B01AC",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "estimated_end_date": "2022-01-31T00:00:00-05:00",
    "actual_start_date": "2021-09-01T00:00:00-04:00",
    "actual_end_date": "2022-01-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-01-20T14:39:27-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-CLOPIDOGREL",
    "en_drug_common_name": "TEVA-CLOPIDOGREL 75MG TAB",
    "fr_drug_brand_name": "TEVA-CLOPIDOGREL 75MG TAB",
    "fr_drug_common_name": "CLOPIDOGREL 75MG TAB",
    "en_ingredients": "CLOPIDOGREL",
    "fr_ingredients": "CLOPIDOGREL",
    "drug_strength": "75MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145127,
    "drug": {
      "current_status": "MARKETED",
      "id": 30368,
      "drug_code": 92431,
      "updated_date": "2025-05-15T02:34:45-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261097,
          "ingredient": {
            "id": 848,
            "ingredient_code": 7554,
            "en_name": "PROGESTERONE",
            "fr_name": "Progestérone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02439913",
      "brand_name": "TEVA-PROGESTERONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106327002"
    },
    "created_date": "2021-09-02T19:56:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02439913",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "G03DA",
    "atc_description": "PROGESTOGENS",
    "estimated_end_date": "2022-04-30T00:00:00-04:00",
    "actual_start_date": "2021-09-01T00:00:00-04:00",
    "actual_end_date": "2022-04-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-04-28T13:29:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-PROGESTERONE",
    "en_drug_common_name": "PROGESTERONE 100MG CAPS",
    "fr_drug_brand_name": "TEVA-PROGESTERONE 100MG CAPS",
    "fr_drug_common_name": "PROGESTERONE 100MG CAPS",
    "en_ingredients": "PROGESTERONE",
    "fr_ingredients": "Progestérone",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "PP 30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145130,
    "drug": {
      "current_status": "MARKETED",
      "id": 14912,
      "drug_code": 75307,
      "updated_date": "2025-05-15T02:31:40-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255340,
          "ingredient": {
            "id": 1558,
            "ingredient_code": 4732,
            "en_name": "ADENOSINE",
            "fr_name": "Adénosine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02267659",
      "brand_name": "ADENOSINE INJECTION",
      "brand_name_fr": "ADÉNOSINE INJECTABLE",
      "descriptor": "SINGLE-DOSE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113219001"
    },
    "created_date": "2021-09-02T20:27:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02267659",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "C01EB",
    "atc_description": "OTHER CARDIAC PREPARATIONS",
    "anticipated_start_date": "2021-09-10T00:00:00-04:00",
    "estimated_end_date": "2021-11-03T00:00:00-04:00",
    "actual_end_date": "2021-11-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-11-04T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ADENOSINE INJECTION",
    "en_drug_common_name": "Adenosine Injection 3 mg/mL SD Vial 2 mL",
    "fr_drug_brand_name": "Adénosine injectable",
    "fr_drug_common_name": "Adénosine injectable, 3 mg/mL, fioles DU, 2 mL",
    "en_ingredients": "ADENOSINE",
    "fr_ingredients": "Adénosine",
    "drug_strength": "3MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "2 mL Vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145133,
    "drug": {
      "current_status": "MARKETED",
      "id": 12886,
      "drug_code": 72026,
      "updated_date": "2025-05-15T02:31:27-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8254720,
          "ingredient": {
            "id": 916,
            "ingredient_code": 1395,
            "en_name": "FAMOTIDINE",
            "fr_name": "Famotidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02247745",
      "brand_name": "FAMOTIDINE OMEGA  -(WITH PRESERVATIVE,BENZYL ALCOHOL)",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0118722003"
    },
    "created_date": "2021-09-02T21:14:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247745",
    "company_name": "OMEGA LABORATORIES LTD",
    "atc_number": "A02BA",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2021-10-23T00:00:00-04:00",
    "actual_start_date": "2021-09-02T00:00:00-04:00",
    "actual_end_date": "2021-10-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-22T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "FAMOTIDINE OMEGA   -(WITH PRESERVATIVE,BENZYL ALCOHOL)",
    "en_drug_common_name": "Famotidine injection",
    "fr_drug_brand_name": "Famotidine injection",
    "fr_drug_common_name": "Famotidine injection",
    "en_ingredients": "FAMOTIDINE",
    "fr_ingredients": "Famotidine",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "1 x 20mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145144,
    "drug": {
      "current_status": "MARKETED",
      "id": 61188,
      "drug_code": 95756,
      "updated_date": "2025-12-03T00:33:34-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8262795,
          "ingredient": {
            "id": 3466,
            "ingredient_code": 20301,
            "en_name": "DABIGATRAN ETEXILATE",
            "fr_name": "Dabigatran étexilate (Mésilate de dabigatran étexilate)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02468913",
      "brand_name": "APO-DABIGATRAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152467003"
    },
    "created_date": "2021-09-03T14:09:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02468913",
    "company_name": "APOTEX INC",
    "atc_number": "B01AE",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "actual_start_date": "2021-09-01T00:00:00-04:00",
    "actual_end_date": "2023-09-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-09-15T17:11:19-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DABIGATRAN",
    "en_drug_common_name": "DABIGATRAN",
    "fr_drug_brand_name": "APO-DABIGATRAN",
    "fr_drug_common_name": "DABIGATRAN",
    "en_ingredients": "DABIGATRAN ETEXILATE",
    "fr_ingredients": "DABIGATRAN",
    "drug_strength": "150MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145147,
    "drug": {
      "current_status": "MARKETED",
      "id": 15586,
      "drug_code": 7627,
      "updated_date": "2025-05-15T02:30:40-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8251022,
          "ingredient": {
            "id": 24,
            "ingredient_code": 8642,
            "en_name": "DOXYCYCLINE",
            "fr_name": "Doxycycline (Hyclate de doxycycline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00740713",
      "brand_name": "APO-DOXY CAP 100MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "65752",
      "number_of_ais": "1",
      "ai_group_no": "0105569001"
    },
    "created_date": "2021-09-03T14:22:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00740713",
    "company_name": "APOTEX INC",
    "atc_number": "J01AA",
    "atc_description": "TETRACYCLINES",
    "estimated_end_date": "2021-09-17T00:00:00-04:00",
    "actual_start_date": "2021-09-01T00:00:00-04:00",
    "actual_end_date": "2021-09-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-09-20T12:32:52-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DOXY CAP 100MG",
    "en_drug_common_name": "DOXYCYCLINE",
    "fr_drug_brand_name": "APO-DOXYCYCLINE",
    "fr_drug_common_name": "DOXYCYCLINE",
    "en_ingredients": "DOXYCYCLINE",
    "fr_ingredients": "Doxycycline",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145150,
    "drug": {
      "current_status": "MARKETED",
      "id": 20168,
      "drug_code": 81611,
      "updated_date": "2025-05-15T02:32:31-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257152,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "54",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02330377",
      "brand_name": "APO-METHYLPHENIDATE ER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548006"
    },
    "created_date": "2021-09-03T14:25:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02330377",
    "company_name": "APOTEX INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2021-11-05T00:00:00-04:00",
    "actual_start_date": "2021-09-01T00:00:00-04:00",
    "actual_end_date": "2021-11-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-11-08T12:56:54-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-METHYLPHENIDATE ER",
    "en_drug_common_name": "METHYLPHANIDATE ER",
    "fr_drug_brand_name": "APO-METHYLPHANIDATE ER",
    "fr_drug_common_name": "METHYLPHANIDATE ER",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "54MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145153,
    "drug": {
      "current_status": "MARKETED",
      "id": 55784,
      "drug_code": 77466,
      "updated_date": "2025-05-15T02:31:51-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255889,
          "ingredient": {
            "id": 1286,
            "ingredient_code": 232,
            "en_name": "PERINDOPRIL ERBUMINE",
            "fr_name": "Périndopril erbumine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02289288",
      "brand_name": "APO-PERINDOPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127178002"
    },
    "created_date": "2021-09-03T14:55:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02289288",
    "company_name": "APOTEX INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2021-09-17T00:00:00-04:00",
    "actual_start_date": "2021-09-01T00:00:00-04:00",
    "actual_end_date": "2021-09-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-09-27T17:16:19-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-PERINDOPRIL",
    "en_drug_common_name": "PERINDOPRIL",
    "fr_drug_brand_name": "APO-PERINDOPRIL",
    "fr_drug_common_name": "PERINDOPRIL",
    "en_ingredients": "PERINDOPRIL ERBUMINE",
    "fr_ingredients": "Périndopril erbumine",
    "drug_strength": "4MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145158,
    "drug": {
      "current_status": "MARKETED",
      "id": 3422,
      "drug_code": 18685,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 458,
        "created_date": "2017-03-09T13:22:47-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 12573,
        "mfr_code": "",
        "name": "GE HEALTHCARE CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1919 MINNESOTA COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C9",
        "post_office_box": "",
        "contact_information": "800-387-7146   \r\n\r\ncanadainfo@gehealthcare.com"
      },
      "drug_ingredients": [
        {
          "id": 8252349,
          "ingredient": {
            "id": 1460,
            "ingredient_code": 250,
            "en_name": "IODIXANOL",
            "fr_name": "Iodixanol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "550",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02145766",
      "brand_name": "VISIPAQUE 270",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80956",
      "number_of_ais": "1",
      "ai_group_no": "0126988001"
    },
    "created_date": "2021-09-03T15:46:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02145766",
    "company_name": "GE HEALTHCARE CANADA INC",
    "atc_number": "V08AB",
    "atc_description": "X-RAY CONTRAST MEDIA, IODINATED",
    "anticipated_start_date": "2021-09-03T00:00:00-04:00",
    "estimated_end_date": "2021-09-09T00:00:00-04:00",
    "actual_start_date": "2021-09-03T00:00:00-04:00",
    "actual_end_date": "2021-09-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-09-09T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "VISIPAQUE 270",
    "en_drug_common_name": "Iodixanol injection USP",
    "fr_drug_brand_name": "VISIPAQUE 270",
    "fr_drug_common_name": "Iodixanol injection USP",
    "en_ingredients": "IODIXANOL",
    "fr_ingredients": "Iodixanol",
    "drug_strength": "550MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRA-ARTERIAL\r\nINTRA-ARTERIAL\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntra-artérielle\r\nIntra-artérielle\r\nIntraveineuse",
    "drug_package_quantity": "50 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145163,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 9182,
      "drug_code": 62045,
      "updated_date": "2025-05-15T03:57:44-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8326682,
          "ingredient": {
            "id": 2604,
            "ingredient_code": 11789,
            "en_name": "NELFINAVIR",
            "fr_name": "Nelfinavir (Mésylate de nelfinavir)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02238617",
      "brand_name": "VIRACEPT -250MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134340001"
    },
    "created_date": "2021-09-03T16:45:03-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02238617",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "J05AE",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "discontinuation_date": "2022-05-25T00:00:00-04:00",
    "anticipated_discontinuation_date": "2022-05-31T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Discontinued for commercial reasons. Distributed by ViiV Healthcare.",
    "fr_discontinuation_comments": "Discontinuation pour raisons commerciales. Distribution par ViiV Healthcare.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2022-05-30T19:15:31-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "VIRACEPT -250MG",
    "en_drug_common_name": "VIRACEPT",
    "fr_drug_brand_name": "VIRACEPT-250MG",
    "fr_drug_common_name": "VIRACEPT",
    "en_ingredients": "NELFINAVIR",
    "fr_ingredients": "NELFINAVIR",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "300 BOTTLE COUNT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145167,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 13448,
      "drug_code": 73129,
      "updated_date": "2025-05-15T04:08:00-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8339432,
          "ingredient": {
            "id": 2604,
            "ingredient_code": 11789,
            "en_name": "NELFINAVIR",
            "fr_name": "Nelfinavir (Mésylate de nelfinavir)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "625",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02248761",
      "brand_name": "VIRACEPT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134340003"
    },
    "created_date": "2021-09-03T16:50:03-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02248761",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "J05AE",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "discontinuation_date": "2021-10-28T00:00:00-04:00",
    "anticipated_discontinuation_date": "2021-10-31T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Discontinued for commercial reasons. Distributed by ViiV Healthcare.",
    "fr_discontinuation_comments": "Discontinuation pour raisons commerciales. Distribution par ViiV Healthcare.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-10-29T13:03:52-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "VIRACEPT",
    "en_drug_common_name": "VIRACEPT",
    "fr_drug_brand_name": "VIRACEPT-625MG",
    "fr_drug_common_name": "VIRACEPT",
    "en_ingredients": "NELFINAVIR",
    "fr_ingredients": "NELFINAVIR",
    "drug_strength": "625MG",
    "drug_dosage_form": "TABLET\r\nTABLET",
    "drug_dosage_form_fr": "Comprimé\r\nComprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "120 BOTTLE COUNT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145172,
    "drug": {
      "current_status": "MARKETED",
      "id": 28418,
      "drug_code": 90545,
      "updated_date": "2025-12-03T00:32:28-05:00",
      "company": {
        "id": 826,
        "created_date": "2017-03-09T13:23:21-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 8946,
        "mfr_code": "",
        "name": "OTSUKA PHARMACEUTICAL CO LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2-9 KANDA-TSUKASAMACHI",
        "province": "--",
        "country": "JAPAN",
        "city": "CHIYODA-KU TOKYO",
        "postal_code": "101-8535",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260299,
          "ingredient": {
            "id": 3528,
            "ingredient_code": 20435,
            "en_name": "ARIPIPRAZOLE",
            "fr_name": "Aripiprazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02420864",
      "brand_name": "ABILIFY MAINTENA",
      "brand_name_fr": "",
      "descriptor": "200MG/ML AFTER RECONSTITUTION. SYRINGE AND DILUENT INCLUDED IN THE KIT",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152514007"
    },
    "created_date": "2021-09-03T18:53:28-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02420864",
    "company_name": "OTSUKA PHARMACEUTICAL CO LTD",
    "atc_number": "N05AX",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2021-09-15T00:00:00-04:00",
    "actual_start_date": "2021-09-15T00:00:00-04:00",
    "actual_end_date": "2021-09-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-09-28T23:59:24-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ABILIFY MAINTENA",
    "en_drug_common_name": "Abilify Maintena",
    "fr_drug_brand_name": "Abilify Maintena",
    "fr_drug_common_name": "Abilify Maintena",
    "en_ingredients": "ARIPIPRAZOLE",
    "fr_ingredients": "Aripiprazole",
    "drug_strength": "300MG",
    "drug_dosage_form": "KIT\r\nPOWDER FOR SUSPENSION, SUSTAINED-RELEASE",
    "drug_dosage_form_fr": "Trousse\r\nPoudre pour suspension, à libération prolongée",
    "drug_route": "INTRAMUSCULAR\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire\r\nIntramusculaire",
    "drug_package_quantity": "kit",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145175,
    "drug": {
      "current_status": "MARKETED",
      "id": 28420,
      "drug_code": 90546,
      "updated_date": "2025-12-03T00:32:28-05:00",
      "company": {
        "id": 826,
        "created_date": "2017-03-09T13:23:21-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 8946,
        "mfr_code": "",
        "name": "OTSUKA PHARMACEUTICAL CO LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2-9 KANDA-TSUKASAMACHI",
        "province": "--",
        "country": "JAPAN",
        "city": "CHIYODA-KU TOKYO",
        "postal_code": "101-8535",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260300,
          "ingredient": {
            "id": 3528,
            "ingredient_code": 20435,
            "en_name": "ARIPIPRAZOLE",
            "fr_name": "Aripiprazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02420872",
      "brand_name": "ABILIFY MAINTENA",
      "brand_name_fr": "",
      "descriptor": "200MG/ML AFTER RECONSTITUTION. SYRINGE AND DILUENT INCLUDED IN THE KIT",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152514008"
    },
    "created_date": "2021-09-03T18:56:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02420872",
    "company_name": "OTSUKA PHARMACEUTICAL CO LTD",
    "atc_number": "N05AX",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2021-09-02T00:00:00-04:00",
    "actual_start_date": "2021-09-15T00:00:00-04:00",
    "actual_end_date": "2021-09-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-09-21T05:00:01-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ABILIFY MAINTENA",
    "en_drug_common_name": "Abilify Maintena",
    "fr_drug_brand_name": "Abilify Maintena",
    "fr_drug_common_name": "Abilify Maintena",
    "en_ingredients": "ARIPIPRAZOLE",
    "fr_ingredients": "Aripiprazole",
    "drug_strength": "400MG",
    "drug_dosage_form": "KIT\r\nPOWDER FOR SUSPENSION, SUSTAINED-RELEASE",
    "drug_dosage_form_fr": "Trousse\r\nPoudre pour suspension, à libération prolongée",
    "drug_route": "INTRAMUSCULAR\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire\r\nIntramusculaire",
    "drug_package_quantity": "kit",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145178,
    "drug": {
      "current_status": "DORMANT",
      "id": 17754,
      "drug_code": 78825,
      "updated_date": "2025-12-03T02:32:23-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368113,
          "ingredient": {
            "id": 2812,
            "ingredient_code": 12012,
            "en_name": "PIOGLITAZONE",
            "fr_name": "Pioglitazone (Chlorhydrate de pioglitazone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02302950",
      "brand_name": "APO-PIOGLITAZONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0141541002"
    },
    "created_date": "2021-09-03T19:40:03-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02302950",
    "company_name": "APOTEX INC",
    "atc_number": "A10BG",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2021-09-17T00:00:00-04:00",
    "actual_start_date": "2021-09-01T00:00:00-04:00",
    "actual_end_date": "2021-09-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-09-20T12:39:16-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-PIOGLITAZONE",
    "en_drug_common_name": "PIOGLITAZONE",
    "fr_drug_brand_name": "APO-PIOGLITAZONE",
    "fr_drug_common_name": "PIOGLITAZONE",
    "en_ingredients": "PIOGLITAZONE",
    "fr_ingredients": "PIOGLITAZONE",
    "drug_strength": "30MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145181,
    "drug": {
      "current_status": "MARKETED",
      "id": 12532,
      "drug_code": 71246,
      "updated_date": "2025-05-15T02:31:24-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254604,
          "ingredient": {
            "id": 282,
            "ingredient_code": 1221,
            "en_name": "SIMVASTATIN",
            "fr_name": "Simvastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247012",
      "brand_name": "APO-SIMVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122415004"
    },
    "created_date": "2021-09-03T19:44:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247012",
    "company_name": "APOTEX INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2021-10-29T00:00:00-04:00",
    "actual_start_date": "2021-09-01T00:00:00-04:00",
    "actual_end_date": "2021-10-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-25T12:10:40-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-SIMVASTATIN",
    "en_drug_common_name": "SIMVASTATIN",
    "fr_drug_brand_name": "APO-SIMVASTATIN",
    "fr_drug_common_name": "SIMVASTATIN",
    "en_ingredients": "SIMVASTATIN",
    "fr_ingredients": "Simvastatine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145206,
    "drug": {
      "current_status": "MARKETED",
      "id": 2566,
      "drug_code": 16162,
      "updated_date": "2025-05-15T02:30:55-04:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252090,
          "ingredient": {
            "id": 664,
            "ingredient_code": 8926,
            "en_name": "EPINEPHRINE",
            "fr_name": "Épinéphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        },
        {
          "id": 8252089,
          "ingredient": {
            "id": 1228,
            "ingredient_code": 2493,
            "en_name": "BUPIVACAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bupivacaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "01976184",
      "brand_name": "SENSORCAINE WITH EPINEPHRINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "77948",
      "number_of_ais": "2",
      "ai_group_no": "0204884001"
    },
    "created_date": "2021-09-03T20:31:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01976184",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "estimated_end_date": "2021-09-20T00:00:00-04:00",
    "actual_start_date": "2021-09-03T00:00:00-04:00",
    "actual_end_date": "2021-09-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-09-28T18:15:19-04:00",
    "status": "resolved",
    "en_comments": "VR44563CA1",
    "en_drug_brand_name": "SENSORCAINE WITH EPINEPHRINE",
    "en_drug_common_name": "Sensorcaine®",
    "fr_drug_brand_name": "Sensorcaine®",
    "fr_drug_common_name": "Sensorcaine®",
    "en_ingredients": "BUPIVACAINE HYDROCHLORIDE\r\nEPINEPHRINE",
    "fr_ingredients": "Chlorhydrate de bupivacaïne\r\nÉpinéphrine",
    "drug_strength": "2.5MG\r\n5MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "EPIDURAL\r\nBLOCK/INFILTRATION\r\nEPIDURAL\r\nBLOCK/INFILTRATION",
    "drug_route_fr": "Épidurale\r\nBloc/Infiltration\r\nÉpidurale\r\nBloc/Infiltration",
    "drug_package_quantity": "10 vials",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145209,
    "drug": {
      "current_status": "MARKETED",
      "id": 2564,
      "drug_code": 16161,
      "updated_date": "2025-05-15T02:30:55-04:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252088,
          "ingredient": {
            "id": 1228,
            "ingredient_code": 2493,
            "en_name": "BUPIVACAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bupivacaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "01976141",
      "brand_name": "SENSORCAINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "77947",
      "number_of_ais": "1",
      "ai_group_no": "0108896001"
    },
    "created_date": "2021-09-03T20:35:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01976141",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "estimated_end_date": "2021-09-20T00:00:00-04:00",
    "actual_start_date": "2021-09-03T00:00:00-04:00",
    "actual_end_date": "2021-09-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-09-28T18:14:20-04:00",
    "status": "resolved",
    "en_comments": "VR89889CA1",
    "en_drug_brand_name": "SENSORCAINE",
    "en_drug_common_name": "bupivacaine HCI 0.25% Plain 50x10mL SU Polyamp® Duofit®",
    "fr_drug_brand_name": "Sensorcaine®",
    "fr_drug_common_name": "bupivacaine HCI 0.25% Plain 50x10mL SU Polyamp® Duofit®",
    "en_ingredients": "BUPIVACAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bupivacaïne",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "EPIDURAL\r\nBLOCK/INFILTRATION\r\nEPIDURAL\r\nBLOCK/INFILTRATION",
    "drug_route_fr": "Épidurale\r\nBloc/Infiltration\r\nÉpidurale\r\nBloc/Infiltration",
    "drug_package_quantity": "50 PE Polyamp",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145250,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 99324,
      "drug_code": 96149,
      "updated_date": "2020-04-03T06:53:36-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8357692,
          "ingredient": {
            "id": 558,
            "ingredient_code": 8970,
            "en_name": "ATROPINE SULFATE",
            "fr_name": "Sulfate d'atropine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02472171",
      "brand_name": "ATROPINE SULFATE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "5ML PREFILLED SYRINGE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104748003"
    },
    "created_date": "2021-09-07T17:10:07-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02472171",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "A03BA",
    "atc_description": "BELLADONNAAND DERIVATIVES, PLAIN",
    "discontinuation_date": "2021-09-07T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-09-08T05:00:04-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "ATROPINE SULFATE INJECTION USP",
    "en_drug_common_name": "ATROPINE SULFATE INJECTION USP",
    "fr_drug_brand_name": "Sulfate d'atropine injectable USP",
    "fr_drug_common_name": "Sulfate d'atropine injectable USP",
    "en_ingredients": "ATROPINE SULFATE",
    "fr_ingredients": "Sulfate d'atropine",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "10 x 5mL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145256,
    "drug": {
      "current_status": "MARKETED",
      "id": 27254,
      "drug_code": 89506,
      "updated_date": "2025-05-15T02:34:00-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8259843,
          "ingredient": {
            "id": 1458,
            "ingredient_code": 2298,
            "en_name": "DOXORUBICIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de doxorubicine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02410397",
      "brand_name": "DOXORUBICIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0110825002"
    },
    "created_date": "2021-09-07T17:26:30-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02410397",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "L01DB",
    "atc_description": "CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES",
    "discontinuation_date": "2021-08-25T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-09-07T17:28:20-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "DOXORUBICIN",
    "en_drug_common_name": "DOXORUBICIN",
    "fr_drug_brand_name": "DOXORUBICIN",
    "fr_drug_common_name": "DOXORUBICIN",
    "en_ingredients": "DOXORUBICIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de doxorubicine",
    "drug_strength": "2MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVESICAL\r\nINTRAVENOUS\r\nINTRAVESICAL\r\nINTRAVENOUS",
    "drug_route_fr": "Intravésicale\r\nIntraveineuse\r\nIntravésicale\r\nIntraveineuse",
    "drug_package_quantity": "1 x 100mL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145265,
    "drug": {
      "current_status": "MARKETED",
      "id": 3958,
      "drug_code": 19610,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252537,
          "ingredient": {
            "id": 224,
            "ingredient_code": 8865,
            "en_name": "GLYCINE",
            "fr_name": "Glycine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.04",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252536,
          "ingredient": {
            "id": 646,
            "ingredient_code": 8700,
            "en_name": "L-LYSINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de L-lysine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "290",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252535,
          "ingredient": {
            "id": 1020,
            "ingredient_code": 935,
            "en_name": "L-PROLINE",
            "fr_name": "L-proline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "210",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252534,
          "ingredient": {
            "id": 1022,
            "ingredient_code": 938,
            "en_name": "L-ARGININE",
            "fr_name": "L-arginine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "520",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252533,
          "ingredient": {
            "id": 1018,
            "ingredient_code": 897,
            "en_name": "L-TYROSINE",
            "fr_name": "L-tyrosine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252532,
          "ingredient": {
            "id": 1014,
            "ingredient_code": 750,
            "en_name": "L-PHENYLALANINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de l-phénylalanine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "310",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252531,
          "ingredient": {
            "id": 1026,
            "ingredient_code": 941,
            "en_name": "L-THREONINE",
            "fr_name": "L-thréonine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "210",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252530,
          "ingredient": {
            "id": 1028,
            "ingredient_code": 944,
            "en_name": "L-ISOLEUCINE",
            "fr_name": "L-isoleucine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "240",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252529,
          "ingredient": {
            "id": 392,
            "ingredient_code": 7217,
            "en_name": "METHIONINE",
            "fr_name": "Méhionine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "290",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252528,
          "ingredient": {
            "id": 1016,
            "ingredient_code": 751,
            "en_name": "L-LEUCINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de l-leucine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "310",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252527,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252526,
          "ingredient": {
            "id": 1024,
            "ingredient_code": 939,
            "en_name": "L-VALINE",
            "fr_name": "L-valine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "230",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252525,
          "ingredient": {
            "id": 380,
            "ingredient_code": 10238,
            "en_name": "TRYPTOPHAN",
            "fr_name": "Tryptophane"
          },
          "ingredient_supplied_ind": "I",
          "strength": "90",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252524,
          "ingredient": {
            "id": 390,
            "ingredient_code": 2959,
            "en_name": "L-ALANINE",
            "fr_name": "L-ALANINE"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.04",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252523,
          "ingredient": {
            "id": 378,
            "ingredient_code": 10237,
            "en_name": "HISTIDINE",
            "fr_name": "Histidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "220",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02013932",
      "brand_name": "CLINIMIX",
      "brand_name_fr": "",
      "descriptor": "5% AMINO ACIDS (BLEND B) WITHOUT ELECTROLYTES IN 10% DEXTROSE INJECTION",
      "pediatric_flag": false,
      "accession_number": "81907",
      "number_of_ais": "15",
      "ai_group_no": "1550853010"
    },
    "created_date": "2021-09-07T20:46:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02013932",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05BA",
    "atc_description": "I.V. SOLUTIONS",
    "anticipated_start_date": "2021-09-07T00:00:00-04:00",
    "estimated_end_date": "2021-11-30T00:00:00-05:00",
    "actual_start_date": "2021-09-07T00:00:00-04:00",
    "actual_end_date": "2021-10-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-10-21T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "Baxter is experiencing a delay in raw materials which has resulted in a supply disruption on certain CLINIMIX and TRAVASOL products.  Impacted products have been placed on allocation.  The supply issue is expected to be resolved in early October.  Contact your Baxter sales rep or Baxter customer service for list of available CLINIMIX products which remain available to order.",
    "fr_comments": "Baxter connaît un retard dans son approvisionnement en matières premières, ce qui a entraîné une perturbation de l’approvisionnement de certains produits CLINIMIX et TRAVASOL. Les produits touchés ont été mis sous allocation. Le problème d’approvisionnement devrait être résolu au début d’octobre. Veuillez communiquer avec votre représentant Baxter ou avec le Service à la clientèle de Baxter pour obtenir la liste des produits CILINIMIX disponibles qui peuvent encore être commandés.",
    "en_drug_brand_name": "CLINIMIX",
    "en_drug_common_name": "CLINIMIX 5% Amino Acids (Blend B) without Electrolytes in 10% Dextrose Injection",
    "fr_drug_brand_name": "CLINIMIX",
    "fr_drug_common_name": "CLINIMIX 5% Amino Acids (Blend B) without Electrolytes in 10% Dextrose Injection",
    "en_ingredients": "L-TYROSINE\r\nL-PROLINE\r\nTRYPTOPHAN\r\nL-THREONINE\r\nHISTIDINE\r\nL-VALINE\r\nL-ISOLEUCINE\r\nL-ARGININE\r\nGLYCINE\r\nL-ALANINE\r\nMETHIONINE\r\nL-LYSINE HYDROCHLORIDE\r\nL-PHENYLALANINE HYDROCHLORIDE\r\nL-LEUCINE HYDROCHLORIDE\r\nDEXTROSE",
    "fr_ingredients": "L-tyrosine\r\nL-proline\r\nTryptophane\r\nL-thréonine\r\nHistidine\r\nL-valine\r\nL-isoleucine\r\nL-arginine\r\nGlycine\r\nMéhionine\r\nChlorhydrate de L-lysine\r\nChlorhydrate de l-phénylalanine\r\nChlorhydrate de l-leucine\r\nDextrose",
    "drug_strength": "20MG\r\n210MG\r\n90MG\r\n210MG\r\n220MG\r\n230MG\r\n240MG\r\n520MG\r\n1.04G\r\n1.04G\r\n290MG\r\n290MG\r\n310MG\r\n310MG\r\n10G",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "1000 mL (JB6766)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145268,
    "drug": {
      "current_status": "MARKETED",
      "id": 3374,
      "drug_code": 18550,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252335,
          "ingredient": {
            "id": 392,
            "ingredient_code": 7217,
            "en_name": "METHIONINE",
            "fr_name": "Méhionine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "290",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252334,
          "ingredient": {
            "id": 1020,
            "ingredient_code": 935,
            "en_name": "L-PROLINE",
            "fr_name": "L-proline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "210",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252333,
          "ingredient": {
            "id": 1024,
            "ingredient_code": 939,
            "en_name": "L-VALINE",
            "fr_name": "L-valine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "230",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252332,
          "ingredient": {
            "id": 1014,
            "ingredient_code": 750,
            "en_name": "L-PHENYLALANINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de l-phénylalanine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "310",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252331,
          "ingredient": {
            "id": 1028,
            "ingredient_code": 944,
            "en_name": "L-ISOLEUCINE",
            "fr_name": "L-isoleucine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "240",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252330,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252329,
          "ingredient": {
            "id": 1022,
            "ingredient_code": 938,
            "en_name": "L-ARGININE",
            "fr_name": "L-arginine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "520",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252328,
          "ingredient": {
            "id": 390,
            "ingredient_code": 2959,
            "en_name": "L-ALANINE",
            "fr_name": "L-ALANINE"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.04",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252327,
          "ingredient": {
            "id": 380,
            "ingredient_code": 10238,
            "en_name": "TRYPTOPHAN",
            "fr_name": "Tryptophane"
          },
          "ingredient_supplied_ind": "I",
          "strength": "90",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252326,
          "ingredient": {
            "id": 1018,
            "ingredient_code": 897,
            "en_name": "L-TYROSINE",
            "fr_name": "L-tyrosine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252325,
          "ingredient": {
            "id": 646,
            "ingredient_code": 8700,
            "en_name": "L-LYSINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de L-lysine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "290",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252324,
          "ingredient": {
            "id": 1026,
            "ingredient_code": 941,
            "en_name": "L-THREONINE",
            "fr_name": "L-thréonine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "210",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252323,
          "ingredient": {
            "id": 378,
            "ingredient_code": 10237,
            "en_name": "HISTIDINE",
            "fr_name": "Histidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "220",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252322,
          "ingredient": {
            "id": 224,
            "ingredient_code": 8865,
            "en_name": "GLYCINE",
            "fr_name": "Glycine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.04",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252321,
          "ingredient": {
            "id": 1016,
            "ingredient_code": 751,
            "en_name": "L-LEUCINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de l-leucine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "310",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02013940",
      "brand_name": "CLINIMIX",
      "brand_name_fr": "",
      "descriptor": "5% AMINO ACIDS (BLEND B) WITHOUT ELECTROLYTES IN 20% DEXTROSE INJECTION",
      "pediatric_flag": false,
      "accession_number": "80809",
      "number_of_ais": "15",
      "ai_group_no": "1550853014"
    },
    "created_date": "2021-09-07T20:48:31-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02013940",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05BA",
    "atc_description": "I.V. SOLUTIONS",
    "anticipated_start_date": "2021-09-07T00:00:00-04:00",
    "estimated_end_date": "2021-11-25T00:00:00-05:00",
    "actual_start_date": "2021-09-07T00:00:00-04:00",
    "actual_end_date": "2021-11-25T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-11-26T06:00:02-05:00",
    "status": "resolved",
    "en_comments": "Baxter is experiencing a delay in raw materials which has resulted in a supply disruption on certain CLINIMIX and TRAVASOL products.  Impacted products have been placed on allocation.  The supply issue is expected to be resolved in early October.  Contact your Baxter sales rep or Baxter customer service for list of available CLINIMIX products which remain available to order.",
    "fr_comments": "Baxter connaît un retard dans son approvisionnement en matières premières, ce qui a entraîné une perturbation de l’approvisionnement de certains produits CLINIMIX et TRAVASOL. Les produits touchés ont été mis sous allocation. Le problème d’approvisionnement devrait être résolu au début d’octobre. Veuillez communiquer avec votre représentant Baxter ou avec le Service à la clientèle de Baxter pour obtenir la liste des produits CILINIMIX disponibles qui peuvent encore être commandés.",
    "en_drug_brand_name": "CLINIMIX",
    "en_drug_common_name": "CLINIMIX TR5%/D20% 5% Amino Acids (Blend B) without Electrolytes in 20% Dextrose Injection",
    "fr_drug_brand_name": "CLINIMIX",
    "fr_drug_common_name": "CLINIMIX TR5%/D20% 5% Amino Acids (Blend B) without Electrolytes in 20% Dextrose Injection",
    "en_ingredients": "HISTIDINE\r\nL-VALINE\r\nL-ISOLEUCINE\r\nL-ARGININE\r\nGLYCINE\r\nL-ALANINE\r\nMETHIONINE\r\nL-LYSINE HYDROCHLORIDE\r\nL-PHENYLALANINE HYDROCHLORIDE\r\nL-LEUCINE HYDROCHLORIDE\r\nDEXTROSE\r\nL-TYROSINE\r\nL-PROLINE\r\nTRYPTOPHAN\r\nL-THREONINE",
    "fr_ingredients": "Histidine\r\nL-valine\r\nL-isoleucine\r\nL-arginine\r\nGlycine\r\nMéhionine\r\nChlorhydrate de L-lysine\r\nChlorhydrate de l-phénylalanine\r\nChlorhydrate de l-leucine\r\nDextrose\r\nL-tyrosine\r\nL-proline\r\nTryptophane\r\nL-thréonine",
    "drug_strength": "220MG\r\n230MG\r\n240MG\r\n520MG\r\n1.04G\r\n1.04G\r\n290MG\r\n290MG\r\n310MG\r\n310MG\r\n20G\r\n20MG\r\n210MG\r\n90MG\r\n210MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "1000 mL (JB6762P)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145271,
    "drug": {
      "current_status": "MARKETED",
      "id": 1916,
      "drug_code": 14075,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251876,
          "ingredient": {
            "id": 1022,
            "ingredient_code": 938,
            "en_name": "L-ARGININE",
            "fr_name": "L-arginine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "520",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251875,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "58.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251874,
          "ingredient": {
            "id": 378,
            "ingredient_code": 10237,
            "en_name": "HISTIDINE",
            "fr_name": "Histidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "220",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251873,
          "ingredient": {
            "id": 390,
            "ingredient_code": 2959,
            "en_name": "L-ALANINE",
            "fr_name": "L-ALANINE"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.04",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251872,
          "ingredient": {
            "id": 678,
            "ingredient_code": 10292,
            "en_name": "SODIUM ACETATE",
            "fr_name": "Acétate de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "205",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251871,
          "ingredient": {
            "id": 1028,
            "ingredient_code": 944,
            "en_name": "L-ISOLEUCINE",
            "fr_name": "L-isoleucine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "240",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251870,
          "ingredient": {
            "id": 158,
            "ingredient_code": 5319,
            "en_name": "POTASSIUM PHOSPHATE DIBASIC",
            "fr_name": "Phosphate de potassium dibasique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "261",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251869,
          "ingredient": {
            "id": 1016,
            "ingredient_code": 751,
            "en_name": "L-LEUCINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de l-leucine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "310",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251868,
          "ingredient": {
            "id": 12,
            "ingredient_code": 49,
            "en_name": "MAGNESIUM CHLORIDE",
            "fr_name": "Chlorure de magnésium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "24",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251867,
          "ingredient": {
            "id": 392,
            "ingredient_code": 7217,
            "en_name": "METHIONINE",
            "fr_name": "Méhionine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "290",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251866,
          "ingredient": {
            "id": 380,
            "ingredient_code": 10238,
            "en_name": "TRYPTOPHAN",
            "fr_name": "Tryptophane"
          },
          "ingredient_supplied_ind": "I",
          "strength": "90",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251865,
          "ingredient": {
            "id": 1020,
            "ingredient_code": 935,
            "en_name": "L-PROLINE",
            "fr_name": "L-proline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "210",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251864,
          "ingredient": {
            "id": 224,
            "ingredient_code": 8865,
            "en_name": "GLYCINE",
            "fr_name": "Glycine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.04",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251863,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251862,
          "ingredient": {
            "id": 1014,
            "ingredient_code": 750,
            "en_name": "L-PHENYLALANINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de l-phénylalanine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "310",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251861,
          "ingredient": {
            "id": 1024,
            "ingredient_code": 939,
            "en_name": "L-VALINE",
            "fr_name": "L-valine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "230",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251860,
          "ingredient": {
            "id": 646,
            "ingredient_code": 8700,
            "en_name": "L-LYSINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de L-lysine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "290",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251859,
          "ingredient": {
            "id": 1018,
            "ingredient_code": 897,
            "en_name": "L-TYROSINE",
            "fr_name": "L-tyrosine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251858,
          "ingredient": {
            "id": 1026,
            "ingredient_code": 941,
            "en_name": "L-THREONINE",
            "fr_name": "L-thréonine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "210",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02014076",
      "brand_name": "CLINIMIX E",
      "brand_name_fr": "",
      "descriptor": "5% AMINO ACIDS (BLEND B) WITH ELECTROLYTES IN 10% DEXTROSE INJECTION",
      "pediatric_flag": false,
      "accession_number": "75582",
      "number_of_ais": "19",
      "ai_group_no": "1950854027"
    },
    "created_date": "2021-09-07T20:49:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02014076",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05BA",
    "atc_description": "I.V. SOLUTIONS",
    "anticipated_start_date": "2021-09-07T00:00:00-04:00",
    "estimated_end_date": "2021-10-21T00:00:00-04:00",
    "actual_start_date": "2021-09-07T00:00:00-04:00",
    "actual_end_date": "2021-10-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-10-25T13:28:11-04:00",
    "status": "resolved",
    "en_comments": "Baxter is experiencing a delay in raw materials which has resulted in a supply disruption on certain CLINIMIX and TRAVASOL products.  Impacted products have been placed on allocation.  The supply issue is expected to be resolved in early October.  Contact your Baxter sales rep or Baxter customer service for list of available CLINIMIX products which remain available to order.",
    "fr_comments": "Baxter connaît un retard dans son approvisionnement en matières premières, ce qui a entraîné une perturbation de l’approvisionnement de certains produits CLINIMIX et TRAVASOL. Les produits touchés ont été mis sous allocation. Le problème d’approvisionnement devrait être résolu au début d’octobre. Veuillez communiquer avec votre représentant Baxter ou avec le Service à la clientèle de Baxter pour obtenir la liste des produits CILINIMIX disponibles qui peuvent encore être commandés.",
    "en_drug_brand_name": "CLINIMIX E",
    "en_drug_common_name": "CLINIMIX E 5% Amino Acids (Blend B) with Electrolytes in 10% Dextrose Injection",
    "fr_drug_brand_name": "CLINIMIX E",
    "fr_drug_common_name": "CLINIMIX E 5% Amino Acids (Blend B) with Electrolytes in 10% Dextrose Injection",
    "en_ingredients": "SODIUM CHLORIDE\r\nPOTASSIUM PHOSPHATE DIBASIC\r\nSODIUM ACETATE\r\nL-TYROSINE\r\nL-PROLINE\r\nTRYPTOPHAN\r\nL-THREONINE\r\nHISTIDINE\r\nL-VALINE\r\nL-ISOLEUCINE\r\nL-ARGININE\r\nL-ALANINE\r\nMETHIONINE\r\nL-LYSINE HYDROCHLORIDE\r\nL-PHENYLALANINE HYDROCHLORIDE\r\nL-LEUCINE HYDROCHLORIDE\r\nDEXTROSE\r\nGLYCINE\r\nMAGNESIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium\r\nPhosphate de potassium dibasique\r\nAcétate de sodium\r\nL-tyrosine\r\nL-proline\r\nTryptophane\r\nL-thréonine\r\nHistidine\r\nL-valine\r\nL-isoleucine\r\nL-arginine\r\nMéhionine\r\nChlorhydrate de L-lysine\r\nChlorhydrate de l-phénylalanine\r\nChlorhydrate de l-leucine\r\nDextrose\r\nGlycine\r\nChlorure de magnésium",
    "drug_strength": "58.5MG\r\n261MG\r\n205MG\r\n20MG\r\n210MG\r\n90MG\r\n210MG\r\n220MG\r\n230MG\r\n240MG\r\n520MG\r\n1.04G\r\n290MG\r\n290MG\r\n310MG\r\n310MG\r\n10G\r\n1.04G\r\n24MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "1000 mL (JB6767P)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145274,
    "drug": {
      "current_status": "MARKETED",
      "id": 1918,
      "drug_code": 14076,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251895,
          "ingredient": {
            "id": 1020,
            "ingredient_code": 935,
            "en_name": "L-PROLINE",
            "fr_name": "L-proline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "210",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251894,
          "ingredient": {
            "id": 646,
            "ingredient_code": 8700,
            "en_name": "L-LYSINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de L-lysine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "290",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251893,
          "ingredient": {
            "id": 1016,
            "ingredient_code": 751,
            "en_name": "L-LEUCINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de l-leucine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "310",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251892,
          "ingredient": {
            "id": 224,
            "ingredient_code": 8865,
            "en_name": "GLYCINE",
            "fr_name": "Glycine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.04",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251891,
          "ingredient": {
            "id": 380,
            "ingredient_code": 10238,
            "en_name": "TRYPTOPHAN",
            "fr_name": "Tryptophane"
          },
          "ingredient_supplied_ind": "I",
          "strength": "90",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251890,
          "ingredient": {
            "id": 1026,
            "ingredient_code": 941,
            "en_name": "L-THREONINE",
            "fr_name": "L-thréonine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "210",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251889,
          "ingredient": {
            "id": 392,
            "ingredient_code": 7217,
            "en_name": "METHIONINE",
            "fr_name": "Méhionine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "290",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251888,
          "ingredient": {
            "id": 1028,
            "ingredient_code": 944,
            "en_name": "L-ISOLEUCINE",
            "fr_name": "L-isoleucine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "240",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251887,
          "ingredient": {
            "id": 1018,
            "ingredient_code": 897,
            "en_name": "L-TYROSINE",
            "fr_name": "L-tyrosine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251886,
          "ingredient": {
            "id": 158,
            "ingredient_code": 5319,
            "en_name": "POTASSIUM PHOSPHATE DIBASIC",
            "fr_name": "Phosphate de potassium dibasique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "261",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251885,
          "ingredient": {
            "id": 1022,
            "ingredient_code": 938,
            "en_name": "L-ARGININE",
            "fr_name": "L-arginine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "520",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251884,
          "ingredient": {
            "id": 12,
            "ingredient_code": 49,
            "en_name": "MAGNESIUM CHLORIDE",
            "fr_name": "Chlorure de magnésium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "24",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251883,
          "ingredient": {
            "id": 390,
            "ingredient_code": 2959,
            "en_name": "L-ALANINE",
            "fr_name": "L-ALANINE"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.04",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251882,
          "ingredient": {
            "id": 678,
            "ingredient_code": 10292,
            "en_name": "SODIUM ACETATE",
            "fr_name": "Acétate de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "205",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251881,
          "ingredient": {
            "id": 1024,
            "ingredient_code": 939,
            "en_name": "L-VALINE",
            "fr_name": "L-valine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "230",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251880,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "58.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251879,
          "ingredient": {
            "id": 1014,
            "ingredient_code": 750,
            "en_name": "L-PHENYLALANINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de l-phénylalanine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "310",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251878,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "16.6",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251877,
          "ingredient": {
            "id": 378,
            "ingredient_code": 10237,
            "en_name": "HISTIDINE",
            "fr_name": "Histidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "220",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02013967",
      "brand_name": "CLINIMIX E",
      "brand_name_fr": "",
      "descriptor": "5% AMINO ACIDS (BLEND B) IN 16.6% DEXTROSE INJECTION",
      "pediatric_flag": false,
      "accession_number": "75583",
      "number_of_ais": "19",
      "ai_group_no": "1950854026"
    },
    "created_date": "2021-09-07T20:51:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02013967",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05BA",
    "atc_description": "I.V. SOLUTIONS",
    "anticipated_start_date": "2021-09-07T00:00:00-04:00",
    "estimated_end_date": "2021-11-25T00:00:00-05:00",
    "actual_start_date": "2021-09-07T00:00:00-04:00",
    "actual_end_date": "2021-11-25T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-11-26T06:00:02-05:00",
    "status": "resolved",
    "en_comments": "Baxter is experiencing a delay in raw materials which has resulted in a supply disruption on certain CLINIMIX and TRAVASOL products.  Impacted products have been placed on allocation.  The supply issue is expected to be resolved in early October.  Contact your Baxter sales rep or Baxter customer service for list of available CLINIMIX products which remain available to order.",
    "fr_comments": "Baxter connaît un retard dans son approvisionnement en matières premières, ce qui a entraîné une perturbation de l’approvisionnement de certains produits CLINIMIX et TRAVASOL. Les produits touchés ont été mis sous allocation. Le problème d’approvisionnement devrait être résolu au début d’octobre. Veuillez communiquer avec votre représentant Baxter ou avec le Service à la clientèle de Baxter pour obtenir la liste des produits CILINIMIX disponibles qui peuvent encore être commandés.",
    "en_drug_brand_name": "CLINIMIX E",
    "en_drug_common_name": "CLINIMIX E 5% Amino Acids (Blend B) with Electrolytes in 16.6% Dextrose Injection",
    "fr_drug_brand_name": "CLINIMIX E",
    "fr_drug_common_name": "CLINIMIX E 5% Amino Acids (Blend B) with Electrolytes in 16.6% Dextrose Injection",
    "en_ingredients": "L-ARGININE\r\nMAGNESIUM CHLORIDE\r\nSODIUM CHLORIDE\r\nPOTASSIUM PHOSPHATE DIBASIC\r\nSODIUM ACETATE\r\nL-TYROSINE\r\nL-PROLINE\r\nTRYPTOPHAN\r\nL-THREONINE\r\nHISTIDINE\r\nL-VALINE\r\nL-ISOLEUCINE\r\nGLYCINE\r\nL-ALANINE\r\nMETHIONINE\r\nL-LYSINE HYDROCHLORIDE\r\nL-PHENYLALANINE HYDROCHLORIDE\r\nL-LEUCINE HYDROCHLORIDE\r\nDEXTROSE",
    "fr_ingredients": "L-arginine\r\nChlorure de magnésium\r\nChlorure de sodium\r\nPhosphate de potassium dibasique\r\nAcétate de sodium\r\nL-tyrosine\r\nL-proline\r\nTryptophane\r\nL-thréonine\r\nHistidine\r\nL-valine\r\nL-isoleucine\r\nGlycine\r\nMéhionine\r\nChlorhydrate de L-lysine\r\nChlorhydrate de l-phénylalanine\r\nChlorhydrate de l-leucine\r\nDextrose",
    "drug_strength": "520MG\r\n24MG\r\n58.5MG\r\n261MG\r\n205MG\r\n20MG\r\n210MG\r\n90MG\r\n210MG\r\n220MG\r\n230MG\r\n240MG\r\n1.04G\r\n1.04G\r\n290MG\r\n290MG\r\n310MG\r\n310MG\r\n16.6G",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "1000 mL (JB6771P)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145277,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 4310,
      "drug_code": 20278,
      "updated_date": "2025-05-15T03:46:18-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8305339,
          "ingredient": {
            "id": 1454,
            "ingredient_code": 942,
            "en_name": "L-PHENYLALANINE",
            "fr_name": "L-phénylalanine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "280",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8305338,
          "ingredient": {
            "id": 1456,
            "ingredient_code": 943,
            "en_name": "L-LEUCINE",
            "fr_name": "L-leucine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "365",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8305337,
          "ingredient": {
            "id": 380,
            "ingredient_code": 10238,
            "en_name": "TRYPTOPHAN",
            "fr_name": "Tryptophane"
          },
          "ingredient_supplied_ind": "I",
          "strength": "90",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8305336,
          "ingredient": {
            "id": 390,
            "ingredient_code": 2959,
            "en_name": "L-ALANINE",
            "fr_name": "L-ALANINE"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.04",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8305335,
          "ingredient": {
            "id": 1020,
            "ingredient_code": 935,
            "en_name": "L-PROLINE",
            "fr_name": "L-proline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "340",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8305334,
          "ingredient": {
            "id": 1024,
            "ingredient_code": 939,
            "en_name": "L-VALINE",
            "fr_name": "L-valine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "290",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8305333,
          "ingredient": {
            "id": 378,
            "ingredient_code": 10237,
            "en_name": "HISTIDINE",
            "fr_name": "Histidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "240",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8305332,
          "ingredient": {
            "id": 1022,
            "ingredient_code": 938,
            "en_name": "L-ARGININE",
            "fr_name": "L-arginine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "575",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8305331,
          "ingredient": {
            "id": 392,
            "ingredient_code": 7217,
            "en_name": "METHIONINE",
            "fr_name": "Méhionine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8305330,
          "ingredient": {
            "id": 224,
            "ingredient_code": 8865,
            "en_name": "GLYCINE",
            "fr_name": "Glycine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "515",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8305329,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "16.6",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8305328,
          "ingredient": {
            "id": 1028,
            "ingredient_code": 944,
            "en_name": "L-ISOLEUCINE",
            "fr_name": "L-isoleucine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8305327,
          "ingredient": {
            "id": 1018,
            "ingredient_code": 897,
            "en_name": "L-TYROSINE",
            "fr_name": "L-tyrosine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8305326,
          "ingredient": {
            "id": 1026,
            "ingredient_code": 941,
            "en_name": "L-THREONINE",
            "fr_name": "L-thréonine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "210",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8305325,
          "ingredient": {
            "id": 1142,
            "ingredient_code": 9806,
            "en_name": "LYSINE",
            "fr_name": "Lysine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "290",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8305324,
          "ingredient": {
            "id": 398,
            "ingredient_code": 9927,
            "en_name": "SERINE",
            "fr_name": "Sérine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02142260",
      "brand_name": "CLINIMIX",
      "brand_name_fr": "",
      "descriptor": "5% AMINO ACIDS (BLEND C) WITHOUT ELECTROLYTES IN 16.6% DEXTROSE INJECTION",
      "pediatric_flag": false,
      "accession_number": "82582",
      "number_of_ais": "16",
      "ai_group_no": "1650849009"
    },
    "created_date": "2021-09-07T20:52:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02142260",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05BA",
    "atc_description": "I.V. SOLUTIONS",
    "anticipated_start_date": "2021-09-07T00:00:00-04:00",
    "estimated_end_date": "2021-11-25T00:00:00-05:00",
    "actual_start_date": "2021-09-07T00:00:00-04:00",
    "actual_end_date": "2021-11-25T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-11-26T06:00:02-05:00",
    "status": "resolved",
    "en_comments": "Baxter is experiencing a delay in raw materials which has resulted in a supply disruption on certain CLINIMIX and TRAVASOL products.  Impacted products have been placed on allocation.  The supply issue is expected to be resolved in early October.  Contact your Baxter sales rep or Baxter customer service for list of available CLINIMIX products which remain available to order.",
    "fr_comments": "Baxter connaît un retard dans son approvisionnement en matières premières, ce qui a entraîné une perturbation de l’approvisionnement de certains produits CLINIMIX et TRAVASOL. Les produits touchés ont été mis sous allocation. Le problème d’approvisionnement devrait être résolu au début d’octobre. Veuillez communiquer avec votre représentant Baxter ou avec le Service à la clientèle de Baxter pour obtenir la liste des produits CILINIMIX disponibles qui peuvent encore être commandés.",
    "en_drug_brand_name": "CLINIMIX",
    "en_drug_common_name": "CLINIMIX 5% Amino Acids (Blend C) without Electrolytes in 16.6% Dextrose Injection",
    "fr_drug_brand_name": "CLINIMIX",
    "fr_drug_common_name": "CLINIMIX 5% Amino Acids (Blend C) without Electrolytes in 16.6% Dextrose Injection",
    "en_ingredients": "LYSINE\r\nL-PHENYLALANINE\r\nL-LEUCINE\r\nDEXTROSE\r\nL-TYROSINE\r\nGLYCINE\r\nSERINE\r\nL-PROLINE\r\nL-ARGININE\r\nL-ALANINE\r\nTRYPTOPHAN\r\nL-THREONINE\r\nHISTIDINE\r\nL-VALINE\r\nL-ISOLEUCINE\r\nMETHIONINE",
    "fr_ingredients": "Lysine\r\nL-phénylalanine\r\nL-leucine\r\nDextrose\r\nL-tyrosine\r\nGlycine\r\nSérine\r\nL-proline\r\nL-arginine\r\nTryptophane\r\nL-thréonine\r\nHistidine\r\nL-valine\r\nL-isoleucine\r\nMéhionine",
    "drug_strength": "290MG\r\n280MG\r\n365MG\r\n16.6G\r\n20MG\r\n515MG\r\n250MG\r\n340MG\r\n575MG\r\n1.04G\r\n90MG\r\n210MG\r\n240MG\r\n290MG\r\n300MG\r\n200MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "2000 mL (JJ7770P)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145280,
    "drug": {
      "current_status": "MARKETED",
      "id": 602,
      "drug_code": 11329,
      "updated_date": "2025-05-15T02:30:51-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251507,
          "ingredient": {
            "id": 400,
            "ingredient_code": 9928,
            "en_name": "VALINE",
            "fr_name": "Valine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "580",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251506,
          "ingredient": {
            "id": 376,
            "ingredient_code": 10223,
            "en_name": "PHENYLALANINE",
            "fr_name": "Phénylalanine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "560",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251505,
          "ingredient": {
            "id": 394,
            "ingredient_code": 9396,
            "en_name": "PROLINE",
            "fr_name": "Proline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "680",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251504,
          "ingredient": {
            "id": 386,
            "ingredient_code": 10243,
            "en_name": "THREONINE",
            "fr_name": "Thréonine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "420",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251503,
          "ingredient": {
            "id": 382,
            "ingredient_code": 10239,
            "en_name": "LEUCINE",
            "fr_name": "Leucine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "730",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251502,
          "ingredient": {
            "id": 384,
            "ingredient_code": 10242,
            "en_name": "ARGININE",
            "fr_name": "Arginine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.15",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251501,
          "ingredient": {
            "id": 380,
            "ingredient_code": 10238,
            "en_name": "TRYPTOPHAN",
            "fr_name": "Tryptophane"
          },
          "ingredient_supplied_ind": "I",
          "strength": "180",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251500,
          "ingredient": {
            "id": 392,
            "ingredient_code": 7217,
            "en_name": "METHIONINE",
            "fr_name": "Méhionine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251499,
          "ingredient": {
            "id": 388,
            "ingredient_code": 193,
            "en_name": "L-LYSINE",
            "fr_name": "L-lysine (Acétate de L-lysine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "580",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": true
        },
        {
          "id": 8251498,
          "ingredient": {
            "id": 398,
            "ingredient_code": 9927,
            "en_name": "SERINE",
            "fr_name": "Sérine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251497,
          "ingredient": {
            "id": 396,
            "ingredient_code": 9750,
            "en_name": "TYROSINE",
            "fr_name": "Tyrosine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251496,
          "ingredient": {
            "id": 378,
            "ingredient_code": 10237,
            "en_name": "HISTIDINE",
            "fr_name": "Histidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "480",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251495,
          "ingredient": {
            "id": 390,
            "ingredient_code": 2959,
            "en_name": "L-ALANINE",
            "fr_name": "L-ALANINE"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.07",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251494,
          "ingredient": {
            "id": 224,
            "ingredient_code": 8865,
            "en_name": "GLYCINE",
            "fr_name": "Glycine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.03",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251493,
          "ingredient": {
            "id": 402,
            "ingredient_code": 9929,
            "en_name": "ISOLEUCINE",
            "fr_name": "Isoleucine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "600",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00872296",
      "brand_name": "TRAVASOL",
      "brand_name_fr": "",
      "descriptor": "BLEND C",
      "pediatric_flag": false,
      "accession_number": "71962",
      "number_of_ais": "15",
      "ai_group_no": "1517080002"
    },
    "created_date": "2021-09-07T20:53:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00872296",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05BA",
    "atc_description": "I.V. SOLUTIONS",
    "anticipated_start_date": "2021-09-07T00:00:00-04:00",
    "actual_start_date": "2021-09-07T00:00:00-04:00",
    "actual_end_date": "2021-10-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2021-10-02T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Baxter is experiencing a delay in raw materials which has resulted in a supply disruption on certain CLINIMIX and TRAVASOL products.  Impacted products have been placed on allocation.  The supply issue is expected to be resolved in early October.  Contact your Baxter sales rep or Baxter customer service for list of available CLINIMIX products which remain available to order.",
    "fr_comments": "Baxter connaît un retard dans son approvisionnement en matières premières, ce qui a entraîné une perturbation de l’approvisionnement de certains produits CLINIMIX et TRAVASOL. Les produits touchés ont été mis sous allocation. Le problème d’approvisionnement devrait être résolu au début d’octobre. Veuillez communiquer avec votre représentant Baxter ou avec le Service à la clientèle de Baxter pour obtenir la liste des produits CILINIMIX disponibles qui peuvent encore être commandés.",
    "en_drug_brand_name": "TRAVASOL",
    "en_drug_common_name": "TRAVASOL Amino acids (Blend C) injection",
    "fr_drug_brand_name": "TRAVASOL",
    "fr_drug_common_name": "TRAVASOL Amino acids (Blend C) injection",
    "en_ingredients": "LEUCINE\r\nSERINE\r\nTYROSINE\r\nPROLINE\r\nARGININE\r\nGLYCINE\r\nL-ALANINE\r\nTRYPTOPHAN\r\nTHREONINE\r\nHISTIDINE\r\nVALINE\r\nISOLEUCINE\r\nL-LYSINE\r\nMETHIONINE\r\nPHENYLALANINE",
    "fr_ingredients": "Leucine\r\nSérine\r\nTyrosine\r\nProline\r\nArginine\r\nGlycine\r\nTryptophane\r\nThréonine\r\nHistidine\r\nValine\r\nIsoleucine\r\nL-lysine\r\nMéhionine\r\nPhénylalanine",
    "drug_strength": "730MG\r\n500MG\r\n40MG\r\n680MG\r\n1.15G\r\n1.03G\r\n2.07G\r\n180MG\r\n420MG\r\n480MG\r\n580MG\r\n600MG\r\n580MG\r\n400MG\r\n560MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "3000 mL (JB6583)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145283,
    "drug": {
      "current_status": "MARKETED",
      "id": 3470,
      "drug_code": 18754,
      "updated_date": "2025-12-03T00:30:33-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8252372,
          "ingredient": {
            "id": 1472,
            "ingredient_code": 7490,
            "en_name": "LEVONORGESTREL",
            "fr_name": "Lévonorgestrel"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8252371,
          "ingredient": {
            "id": 790,
            "ingredient_code": 7426,
            "en_name": "ETHINYL ESTRADIOL",
            "fr_name": "Éthinylestradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02042320",
      "brand_name": "MIN-OVRAL 21",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81028",
      "number_of_ais": "2",
      "ai_group_no": "0220415004"
    },
    "created_date": "2021-09-07T21:26:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02042320",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "G03AA",
    "atc_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
    "anticipated_start_date": "2021-11-17T00:00:00-05:00",
    "estimated_end_date": "2023-01-19T00:00:00-05:00",
    "actual_start_date": "2021-11-17T00:00:00-05:00",
    "actual_end_date": "2023-01-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-01-18T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MIN-OVRAL 21",
    "en_drug_common_name": "MIN-OVRAL 21",
    "fr_drug_brand_name": "MIN-OVRAL 21",
    "fr_drug_common_name": "MIN-OVRAL 21",
    "en_ingredients": "ETHINYL ESTRADIOL\r\nLEVONORGESTREL",
    "fr_ingredients": "Éthinylestradiol\r\nLévonorgestrel",
    "drug_strength": "30MCG\r\n150MCG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "21s",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145299,
    "drug": {
      "current_status": "MARKETED",
      "id": 52273,
      "drug_code": 94975,
      "updated_date": "2025-12-03T00:33:20-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8262384,
          "ingredient": {
            "id": 3016,
            "ingredient_code": 13107,
            "en_name": "LEVETIRACETAM",
            "fr_name": "Lévétiracétam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "750",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02462001",
      "brand_name": "SANDOZ LEVETIRACETAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148843003"
    },
    "created_date": "2021-09-08T13:02:47-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02462001",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "actual_start_date": "2021-09-03T00:00:00-04:00",
    "actual_end_date": "2021-09-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-09-11T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ LEVETIRACETAM",
    "en_drug_common_name": "LEVETIRACETAM 750MG 100FCT BO CA",
    "fr_drug_brand_name": "SANDOZ LEVETIRACETAM",
    "fr_drug_common_name": "LEVETIRACETAM 750MG 100FCT BO CA",
    "en_ingredients": "LEVETIRACETAM",
    "fr_ingredients": "Lévétiracétam",
    "drug_strength": "750MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100FCT BO",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145303,
    "drug": {
      "current_status": "MARKETED",
      "id": 18620,
      "drug_code": 79891,
      "updated_date": "2025-05-15T02:32:12-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256522,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8256521,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02313383",
      "brand_name": "SANDOZ LOSARTAN HCT DS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0233168002"
    },
    "created_date": "2021-09-08T13:08:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02313383",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2022-12-09T00:00:00-05:00",
    "actual_start_date": "2021-09-03T00:00:00-04:00",
    "actual_end_date": "2022-12-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2022-12-12T04:27:10-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ LOSARTAN HCT DS",
    "en_drug_common_name": "LOSARTAN HCT DS SDZ 100+25MG 100FCTBO CA",
    "fr_drug_brand_name": "SANDOZ LOSARTAN HCT DS",
    "fr_drug_common_name": "LOSARTAN HCT DS SDZ 100+25MG 100FCTBO CA",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nLOSARTAN POTASSIUM",
    "fr_ingredients": "Hydrochlorothiazide\r\nLosartan potassique",
    "drug_strength": "25MG\r\n100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100FCT BO",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145309,
    "drug": {
      "current_status": "MARKETED",
      "id": 18620,
      "drug_code": 79891,
      "updated_date": "2025-05-15T02:32:12-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256522,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8256521,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02313383",
      "brand_name": "SANDOZ LOSARTAN HCT DS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0233168002"
    },
    "created_date": "2021-09-08T13:11:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02313383",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2023-04-28T00:00:00-04:00",
    "actual_start_date": "2021-09-03T00:00:00-04:00",
    "actual_end_date": "2023-05-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2023-05-03T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ LOSARTAN HCT DS",
    "en_drug_common_name": "LOSARTAN HCT DS SDZ 100/25MG 30FCT UD CA",
    "fr_drug_brand_name": "SANDOZ LOSARTAN HCT DS",
    "fr_drug_common_name": "LOSARTAN HCT DS SDZ 100/25MG 30FCT UD CA",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nLOSARTAN POTASSIUM",
    "fr_ingredients": "Hydrochlorothiazide\r\nLosartan potassique",
    "drug_strength": "25MG\r\n100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30FCT UD",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145337,
    "drug": {
      "current_status": "MARKETED",
      "id": 22350,
      "drug_code": 84745,
      "updated_date": "2025-05-15T02:32:52-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8258002,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8258001,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02362449",
      "brand_name": "SANDOZ LOSARTAN HCT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0233168003"
    },
    "created_date": "2021-09-08T18:57:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02362449",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2022-12-09T00:00:00-05:00",
    "actual_start_date": "2021-09-08T00:00:00-04:00",
    "actual_end_date": "2022-12-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2022-12-12T04:27:47-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ LOSARTAN HCT",
    "en_drug_common_name": "LOSARTAN HCT",
    "fr_drug_brand_name": "SANDOZ LOSARTAN HCT",
    "fr_drug_common_name": "LOSARTAN HCT",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nLOSARTAN POTASSIUM",
    "fr_ingredients": "Hydrochlorothiazide\r\nLosartan potassique",
    "drug_strength": "12.5MG\r\n100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100FCT BO",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145340,
    "drug": {
      "current_status": "MARKETED",
      "id": 22350,
      "drug_code": 84745,
      "updated_date": "2025-05-15T02:32:52-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8258002,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8258001,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02362449",
      "brand_name": "SANDOZ LOSARTAN HCT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0233168003"
    },
    "created_date": "2021-09-08T19:00:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02362449",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2023-04-28T00:00:00-04:00",
    "actual_start_date": "2021-09-08T00:00:00-04:00",
    "actual_end_date": "2023-05-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2023-05-03T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ LOSARTAN HCT",
    "en_drug_common_name": "LOSARTAN HCT",
    "fr_drug_brand_name": "SANDOZ LOSARTAN HCT",
    "fr_drug_common_name": "LOSARTAN HCT",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nLOSARTAN POTASSIUM",
    "fr_ingredients": "Hydrochlorothiazide\r\nLosartan potassique",
    "drug_strength": "12.5MG\r\n100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30FCT UD",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145343,
    "drug": {
      "current_status": "MARKETED",
      "id": 18618,
      "drug_code": 79890,
      "updated_date": "2025-05-15T02:32:12-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256520,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8256519,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02313375",
      "brand_name": "SANDOZ LOSARTAN HCT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0233168001"
    },
    "created_date": "2021-09-08T19:01:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02313375",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2022-12-09T00:00:00-05:00",
    "actual_start_date": "2021-09-08T00:00:00-04:00",
    "actual_end_date": "2022-12-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2022-12-12T04:28:25-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ LOSARTAN HCT",
    "en_drug_common_name": "LOSARTAN HCT",
    "fr_drug_brand_name": "SANDOZ LOSARTAN HCT",
    "fr_drug_common_name": "LOSARTAN HCT",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nLOSARTAN POTASSIUM",
    "fr_ingredients": "Hydrochlorothiazide\r\nLosartan potassique",
    "drug_strength": "12.5MG\r\n50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100FCT BO",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145346,
    "drug": {
      "current_status": "MARKETED",
      "id": 18618,
      "drug_code": 79890,
      "updated_date": "2025-05-15T02:32:12-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256520,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8256519,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02313375",
      "brand_name": "SANDOZ LOSARTAN HCT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0233168001"
    },
    "created_date": "2021-09-08T19:03:31-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02313375",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2023-04-28T00:00:00-04:00",
    "actual_start_date": "2021-09-08T00:00:00-04:00",
    "actual_end_date": "2023-05-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2023-05-03T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ LOSARTAN HCT",
    "en_drug_common_name": "LOSARTAN HCT",
    "fr_drug_brand_name": "SANDOZ LOSARTAN HCT",
    "fr_drug_common_name": "LOSARTAN HCT",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nLOSARTAN POTASSIUM",
    "fr_ingredients": "Hydrochlorothiazide\r\nLosartan potassique",
    "drug_strength": "12.5MG\r\n50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30FCT UD",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145351,
    "drug": {
      "current_status": "MARKETED",
      "id": 18616,
      "drug_code": 79888,
      "updated_date": "2025-05-15T02:32:12-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256518,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02313359",
      "brand_name": "SANDOZ LOSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127971002"
    },
    "created_date": "2021-09-08T19:07:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02313359",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2022-12-09T00:00:00-05:00",
    "actual_start_date": "2021-09-08T00:00:00-04:00",
    "actual_end_date": "2022-12-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2022-12-12T04:30:45-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ LOSARTAN",
    "en_drug_common_name": "LOSARTAN",
    "fr_drug_brand_name": "SANDOZ LOSARTAN",
    "fr_drug_common_name": "LOSARTAN",
    "en_ingredients": "LOSARTAN POTASSIUM",
    "fr_ingredients": "Losartan potassique",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100FCT BO",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145354,
    "drug": {
      "current_status": "MARKETED",
      "id": 18616,
      "drug_code": 79888,
      "updated_date": "2025-05-15T02:32:12-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256518,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02313359",
      "brand_name": "SANDOZ LOSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127971002"
    },
    "created_date": "2021-09-08T19:08:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02313359",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2023-04-07T00:00:00-04:00",
    "actual_start_date": "2021-09-08T00:00:00-04:00",
    "actual_end_date": "2023-04-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2023-04-05T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ LOSARTAN",
    "en_drug_common_name": "LOSARTAN",
    "fr_drug_brand_name": "SANDOZ LOSARTAN",
    "fr_drug_common_name": "LOSARTAN",
    "en_ingredients": "LOSARTAN POTASSIUM",
    "fr_ingredients": "Losartan potassique",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30FCT UD",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145357,
    "drug": {
      "current_status": "MARKETED",
      "id": 18612,
      "drug_code": 79886,
      "updated_date": "2025-05-15T02:32:12-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256516,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02313332",
      "brand_name": "SANDOZ LOSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127971001"
    },
    "created_date": "2021-09-08T19:09:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02313332",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2022-12-09T00:00:00-05:00",
    "actual_start_date": "2021-09-08T00:00:00-04:00",
    "actual_end_date": "2022-12-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2022-12-12T04:31:39-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ LOSARTAN",
    "en_drug_common_name": "LOSARTAN",
    "fr_drug_brand_name": "SANDOZ LOSARTAN",
    "fr_drug_common_name": "LOSARTAN",
    "en_ingredients": "LOSARTAN POTASSIUM",
    "fr_ingredients": "Losartan potassique",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100FCT BO",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145360,
    "drug": {
      "current_status": "MARKETED",
      "id": 18614,
      "drug_code": 79887,
      "updated_date": "2025-05-15T02:32:12-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256517,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02313340",
      "brand_name": "SANDOZ LOSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127971003"
    },
    "created_date": "2021-09-08T19:10:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02313340",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2022-12-09T00:00:00-05:00",
    "actual_start_date": "2021-09-08T00:00:00-04:00",
    "actual_end_date": "2022-12-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2022-12-12T04:34:31-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ LOSARTAN",
    "en_drug_common_name": "LOSARTAN",
    "fr_drug_brand_name": "SANDOZ LOSARTAN",
    "fr_drug_common_name": "LOSARTAN",
    "en_ingredients": "LOSARTAN POTASSIUM",
    "fr_ingredients": "Losartan potassique",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100FCT BO",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145363,
    "drug": {
      "current_status": "MARKETED",
      "id": 18614,
      "drug_code": 79887,
      "updated_date": "2025-05-15T02:32:12-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256517,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02313340",
      "brand_name": "SANDOZ LOSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127971003"
    },
    "created_date": "2021-09-08T19:12:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02313340",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2023-04-07T00:00:00-04:00",
    "actual_start_date": "2021-09-08T00:00:00-04:00",
    "actual_end_date": "2023-04-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2023-04-05T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ LOSARTAN",
    "en_drug_common_name": "LOSARTAN",
    "fr_drug_brand_name": "SANDOZ LOSARTAN",
    "fr_drug_common_name": "LOSARTAN",
    "en_ingredients": "LOSARTAN POTASSIUM",
    "fr_ingredients": "Losartan potassique",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30FCT UD",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145366,
    "drug": {
      "current_status": "MARKETED",
      "id": 11170,
      "drug_code": 67477,
      "updated_date": "2025-05-15T02:31:14-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254198,
          "ingredient": {
            "id": 1262,
            "ingredient_code": 10058,
            "en_name": "ORPHENADRINE CITRATE",
            "fr_name": "Citrate d'orphénadrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02243559",
      "brand_name": "SANDOZ ORPHENADRINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0102078001"
    },
    "created_date": "2021-09-08T19:13:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243559",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "M03BC",
    "atc_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
    "actual_start_date": "2021-09-08T00:00:00-04:00",
    "actual_end_date": "2021-10-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2021-10-20T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ ORPHENADRINE",
    "en_drug_common_name": "ORPHENADRINE",
    "fr_drug_brand_name": "SANDOZ ORPHENADRINE",
    "fr_drug_common_name": "ORPHENADRINE",
    "en_ingredients": "ORPHENADRINE CITRATE",
    "fr_ingredients": "Citrate d'orphénadrine",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100PRT BO",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145369,
    "drug": {
      "current_status": "MARKETED",
      "id": 17490,
      "drug_code": 78530,
      "updated_date": "2025-05-15T02:32:00-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256166,
          "ingredient": {
            "id": 272,
            "ingredient_code": 20170,
            "en_name": "ENALAPRIL SODIUM",
            "fr_name": "Énalapril sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02299968",
      "brand_name": "SANDOZ ENALAPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152325002"
    },
    "created_date": "2021-09-08T19:26:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02299968",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2021-10-01T00:00:00-04:00",
    "actual_start_date": "2021-09-08T00:00:00-04:00",
    "actual_end_date": "2021-09-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-09-28T19:50:13-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ ENALAPRIL",
    "en_drug_common_name": "ENALAPRIL",
    "fr_drug_brand_name": "SANDOZ ENALAPRIL",
    "fr_drug_common_name": "ENALAPRIL",
    "en_ingredients": "ENALAPRIL SODIUM",
    "fr_ingredients": "Énalapril sodique",
    "drug_strength": "8MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100TAB BO",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145372,
    "drug": {
      "current_status": "MARKETED",
      "id": 6324,
      "drug_code": 43212,
      "updated_date": "2025-05-15T02:31:02-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253040,
          "ingredient": {
            "id": 2152,
            "ingredient_code": 8317,
            "en_name": "ATOVAQUONE",
            "fr_name": "Atovaquone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "750",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02217422",
      "brand_name": "MEPRON",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9539",
      "number_of_ais": "1",
      "ai_group_no": "0124073001"
    },
    "created_date": "2021-09-08T20:33:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02217422",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "P01AX",
    "atc_description": "AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DIS.",
    "estimated_end_date": "2021-09-15T00:00:00-04:00",
    "actual_start_date": "2021-09-03T00:00:00-04:00",
    "actual_end_date": "2021-09-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-09-11T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "For emergency supply, contact GSK Customer Service 1-800-387-7374.",
    "fr_comments": "Pour un approvisionnement d’urgence, communiquez avec le Service à la clientèle de GSK au 1-800-387-7374.",
    "en_drug_brand_name": "MEPRON",
    "en_drug_common_name": "Atovaquone Oral Suspension",
    "fr_drug_brand_name": "MEPRON",
    "fr_drug_common_name": "Suspension orale d’atovaquone",
    "en_ingredients": "ATOVAQUONE",
    "fr_ingredients": "Atovaquone",
    "drug_strength": "750MG",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "210ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145397,
    "drug": {
      "current_status": "MARKETED",
      "id": 60428,
      "drug_code": 95239,
      "updated_date": "2025-05-15T02:35:51-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8262509,
          "ingredient": {
            "id": 3124,
            "ingredient_code": 13311,
            "en_name": "VARDENAFIL",
            "fr_name": "Vardénafil (Chlorhydrate de vardénafil)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02464225",
      "brand_name": "MYLAN-VARDENAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150003002"
    },
    "created_date": "2021-09-09T11:26:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02464225",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "G04BE",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "anticipated_start_date": "2021-09-29T00:00:00-04:00",
    "estimated_end_date": "2021-10-19T00:00:00-04:00",
    "actual_start_date": "2021-10-02T00:00:00-04:00",
    "actual_end_date": "2021-10-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-27T00:17:31-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-VARDENAFIL",
    "en_drug_common_name": "MYLAN-VARDENAFIL",
    "fr_drug_brand_name": "MYLAN-VARDENAFIL",
    "fr_drug_common_name": "VARDENAFIL",
    "en_ingredients": "VARDENAFIL",
    "fr_ingredients": "VARDENAFIL",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "4a",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145402,
    "drug": {
      "current_status": "MARKETED",
      "id": 6140,
      "drug_code": 42848,
      "updated_date": "2025-12-03T00:30:36-05:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252986,
          "ingredient": {
            "id": 142,
            "ingredient_code": 9117,
            "en_name": "MORPHINE SULFATE",
            "fr_name": "Sulfate de morphine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02184451",
      "brand_name": "KADIAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9015",
      "number_of_ais": "1",
      "ai_group_no": "0104545012"
    },
    "created_date": "2021-09-09T11:28:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02184451",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2021-09-02T00:00:00-04:00",
    "estimated_end_date": "2021-10-05T00:00:00-04:00",
    "actual_end_date": "2021-09-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-09-29T17:14:20-04:00",
    "status": "resolved",
    "en_drug_brand_name": "KADIAN",
    "en_drug_common_name": "MORPHINE SULFATE",
    "fr_drug_brand_name": "KADIAN",
    "fr_drug_common_name": "MORPHINE SULFATE",
    "en_ingredients": "MORPHINE SULFATE",
    "fr_ingredients": "Sulfate de morphine",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE (SUSTAINED-RELEASE)",
    "drug_dosage_form_fr": "Capsule (à action soutenue)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "50BT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145407,
    "drug": {
      "current_status": "MARKETED",
      "id": 12452,
      "drug_code": 71082,
      "updated_date": "2025-05-15T02:31:23-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254584,
          "ingredient": {
            "id": 2190,
            "ingredient_code": 1381,
            "en_name": "FENOFIBRATE",
            "fr_name": "Fénofibrate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02246859",
      "brand_name": "AA-FENO-SUPER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0118895002"
    },
    "created_date": "2021-09-09T13:37:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02246859",
    "company_name": "AA PHARMA INC",
    "atc_number": "C10AB",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2021-10-04T00:00:00-04:00",
    "actual_start_date": "2021-09-01T00:00:00-04:00",
    "actual_end_date": "2021-09-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-09-24T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-FENO-SUPER",
    "en_drug_common_name": "APO-FENO_SUPER",
    "fr_drug_brand_name": "APO_FENO_SUPER",
    "fr_drug_common_name": "APO_FENO_SUPER",
    "en_ingredients": "FENOFIBRATE",
    "fr_ingredients": "Fénofibrate",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145410,
    "drug": {
      "current_status": "MARKETED",
      "id": 27296,
      "drug_code": 89542,
      "updated_date": "2025-05-15T02:34:01-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259865,
          "ingredient": {
            "id": 1210,
            "ingredient_code": 2300,
            "en_name": "LORAZEPAM",
            "fr_name": "Lorazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02410753",
      "brand_name": "LORAZEPAM SUBLINGUAL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0110731001"
    },
    "created_date": "2021-09-09T13:40:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02410753",
    "company_name": "AA PHARMA INC",
    "atc_number": "N05BA",
    "atc_description": "ANXIOLYTICS",
    "anticipated_start_date": "2021-09-07T00:00:00-04:00",
    "estimated_end_date": "2021-09-28T00:00:00-04:00",
    "actual_end_date": "2021-09-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-09-30T14:16:16-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LORAZEPAM SUBLINGUAL",
    "en_drug_common_name": "Lorazepam Sublingual",
    "fr_drug_brand_name": "Lorazepam Sublingual",
    "fr_drug_common_name": "Lorazepam Sublingual",
    "en_ingredients": "LORAZEPAM",
    "fr_ingredients": "Lorazépam",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "SUBLINGUAL\r\nSUBLINGUAL",
    "drug_route_fr": "Sublinguale\r\nSublinguale",
    "drug_package_quantity": "100BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145415,
    "drug": {
      "current_status": "MARKETED",
      "id": 24384,
      "drug_code": 87024,
      "updated_date": "2025-05-15T02:33:21-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258797,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02384523",
      "brand_name": "VALSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131885003"
    },
    "created_date": "2021-09-09T18:05:35-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02384523",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "discontinuation_date": "2021-08-16T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Pack size discontinuation only. Other pack size available.",
    "fr_discontinuation_comments": "Abandon d'un format d'emballage. Un autre format est disponible.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-09-09T18:13:44-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "VALSARTAN",
    "en_drug_common_name": "Valsartan",
    "fr_drug_brand_name": "Valsartan",
    "fr_drug_common_name": "Valsartan",
    "en_ingredients": "VALSARTAN",
    "fr_ingredients": "Valsartan",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145446,
    "drug": {
      "current_status": "MARKETED",
      "id": 17726,
      "drug_code": 78809,
      "updated_date": "2025-12-03T00:31:16-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256229,
          "ingredient": {
            "id": 142,
            "ingredient_code": 9117,
            "en_name": "MORPHINE SULFATE",
            "fr_name": "Sulfate de morphine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02302772",
      "brand_name": "TEVA-MORPHINE SR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104545011"
    },
    "created_date": "2021-09-09T19:57:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02302772",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2021-10-31T00:00:00-04:00",
    "actual_start_date": "2021-09-08T00:00:00-04:00",
    "actual_end_date": "2021-12-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-12-08T21:13:11-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-MORPHINE SR",
    "en_drug_common_name": "MORPHINE SR 30MG TAB",
    "fr_drug_brand_name": "TEVA-MORPHINE SR 30MG TAB",
    "fr_drug_common_name": "MORPHINE SR 30MG TAB",
    "en_ingredients": "MORPHINE SULFATE",
    "fr_ingredients": "Sulfate de morphine",
    "drug_strength": "30MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145449,
    "drug": {
      "current_status": "MARKETED",
      "id": 21586,
      "drug_code": 83978,
      "updated_date": "2025-05-15T02:32:47-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257719,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02354616",
      "brand_name": "TEVA-ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963001"
    },
    "created_date": "2021-09-09T19:59:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02354616",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2022-04-10T00:00:00-04:00",
    "actual_start_date": "2021-09-08T00:00:00-04:00",
    "actual_end_date": "2022-03-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-03-26T05:00:04-04:00",
    "status": "resolved",
    "en_comments": "Item is transitioned/discontinued",
    "en_drug_brand_name": "TEVA-ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN 10MG TAB",
    "fr_drug_brand_name": "TEVA-ROSUVASTATIN 10MG TAB",
    "fr_drug_common_name": "ROSUVASTATIN 10MG TAB",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATIN",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145468,
    "drug": {
      "current_status": "MARKETED",
      "id": 23700,
      "drug_code": 86354,
      "updated_date": "2025-05-15T02:33:10-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8258545,
          "ingredient": {
            "id": 2640,
            "ingredient_code": 11819,
            "en_name": "RISEDRONATE SODIUM",
            "fr_name": "Risédronate sodique (Hémipentahydrate de risédronate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02377721",
      "brand_name": "APO-RISEDRONATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135301005"
    },
    "created_date": "2021-09-10T12:25:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02377721",
    "company_name": "APOTEX INC",
    "atc_number": "M05BA",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "estimated_end_date": "2022-03-04T00:00:00-05:00",
    "actual_start_date": "2021-09-08T00:00:00-04:00",
    "actual_end_date": "2022-03-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-03-04T14:42:42-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-RISEDRONATE",
    "en_drug_common_name": "RISEDRONATE",
    "fr_drug_brand_name": "APO-RISEDRONATE",
    "fr_drug_common_name": "RISEDRONATE",
    "en_ingredients": "RISEDRONATE SODIUM",
    "fr_ingredients": "Risédronate sodique",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145477,
    "drug": {
      "current_status": "MARKETED",
      "id": 31334,
      "drug_code": 9361,
      "updated_date": "2025-05-15T02:30:44-04:00",
      "company": {
        "id": 114,
        "created_date": "2017-03-09T13:22:35-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 4056,
        "mfr_code": "DLX07",
        "name": "DORMER LABORATORIES INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "5",
        "street_name": "91 KELFIELD STREET",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 5A3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251156,
          "ingredient": {
            "id": 2458,
            "ingredient_code": 6689,
            "en_name": "PODOPHYLLIN",
            "fr_name": "Podophylline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8251155,
          "ingredient": {
            "id": 838,
            "ingredient_code": 9766,
            "en_name": "SALICYLIC ACID",
            "fr_name": "Acide salicylique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8251154,
          "ingredient": {
            "id": 2456,
            "ingredient_code": 4322,
            "en_name": "CANTHARIDIN",
            "fr_name": "Cantharidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00772011",
      "brand_name": "CANTHARONE PLUS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68373",
      "number_of_ais": "3",
      "ai_group_no": "0315894001"
    },
    "created_date": "2021-09-10T13:53:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00772011",
    "company_name": "DORMER LABORATORIES INC.",
    "atc_number": "D11AF",
    "atc_description": "OTHER DERMATOLOGICAL PREPARATIONS",
    "estimated_end_date": "2021-12-01T00:00:00-05:00",
    "actual_start_date": "2021-08-16T00:00:00-04:00",
    "actual_end_date": "2021-11-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-11-09T16:06:07-05:00",
    "status": "resolved",
    "en_drug_brand_name": "CANTHARONE PLUS",
    "en_drug_common_name": "Cantharone Plus",
    "fr_drug_brand_name": "CANTHARONE PLUS",
    "fr_drug_common_name": "Cantharone Plus",
    "en_ingredients": "CANTHARIDIN\r\nPODOPHYLLIN\r\nSALICYLIC ACID",
    "fr_ingredients": "Cantharidine\r\nPodophylline\r\nAcide salicylique",
    "drug_strength": "1%\r\n2%\r\n30%",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "7.5 mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145481,
    "drug": {
      "current_status": "MARKETED",
      "id": 3414,
      "drug_code": 18647,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252347,
          "ingredient": {
            "id": 1404,
            "ingredient_code": 3289,
            "en_name": "SOYBEAN OIL",
            "fr_name": "Huile de soja"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02065673",
      "brand_name": "INTRALIPID 20%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80918",
      "number_of_ais": "1",
      "ai_group_no": "0124460003"
    },
    "created_date": "2021-09-10T15:04:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02065673",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "B05BA",
    "atc_description": "I.V. SOLUTIONS",
    "anticipated_start_date": "2021-09-07T00:00:00-04:00",
    "estimated_end_date": "2021-10-21T00:00:00-04:00",
    "actual_start_date": "2021-09-07T00:00:00-04:00",
    "actual_end_date": "2021-10-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-22T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "INTRALIPID 20%",
    "en_drug_common_name": "Intralipid 20% (Lipid injectable emulsion) 500 mL",
    "fr_drug_brand_name": "Intralipid 20 % (émulsion lipidique injectable)",
    "fr_drug_common_name": "Intralipid 20 % (émulsion lipidique injectable) 500 mL",
    "en_ingredients": "SOYBEAN OIL",
    "fr_ingredients": "Huile de soja",
    "drug_strength": "20%",
    "drug_dosage_form": "EMULSION",
    "drug_dosage_form_fr": "Émulsion",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "500 mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145497,
    "drug": {
      "current_status": "MARKETED",
      "id": 9892,
      "drug_code": 64089,
      "updated_date": "2025-05-15T02:31:07-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8253779,
          "ingredient": {
            "id": 2720,
            "ingredient_code": 11899,
            "en_name": "RIZATRIPTAN",
            "fr_name": "Rizatriptan (Benzoate de rizatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02240518",
      "brand_name": "MAXALT RPD",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137841001"
    },
    "created_date": "2021-09-10T19:19:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02240518",
    "company_name": "ORGANON CANADA INC.",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "anticipated_start_date": "2021-09-17T00:00:00-04:00",
    "estimated_end_date": "2021-09-29T00:00:00-04:00",
    "actual_start_date": "2021-09-16T00:00:00-04:00",
    "actual_end_date": "2021-09-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-09-30T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAXALT RPD",
    "en_drug_common_name": "rizatriptan benzoate wafers",
    "fr_drug_brand_name": "MAXALT RPD",
    "fr_drug_common_name": "cachets ultra-fondants de benzoate de rizatriptan",
    "en_ingredients": "RIZATRIPTAN",
    "fr_ingredients": "rizatriptan",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "12",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145500,
    "drug": {
      "current_status": "MARKETED",
      "id": 6730,
      "drug_code": 44188,
      "updated_date": "2025-12-03T00:30:37-05:00",
      "company": {
        "id": 458,
        "created_date": "2017-03-09T13:22:47-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 12573,
        "mfr_code": "",
        "name": "GE HEALTHCARE CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1919 MINNESOTA COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C9",
        "post_office_box": "",
        "contact_information": "800-387-7146   \r\n\r\ncanadainfo@gehealthcare.com"
      },
      "drug_ingredients": [
        {
          "id": 8253162,
          "ingredient": {
            "id": 2236,
            "ingredient_code": 420,
            "en_name": "GADODIAMIDE",
            "fr_name": "Gadodiamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "287",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02172771",
      "brand_name": "OMNISCAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "T9823",
      "number_of_ais": "1",
      "ai_group_no": "0126095001"
    },
    "created_date": "2021-09-10T19:30:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02172771",
    "company_name": "GE HEALTHCARE CANADA INC",
    "atc_number": "V08CA",
    "atc_description": "MAGNETIC RESONANCE IMAGING CONTRAST MEDIA",
    "estimated_end_date": "2021-10-19T00:00:00-04:00",
    "actual_start_date": "2021-09-10T00:00:00-04:00",
    "actual_end_date": "2021-10-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2021-10-19T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Package insert delay",
    "fr_comments": "Feuillet d’information en retard",
    "en_drug_brand_name": "OMNISCAN",
    "en_drug_common_name": "Gadodiamide injection USP",
    "fr_drug_brand_name": "OMNISCAN",
    "fr_drug_common_name": "gadodiamide pour injection USP",
    "en_ingredients": "GADODIAMIDE",
    "fr_ingredients": "Gadodiamide",
    "drug_strength": "287MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "20 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145506,
    "drug": {
      "current_status": "MARKETED",
      "id": 53893,
      "drug_code": 95575,
      "updated_date": "2025-05-15T02:36:02-04:00",
      "company": {
        "id": 1864,
        "created_date": "2017-03-09T13:26:05-05:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 13936,
        "mfr_code": "",
        "name": "MANTRA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1000 RUE DU LUX SUITE 201",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BROSSARD",
        "postal_code": "J4Y 0E3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262680,
          "ingredient": {
            "id": 2294,
            "ingredient_code": 11086,
            "en_name": "PANTOPRAZOLE",
            "fr_name": "Pantoprazole (Pantoprazole sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02467372",
      "brand_name": "M-PANTOPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133229001"
    },
    "created_date": "2021-09-10T21:00:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02467372",
    "company_name": "MANTRA PHARMA INC",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2021-09-20T00:00:00-04:00",
    "actual_start_date": "2021-08-30T00:00:00-04:00",
    "actual_end_date": "2021-09-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-09-17T20:15:40-04:00",
    "status": "resolved",
    "en_drug_brand_name": "M-PANTOPRAZOLE",
    "en_drug_common_name": "Pantoprazole",
    "fr_drug_brand_name": "M-Pantoprazole",
    "fr_drug_common_name": "Pantoprazole",
    "en_ingredients": "PANTOPRAZOLE",
    "fr_ingredients": "pantoprazole",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145528,
    "drug": {
      "current_status": "MARKETED",
      "id": 24926,
      "drug_code": 87443,
      "updated_date": "2025-05-15T02:33:36-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259017,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02388898",
      "brand_name": "LOSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127971002"
    },
    "created_date": "2021-09-13T13:29:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02388898",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "actual_start_date": "2021-09-13T00:00:00-04:00",
    "actual_end_date": "2024-03-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-02T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "LOSARTAN",
    "en_drug_common_name": "LOSARTAN",
    "fr_drug_brand_name": "LOSARTAN",
    "fr_drug_common_name": "LOSARTAN",
    "en_ingredients": "LOSARTAN POTASSIUM",
    "fr_ingredients": "Losartan potassique",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145531,
    "drug": {
      "current_status": "MARKETED",
      "id": 24922,
      "drug_code": 87441,
      "updated_date": "2025-05-15T02:33:36-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259015,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02388863",
      "brand_name": "LOSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127971001"
    },
    "created_date": "2021-09-13T13:30:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02388863",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2024-12-06T00:00:00-05:00",
    "actual_start_date": "2021-09-13T00:00:00-04:00",
    "actual_end_date": "2024-12-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-12-03T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "LOSARTAN",
    "en_drug_common_name": "LOSARTAN",
    "fr_drug_brand_name": "LOSARTAN",
    "fr_drug_common_name": "LOSARTAN",
    "en_ingredients": "LOSARTAN POTASSIUM",
    "fr_ingredients": "Losartan potassique",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145534,
    "drug": {
      "current_status": "MARKETED",
      "id": 24924,
      "drug_code": 87442,
      "updated_date": "2025-05-15T02:33:36-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259016,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02388871",
      "brand_name": "LOSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127971003"
    },
    "created_date": "2021-09-13T13:31:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02388871",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2024-09-24T00:00:00-04:00",
    "actual_start_date": "2021-09-13T00:00:00-04:00",
    "actual_end_date": "2024-09-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-09-17T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LOSARTAN",
    "en_drug_common_name": "LOSARTAN",
    "fr_drug_brand_name": "LOSARTAN",
    "fr_drug_common_name": "LOSARTAN",
    "en_ingredients": "LOSARTAN POTASSIUM",
    "fr_ingredients": "Losartan potassique",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145537,
    "drug": {
      "current_status": "MARKETED",
      "id": 29184,
      "drug_code": 91216,
      "updated_date": "2025-05-15T02:34:23-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260584,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8260583,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02427656",
      "brand_name": "LOSARTAN/HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0233168003"
    },
    "created_date": "2021-09-13T13:31:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02427656",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "actual_start_date": "2021-09-13T00:00:00-04:00",
    "actual_end_date": "2024-03-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-02T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "LOSARTAN/HCTZ",
    "en_drug_common_name": "LOSARTAN/HCTZ",
    "fr_drug_brand_name": "LOSARTAN/HCTZ",
    "fr_drug_common_name": "LOSARTAN/HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nLOSARTAN POTASSIUM",
    "fr_ingredients": "Hydrochlorothiazide\r\nLosartan potassique",
    "drug_strength": "12.5MG\r\n100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145541,
    "drug": {
      "current_status": "MARKETED",
      "id": 29186,
      "drug_code": 91217,
      "updated_date": "2025-05-15T02:34:23-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260586,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8260585,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02427664",
      "brand_name": "LOSARTAN/HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0233168002"
    },
    "created_date": "2021-09-13T13:32:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02427664",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "actual_start_date": "2021-09-13T00:00:00-04:00",
    "actual_end_date": "2024-05-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-05-29T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LOSARTAN/HCTZ",
    "en_drug_common_name": "LOSARTAN/HCTZ",
    "fr_drug_brand_name": "LOSARTAN/HCTZ",
    "fr_drug_common_name": "LOSARTAN/HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nLOSARTAN POTASSIUM",
    "fr_ingredients": "Hydrochlorothiazide\r\nLosartan potassique",
    "drug_strength": "25MG\r\n100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145547,
    "drug": {
      "current_status": "MARKETED",
      "id": 29182,
      "drug_code": 91215,
      "updated_date": "2025-05-15T02:34:23-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260582,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8260581,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02427648",
      "brand_name": "LOSARTAN/HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0233168001"
    },
    "created_date": "2021-09-13T13:33:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02427648",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "actual_start_date": "2021-09-13T00:00:00-04:00",
    "actual_end_date": "2024-05-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-05-29T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LOSARTAN/HCTZ",
    "en_drug_common_name": "LOSARTAN/HCTZ",
    "fr_drug_brand_name": "LOSARTAN/HCTZ",
    "fr_drug_common_name": "LOSARTAN/HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nLOSARTAN POTASSIUM",
    "fr_ingredients": "Hydrochlorothiazide\r\nLosartan potassique",
    "drug_strength": "12.5MG\r\n50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145564,
    "drug": {
      "current_status": "MARKETED",
      "id": 2530,
      "drug_code": 16102,
      "updated_date": "2025-05-15T02:30:55-04:00",
      "company": {
        "id": 32,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7054,
        "mfr_code": "PFR08",
        "name": "PURDUE PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252087,
          "ingredient": {
            "id": 142,
            "ingredient_code": 9117,
            "en_name": "MORPHINE SULFATE",
            "fr_name": "Sulfate de morphine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02014203",
      "brand_name": "MS.IR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "77888",
      "number_of_ais": "1",
      "ai_group_no": "0104545003"
    },
    "created_date": "2021-09-13T15:51:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02014203",
    "company_name": "PURDUE PHARMA",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2021-09-13T00:00:00-04:00",
    "estimated_end_date": "2021-10-15T00:00:00-04:00",
    "actual_start_date": "2021-09-13T00:00:00-04:00",
    "actual_end_date": "2021-10-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-10-08T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MS.IR",
    "en_drug_common_name": "Morphine Sulfate Immediate Release Tablets",
    "fr_drug_brand_name": "MS•IR",
    "fr_drug_common_name": "Comprimés de sulfate de morphine à libération immédiate",
    "en_ingredients": "MORPHINE SULFATE",
    "fr_ingredients": "Sulfate de morphine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET (IMMEDIATE RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération immédiate)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145567,
    "drug": {
      "current_status": "DORMANT",
      "id": 24132,
      "drug_code": 86758,
      "updated_date": "2025-05-15T06:55:45-04:00",
      "company": {
        "id": 3128,
        "created_date": "2017-08-17T01:15:06-04:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 16816,
        "mfr_code": "",
        "name": "KNIGHT THERAPEUTICS INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "100 ALEXIS-NIHON BLVD., SUITE 600",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4M 2P2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368763,
          "ingredient": {
            "id": 3786,
            "ingredient_code": 21240,
            "en_name": "PALONOSETRON",
            "fr_name": "Palonosétron (Chlorhydrate de Palonosétron)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02381729",
      "brand_name": "ALOXI",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0153130002"
    },
    "created_date": "2021-09-13T15:56:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02381729",
    "company_name": "ELVIUM LIFE SCIENCES",
    "atc_number": "A04AA",
    "atc_description": "ANTIEMETICS AND ANTINAUSEANTS",
    "anticipated_start_date": "2021-09-13T00:00:00-04:00",
    "estimated_end_date": "2021-09-30T00:00:00-04:00",
    "actual_start_date": "2021-09-13T00:00:00-04:00",
    "actual_end_date": "2021-09-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2021-09-25T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ALOXI",
    "en_drug_common_name": "palonosetron hydrochloride",
    "fr_drug_brand_name": "ALOXI",
    "fr_drug_common_name": "chlorhydrate de palonosétron",
    "en_ingredients": "PALONOSETRON",
    "fr_ingredients": "chlorhydrate de palonosétron",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145576,
    "drug": {
      "current_status": "MARKETED",
      "id": 29350,
      "drug_code": 91352,
      "updated_date": "2025-05-15T02:34:25-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8260643,
          "ingredient": {
            "id": 2974,
            "ingredient_code": 12108,
            "en_name": "BIMATOPROST",
            "fr_name": "Bimatoprost"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.03",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02429063",
      "brand_name": "VISTITAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0147303001"
    },
    "created_date": "2021-09-13T18:45:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02429063",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "S01EE",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "estimated_end_date": "2021-10-01T00:00:00-04:00",
    "actual_start_date": "2021-09-13T00:00:00-04:00",
    "actual_end_date": "2021-10-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-05T02:48:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "VISTITAN",
    "en_drug_common_name": "VISTITAN",
    "fr_drug_brand_name": "VISTITAN",
    "fr_drug_common_name": "VISTITAN",
    "en_ingredients": "BIMATOPROST",
    "fr_ingredients": "Bimatoprost",
    "drug_strength": "0.03%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "5ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145579,
    "drug": {
      "current_status": "MARKETED",
      "id": 18324,
      "drug_code": 79599,
      "updated_date": "2025-05-15T02:32:10-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256423,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02310341",
      "brand_name": "SANDOZ OLANZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783001"
    },
    "created_date": "2021-09-13T18:47:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02310341",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2021-10-01T00:00:00-04:00",
    "actual_start_date": "2021-09-13T00:00:00-04:00",
    "actual_end_date": "2021-09-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-09-28T19:50:58-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ OLANZAPINE",
    "en_drug_common_name": "OLANZAPINE",
    "fr_drug_brand_name": "SANDOZ OLANZAPINE",
    "fr_drug_common_name": "OLANZAPINE",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100FCT BO",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145637,
    "drug": {
      "current_status": "MARKETED",
      "id": 11174,
      "drug_code": 67481,
      "updated_date": "2025-05-15T02:31:14-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8254200,
          "ingredient": {
            "id": 154,
            "ingredient_code": 3776,
            "en_name": "METOCLOPRAMIDE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de métoclopramide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02243563",
      "brand_name": "METOCLOPRAMIDE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0109394003"
    },
    "created_date": "2021-09-14T20:24:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243563",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "A03FA",
    "atc_description": "PROPULSIVES",
    "estimated_end_date": "2021-10-05T00:00:00-04:00",
    "actual_start_date": "2021-09-14T00:00:00-04:00",
    "actual_end_date": "2021-10-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-12T12:35:20-04:00",
    "status": "resolved",
    "en_drug_brand_name": "METOCLOPRAMIDE OMEGA",
    "en_drug_common_name": "Metoclopramide Hydrochloride Injection USP",
    "fr_drug_brand_name": "Injection de chlorhydrate de métoclopramide USP",
    "fr_drug_common_name": "Injection de chlorhydrate de métoclopramide USP",
    "en_ingredients": "METOCLOPRAMIDE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de métoclopramide",
    "drug_strength": "5MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "10 x 2 mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145663,
    "drug": {
      "current_status": "MARKETED",
      "id": 12454,
      "drug_code": 71083,
      "updated_date": "2025-05-15T02:31:23-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254585,
          "ingredient": {
            "id": 2190,
            "ingredient_code": 1381,
            "en_name": "FENOFIBRATE",
            "fr_name": "Fénofibrate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "160",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02246860",
      "brand_name": "AA-FENO-SUPER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0118895004"
    },
    "created_date": "2021-09-15T13:19:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02246860",
    "company_name": "AA PHARMA INC",
    "atc_number": "C10AB",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2021-09-29T00:00:00-04:00",
    "actual_start_date": "2021-09-15T00:00:00-04:00",
    "actual_end_date": "2021-09-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-09-24T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-FENO-SUPER",
    "en_drug_common_name": "APO-FENO-SUPER",
    "fr_drug_brand_name": "APO-FENO-SUPER",
    "fr_drug_common_name": "APO-FENO-SUPER",
    "en_ingredients": "FENOFIBRATE",
    "fr_ingredients": "Fénofibrate",
    "drug_strength": "160MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145708,
    "drug": {
      "current_status": "DORMANT",
      "id": 30856,
      "drug_code": 92989,
      "updated_date": "2025-05-15T06:55:55-04:00",
      "company": {
        "id": 16877,
        "created_date": "2020-06-16T21:30:06-04:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 17770,
        "mfr_code": "",
        "name": "JUNO PHARMACEUTICALS CORP.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "402",
        "street_name": "2233 ARGENTIA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 2X7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369319,
          "ingredient": {
            "id": 3086,
            "ingredient_code": 12024,
            "en_name": "ZOLEDRONIC ACID",
            "fr_name": "Acide zolédronique (Acide zolédronique monohydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02444739",
      "brand_name": "ZOLEDRONIC ACID FOR INJECTION",
      "brand_name_fr": "ACIDE ZOLÉDRONIQUE POUR INJECTION",
      "descriptor": "SINGLE-USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0141761002"
    },
    "created_date": "2021-09-15T17:57:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02444739",
    "company_name": "JUNO PHARMACEUTICALS CORP.",
    "atc_number": "M05BA",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "estimated_end_date": "2022-12-23T00:00:00-05:00",
    "actual_start_date": "2021-09-15T00:00:00-04:00",
    "actual_end_date": "2022-12-23T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-12-24T06:00:04-05:00",
    "status": "resolved",
    "en_comments": "Discontinuation report initiated",
    "en_drug_brand_name": "ZOLEDRONIC ACID FOR INJECTION",
    "en_drug_common_name": "Zoledronic Acid",
    "fr_drug_brand_name": "Acide Zolédronique pour Injection",
    "fr_drug_common_name": "Acide Zolédronique",
    "en_ingredients": "ZOLEDRONIC ACID",
    "fr_ingredients": "Acide Zolédronique",
    "drug_strength": "4MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "5mL Vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145714,
    "drug": {
      "current_status": "MARKETED",
      "id": 26500,
      "drug_code": 88814,
      "updated_date": "2025-05-15T02:33:51-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8259558,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25.0",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02403323",
      "brand_name": "AURO-LOSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127971001"
    },
    "created_date": "2021-09-15T19:11:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02403323",
    "company_name": "AURO PHARMA INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "anticipated_start_date": "2021-09-15T00:00:00-04:00",
    "actual_end_date": "2023-12-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-12-07T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-LOSARTAN",
    "en_drug_common_name": "LOSARTAN POTASSIUM",
    "fr_drug_brand_name": "AURO-LOSARTAN",
    "fr_drug_common_name": "LOSARTAN POTASSIUM",
    "en_ingredients": "LOSARTAN POTASSIUM",
    "fr_ingredients": "Losartan potassique",
    "drug_strength": "25.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145717,
    "drug": {
      "current_status": "MARKETED",
      "id": 26222,
      "drug_code": 88577,
      "updated_date": "2025-05-15T02:33:47-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259447,
          "ingredient": {
            "id": 1568,
            "ingredient_code": 11180,
            "en_name": "CEFAZOLIN",
            "fr_name": "Céfazoline (Céfazoline sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "BAG",
          "base": false
        }
      ],
      "din": "02401029",
      "brand_name": "CEFAZOLIN FOR INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "SMARTPAK BULK PACKAGE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0109442007"
    },
    "created_date": "2021-09-15T19:49:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02401029",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "J01DB",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "anticipated_start_date": "2021-09-24T00:00:00-04:00",
    "estimated_end_date": "2021-10-14T00:00:00-04:00",
    "actual_end_date": "2021-10-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-10-15T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CEFAZOLIN FOR INJECTION, USP",
    "en_drug_common_name": "Cefazolin for Injection, USP 100 g SmartPak®",
    "fr_drug_brand_name": "Céfazoline pour injection, USP",
    "fr_drug_common_name": "Céfazoline pour injection, USP SmartPakᴹᴰ, 100 g",
    "en_ingredients": "CEFAZOLIN",
    "fr_ingredients": "Céfazoline pour injection",
    "drug_strength": "100G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "100 g",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145732,
    "drug": {
      "current_status": "MARKETED",
      "id": 26504,
      "drug_code": 88816,
      "updated_date": "2025-05-15T02:33:51-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8259560,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100.0",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02403358",
      "brand_name": "AURO-LOSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127971002"
    },
    "created_date": "2021-09-15T20:50:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02403358",
    "company_name": "AURO PHARMA INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "anticipated_start_date": "2021-09-15T00:00:00-04:00",
    "actual_end_date": "2023-11-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-11-11T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-LOSARTAN",
    "en_drug_common_name": "LOSARTAN POTASSIUM",
    "fr_drug_brand_name": "Auro-Losartan",
    "fr_drug_common_name": "Losartan potassique",
    "en_ingredients": "LOSARTAN POTASSIUM",
    "fr_ingredients": "Losartan potassique",
    "drug_strength": "100.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145750,
    "drug": {
      "current_status": "MARKETED",
      "id": 23956,
      "drug_code": 86602,
      "updated_date": "2025-05-15T02:33:13-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258622,
          "ingredient": {
            "id": 1118,
            "ingredient_code": 10147,
            "en_name": "METFORMIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de metformine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02380196",
      "brand_name": "JAMP METFORMIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101773001"
    },
    "created_date": "2021-09-16T15:30:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02380196",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "A10BA",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2023-06-30T00:00:00-04:00",
    "actual_start_date": "2021-09-15T00:00:00-04:00",
    "actual_end_date": "2023-01-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-01-10T23:17:14-05:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-METFORMIN",
    "en_drug_common_name": "Metformin Hydrochloride Tablets",
    "fr_drug_brand_name": "JAMP Metformin",
    "fr_drug_common_name": "Comprimés de chlorhydrate de metformine",
    "en_ingredients": "METFORMIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de metformine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145777,
    "drug": {
      "current_status": "MARKETED",
      "id": 28730,
      "drug_code": 90861,
      "updated_date": "2025-05-15T02:34:19-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260425,
          "ingredient": {
            "id": 2926,
            "ingredient_code": 12371,
            "en_name": "ESOMEPRAZOLE",
            "fr_name": "Ésoméprazole (Ésoméprazole magnésien dihydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02423863",
      "brand_name": "TEVA-ESOMEPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0145162002"
    },
    "created_date": "2021-09-16T17:55:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02423863",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2021-10-31T00:00:00-04:00",
    "actual_start_date": "2021-09-15T00:00:00-04:00",
    "actual_end_date": "2021-10-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-10-07T15:01:51-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-ESOMEPRAZOLE",
    "en_drug_common_name": "ESOMEPRAZOLE 40MG OG TAB",
    "fr_drug_brand_name": "TEVA-ESOMEPRAZOLE 40MG OG TAB",
    "fr_drug_common_name": "ESOMEPRAZOLE 40MG OG TAB",
    "en_ingredients": "ESOMEPRAZOLE",
    "fr_ingredients": "ESOMEPRAZOLE",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30UD",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145780,
    "drug": {
      "current_status": "MARKETED",
      "id": 3906,
      "drug_code": 19524,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252505,
          "ingredient": {
            "id": 1086,
            "ingredient_code": 14088,
            "en_name": "MESALAZINE",
            "fr_name": "Mésalazine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02171929",
      "brand_name": "TEVA-5 ASA",
      "brand_name_fr": "",
      "descriptor": "ALSO KNOWN AS MESALAMINE",
      "pediatric_flag": false,
      "accession_number": "81821",
      "number_of_ais": "1",
      "ai_group_no": "0116808001"
    },
    "created_date": "2021-09-16T17:57:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02171929",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "A07EC",
    "atc_description": "INTESTINALANTIINFLAMMATORY AGENTS",
    "estimated_end_date": "2022-04-20T00:00:00-04:00",
    "actual_start_date": "2021-09-15T00:00:00-04:00",
    "actual_end_date": "2022-04-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-21T12:49:12-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-5 ASA",
    "en_drug_common_name": "TEVA-5 ASA 400MG TAB",
    "fr_drug_brand_name": "TEVA-5 ASA 400MG TAB",
    "fr_drug_common_name": "ASA 400MG TAB",
    "en_ingredients": "MESALAZINE",
    "fr_ingredients": "Mésalazine",
    "drug_strength": "400MG",
    "drug_dosage_form": "TABLET (ENTERIC-COATED)",
    "drug_dosage_form_fr": "Comprimé (entérosoluble)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 & 100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145783,
    "drug": {
      "current_status": "MARKETED",
      "id": 15866,
      "drug_code": 76617,
      "updated_date": "2025-05-15T02:31:45-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255681,
          "ingredient": {
            "id": 1412,
            "ingredient_code": 180,
            "en_name": "LANSOPRAZOLE",
            "fr_name": "Lansoprazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02280515",
      "brand_name": "TEVA-LANSOPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127666002"
    },
    "created_date": "2021-09-16T17:59:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02280515",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "actual_start_date": "2021-09-15T00:00:00-04:00",
    "actual_end_date": "2025-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-04-29T13:36:44-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-LANSOPRAZOLE",
    "en_drug_common_name": "LANSOPRAZOLE 15MG DR CAPS",
    "fr_drug_brand_name": "TEVA-LANSOPRAZOLE 15MG DR CAPS",
    "fr_drug_common_name": "LANSOPRAZOLE 15MG DR CAPS",
    "en_ingredients": "LANSOPRAZOLE",
    "fr_ingredients": "Lansoprazole",
    "drug_strength": "15MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145786,
    "drug": {
      "current_status": "MARKETED",
      "id": 7972,
      "drug_code": 5182,
      "updated_date": "2025-05-15T02:30:32-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250711,
          "ingredient": {
            "id": 496,
            "ingredient_code": 8376,
            "en_name": "CEPHALEXIN",
            "fr_name": "Céphalexine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00583421",
      "brand_name": "TEVA-CEPHALEXIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "59857",
      "number_of_ais": "1",
      "ai_group_no": "0105911003"
    },
    "created_date": "2021-09-16T18:01:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00583421",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01DB",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "estimated_end_date": "2022-04-10T00:00:00-04:00",
    "actual_start_date": "2021-09-15T00:00:00-04:00",
    "actual_end_date": "2022-04-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-21T12:49:53-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-CEPHALEXIN",
    "en_drug_common_name": "CEPHALEXIN 500MG TAB",
    "fr_drug_brand_name": "TEVA-CEPHALEXIN 500MG TAB",
    "fr_drug_common_name": "CEPHALEXIN 500MG TAB",
    "en_ingredients": "CEPHALEXIN",
    "fr_ingredients": "Céphalexine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145791,
    "drug": {
      "current_status": "MARKETED",
      "id": 17726,
      "drug_code": 78809,
      "updated_date": "2025-12-03T00:31:16-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256229,
          "ingredient": {
            "id": 142,
            "ingredient_code": 9117,
            "en_name": "MORPHINE SULFATE",
            "fr_name": "Sulfate de morphine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02302772",
      "brand_name": "TEVA-MORPHINE SR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104545011"
    },
    "created_date": "2021-09-16T18:03:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02302772",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2021-11-30T00:00:00-05:00",
    "actual_start_date": "2021-09-15T00:00:00-04:00",
    "actual_end_date": "2021-11-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-11-11T19:25:07-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-MORPHINE SR",
    "en_drug_common_name": "MORPHINE SR 30MG TAB",
    "fr_drug_brand_name": "TEVA-MORPHINE SR 30MG TAB",
    "fr_drug_common_name": "MORPHINE SR 30MG TAB",
    "en_ingredients": "MORPHINE SULFATE",
    "fr_ingredients": "Sulfate de morphine",
    "drug_strength": "30MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145805,
    "drug": {
      "current_status": "MARKETED",
      "id": 54636,
      "drug_code": 95931,
      "updated_date": "2025-05-15T02:36:11-04:00",
      "company": {
        "id": 16952,
        "created_date": "2020-09-03T01:00:04-04:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 17643,
        "mfr_code": "",
        "name": "ELVIUM LIFE SCIENCES",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262891,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "70",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02470330",
      "brand_name": "FOQUEST",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548017"
    },
    "created_date": "2021-09-17T13:16:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02470330",
    "company_name": "ELVIUM LIFE SCIENCES",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2021-09-17T00:00:00-04:00",
    "estimated_end_date": "2021-09-30T00:00:00-04:00",
    "actual_start_date": "2021-09-17T00:00:00-04:00",
    "actual_end_date": "2021-09-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-09-28T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "FOQUEST",
    "en_drug_common_name": "methylphenidate hydrochloride Controlled Release Capsules",
    "fr_drug_brand_name": "FOQUEST",
    "fr_drug_common_name": "chlorhydrate de méthylphénidate  Capsules à libération contrôlée",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "70MG",
    "drug_dosage_form": "CAPSULE (CONTROLLED RELEASE)",
    "drug_dosage_form_fr": "Capsule à libération contrôlée",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145808,
    "drug": {
      "current_status": "MARKETED",
      "id": 26198,
      "drug_code": 88535,
      "updated_date": "2025-05-15T02:33:47-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259437,
          "ingredient": {
            "id": 2616,
            "ingredient_code": 11795,
            "en_name": "CLOPIDOGREL",
            "fr_name": "Clopidogrel (Bisulfate de clopidogrel)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02400553",
      "brand_name": "CLOPIDOGREL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134440001"
    },
    "created_date": "2021-09-17T13:26:50-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02400553",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "B01AC",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "estimated_end_date": "2021-12-12T00:00:00-05:00",
    "actual_start_date": "2021-09-17T00:00:00-04:00",
    "actual_end_date": "2021-12-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-12-13T02:39:52-05:00",
    "status": "resolved",
    "en_drug_brand_name": "CLOPIDOGREL",
    "en_drug_common_name": "CLOPIDOGREL",
    "fr_drug_brand_name": "CLOPIDOGREL",
    "fr_drug_common_name": "CLOPIDOGREL",
    "en_ingredients": "CLOPIDOGREL",
    "fr_ingredients": "CLOPIDOGREL",
    "drug_strength": "75MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145816,
    "drug": {
      "current_status": "MARKETED",
      "id": 9276,
      "drug_code": 62344,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8253623,
          "ingredient": {
            "id": 1890,
            "ingredient_code": 5922,
            "en_name": "BENZTROPINE MESYLATE",
            "fr_name": "Mésylate de benztropine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02238903",
      "brand_name": "BENZTROPINE OMEGA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107632001"
    },
    "created_date": "2021-09-17T15:15:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238903",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "N04AC",
    "atc_description": "ANTICHOLINERGIC AGENTS",
    "estimated_end_date": "2021-10-06T00:00:00-04:00",
    "actual_start_date": "2021-09-03T00:00:00-04:00",
    "actual_end_date": "2021-10-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-10-06T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BENZTROPINE OMEGA",
    "en_drug_common_name": "Benztropine Mesylate Injection USP",
    "fr_drug_brand_name": "Injection de mésylate de benztropine USP",
    "fr_drug_common_name": "Injection de mésylate de benztropine USP",
    "en_ingredients": "BENZTROPINE MESYLATE",
    "fr_ingredients": "Mésylate de benztropine",
    "drug_strength": "1MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "10 x 2mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145818,
    "drug": {
      "current_status": "MARKETED",
      "id": 6230,
      "drug_code": 43019,
      "updated_date": "2025-05-15T02:31:02-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253025,
          "ingredient": {
            "id": 422,
            "ingredient_code": 1950,
            "en_name": "ACYCLOVIR",
            "fr_name": "Acyclovir (Acyclovir sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02207648",
      "brand_name": "APO-ACYCLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9275",
      "number_of_ais": "1",
      "ai_group_no": "0115506004"
    },
    "created_date": "2021-09-17T15:16:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02207648",
    "company_name": "APOTEX INC",
    "atc_number": "J05AB",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2021-09-28T00:00:00-04:00",
    "actual_start_date": "2021-09-14T00:00:00-04:00",
    "actual_end_date": "2021-09-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-09-27T17:00:59-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ACYCLOVIR - TAB 400MG",
    "en_drug_common_name": "ACYCLOVIR",
    "fr_drug_brand_name": "APO-ACYCLOVIR",
    "fr_drug_common_name": "ACYCLOVIR",
    "en_ingredients": "ACYCLOVIR",
    "fr_ingredients": "Acyclovir",
    "drug_strength": "400MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145822,
    "drug": {
      "current_status": "MARKETED",
      "id": 56780,
      "drug_code": 95587,
      "updated_date": "2025-05-15T02:36:02-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8262688,
          "ingredient": {
            "id": 3486,
            "ingredient_code": 11359,
            "en_name": "CEFEPIME",
            "fr_name": "Céfépime (Chlorhydrate de céfépime)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02467518",
      "brand_name": "APO-CEFEPIME",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150504005"
    },
    "created_date": "2021-09-17T15:19:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02467518",
    "company_name": "APOTEX INC",
    "atc_number": "J01DE",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "estimated_end_date": "2021-10-31T00:00:00-04:00",
    "actual_start_date": "2021-09-14T00:00:00-04:00",
    "actual_end_date": "2021-10-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-25T12:04:13-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-CEFEPIME",
    "en_drug_common_name": "CEFEPIME",
    "fr_drug_brand_name": "APO-CEFEPIME",
    "fr_drug_common_name": "CEFEPIME",
    "en_ingredients": "CEFEPIME",
    "fr_ingredients": "CEFEPIME",
    "drug_strength": "2G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "20 ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145824,
    "drug": {
      "current_status": "MARKETED",
      "id": 3188,
      "drug_code": 18136,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8252257,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "9",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02150204",
      "brand_name": "0.9% SODIUM CHLORIDE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80354",
      "number_of_ais": "1",
      "ai_group_no": "0100053002"
    },
    "created_date": "2021-09-17T15:20:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02150204",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "estimated_end_date": "2022-05-05T00:00:00-04:00",
    "actual_start_date": "2022-02-01T00:00:00-05:00",
    "actual_end_date": "2022-05-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-01-20T14:50:15-05:00",
    "status": "resolved",
    "en_comments": "Product available. No longer on allocation.",
    "fr_comments": "Produit disponible",
    "en_drug_brand_name": "0.9% SODIUM CHLORIDE INJECTION USP",
    "en_drug_common_name": "Sodium Chloride for Injection USP",
    "fr_drug_brand_name": "Chlorure de sodium pour injection USP",
    "fr_drug_common_name": "Chlorure de sodium pour injection USP",
    "en_ingredients": "SODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium",
    "drug_strength": "9MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nIntramusculaire\r\nSous-cutanée\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "10 x 10mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145828,
    "drug": {
      "current_status": "MARKETED",
      "id": 11540,
      "drug_code": 68362,
      "updated_date": "2025-05-15T02:31:16-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254303,
          "ingredient": {
            "id": 2134,
            "ingredient_code": 11118,
            "en_name": "CEFUROXIME",
            "fr_name": "Céfuroxime (Céfuroxime sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02244393",
      "brand_name": "APO-CEFUROXIME",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122448001"
    },
    "created_date": "2021-09-17T15:23:31-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02244393",
    "company_name": "APOTEX INC",
    "atc_number": "J01DC",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "estimated_end_date": "2021-10-20T00:00:00-04:00",
    "actual_start_date": "2021-09-14T00:00:00-04:00",
    "actual_end_date": "2021-10-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-12T12:59:36-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-CEFUROXIME",
    "en_drug_common_name": "CEFUROXIME",
    "fr_drug_brand_name": "APO-CEFUROXIME",
    "fr_drug_common_name": "CEFUROXIME",
    "en_ingredients": "CEFUROXIME",
    "fr_ingredients": "CEFUROXIME",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145831,
    "drug": {
      "current_status": "MARKETED",
      "id": 53517,
      "drug_code": 95540,
      "updated_date": "2025-05-15T02:35:58-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8262665,
          "ingredient": {
            "id": 3520,
            "ingredient_code": 20430,
            "en_name": "DESVENLAFAXINE",
            "fr_name": "Desvenlafaxine (Succinate de desvenlafaxine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02466996",
      "brand_name": "APO-DESVENLAFAXINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152509002"
    },
    "created_date": "2021-09-17T15:27:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02466996",
    "company_name": "APOTEX INC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2021-10-15T00:00:00-04:00",
    "actual_start_date": "2021-09-14T00:00:00-04:00",
    "actual_end_date": "2021-10-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-12T13:13:17-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DESVENLAFAXINE",
    "en_drug_common_name": "DESVENLAFAXINE",
    "fr_drug_brand_name": "APO-DESVENLAFAXINE",
    "fr_drug_common_name": "DESVENLAFAXINE",
    "en_ingredients": "DESVENLAFAXINE",
    "fr_ingredients": "DESVENLAFAXINE",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145834,
    "drug": {
      "current_status": "MARKETED",
      "id": 22332,
      "drug_code": 84729,
      "updated_date": "2025-12-03T00:31:43-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257988,
          "ingredient": {
            "id": 2434,
            "ingredient_code": 11485,
            "en_name": "DONEPEZIL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de donépézil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02362279",
      "brand_name": "APO-DONEPEZIL",
      "brand_name_fr": "",
      "descriptor": "FILM-COATED",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131548002"
    },
    "created_date": "2021-09-17T15:29:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02362279",
    "company_name": "APOTEX INC",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "estimated_end_date": "2021-09-20T00:00:00-04:00",
    "actual_start_date": "2021-09-14T00:00:00-04:00",
    "actual_end_date": "2021-09-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-09-27T17:05:54-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DONEPEZIL",
    "en_drug_common_name": "DONEPEZIL",
    "fr_drug_brand_name": "APO-DONEPEZIL",
    "fr_drug_common_name": "DONEPEZIL",
    "en_ingredients": "DONEPEZIL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de donépézil",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145837,
    "drug": {
      "current_status": "MARKETED",
      "id": 11516,
      "drug_code": 68274,
      "updated_date": "2025-05-15T02:31:16-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254284,
          "ingredient": {
            "id": 1190,
            "ingredient_code": 470,
            "en_name": "GABAPENTIN",
            "fr_name": "Gabapentine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02244306",
      "brand_name": "APO-GABAPENTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125929002"
    },
    "created_date": "2021-09-17T15:32:28-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02244306",
    "company_name": "APOTEX INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2021-11-26T00:00:00-05:00",
    "actual_start_date": "2021-09-14T00:00:00-04:00",
    "actual_end_date": "2021-11-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-11-22T14:20:56-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-GABAPENTIN",
    "en_drug_common_name": "GABAPENTIN",
    "fr_drug_brand_name": "APO-GABAPENTIN",
    "fr_drug_common_name": "GABAPENTIN",
    "en_ingredients": "GABAPENTIN",
    "fr_ingredients": "Gabapentine",
    "drug_strength": "400MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 BTL and 100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145840,
    "drug": {
      "current_status": "MARKETED",
      "id": 282,
      "drug_code": 10770,
      "updated_date": "2025-05-15T02:30:50-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8251383,
          "ingredient": {
            "id": 14,
            "ingredient_code": 51,
            "en_name": "CALCIUM CHLORIDE",
            "fr_name": "Chlorure de calcium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00821780",
      "brand_name": "CALCIJECT INJ 100MG/ML",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "70811",
      "number_of_ais": "1",
      "ai_group_no": "0108565001"
    },
    "created_date": "2021-09-17T15:34:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00821780",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "estimated_end_date": "2021-10-08T00:00:00-04:00",
    "actual_start_date": "2021-09-17T00:00:00-04:00",
    "actual_end_date": "2021-10-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-13T13:24:53-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CALCIJECT INJ 100MG/ML",
    "en_drug_common_name": "Calcium Chloride for Injection USP",
    "fr_drug_brand_name": "Chlorure de calcium pour injection USP",
    "fr_drug_common_name": "Chlorure de calcium pour injection USP",
    "en_ingredients": "CALCIUM CHLORIDE",
    "fr_ingredients": "Chlorure de calcium",
    "drug_strength": "100MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 x 50mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145843,
    "drug": {
      "current_status": "MARKETED",
      "id": 25424,
      "drug_code": 87868,
      "updated_date": "2025-05-15T02:33:40-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8259211,
          "ingredient": {
            "id": 2720,
            "ingredient_code": 11899,
            "en_name": "RIZATRIPTAN",
            "fr_name": "Rizatriptan (Benzoate de rizatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02393468",
      "brand_name": "APO-RIZATRIPTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137841001"
    },
    "created_date": "2021-09-17T15:34:47-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02393468",
    "company_name": "APOTEX INC",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2021-11-05T00:00:00-04:00",
    "actual_start_date": "2021-09-14T00:00:00-04:00",
    "actual_end_date": "2021-11-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-11-08T12:57:45-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-RIZATRIPTAN",
    "en_drug_common_name": "RIZATRIPTAN",
    "fr_drug_brand_name": "APO-RIZATRIPTAN",
    "fr_drug_common_name": "RIZATRIPTAN",
    "en_ingredients": "RIZATRIPTAN",
    "fr_ingredients": "RIZATRIPTAN",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "6 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145846,
    "drug": {
      "current_status": "MARKETED",
      "id": 9090,
      "drug_code": 61817,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8253574,
          "ingredient": {
            "id": 78,
            "ingredient_code": 10258,
            "en_name": "PHENYLEPHRINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de phényléphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "1",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02238400",
      "brand_name": "PHENYLEPHRINE HYDROCHLORIDE INJECTION USP 1%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0100662004"
    },
    "created_date": "2021-09-17T15:48:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238400",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "C01CA",
    "atc_description": "CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES",
    "estimated_end_date": "2021-11-10T00:00:00-05:00",
    "actual_start_date": "2021-09-24T00:00:00-04:00",
    "actual_end_date": "2021-11-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-11-04T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PHENYLEPHRINE HYDROCHLORIDE INJECTION USP 1%",
    "en_drug_common_name": "Phenylephrine Hydrochloride Injection USP",
    "fr_drug_brand_name": "Injection de chlorhydrate de phényléphrine USP",
    "fr_drug_common_name": "Injection de chlorhydrate de phényléphrine USP",
    "en_ingredients": "PHENYLEPHRINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de phényléphrine",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nIntramusculaire\r\nSous-cutanée\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "10 x 1mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145853,
    "drug": {
      "current_status": "MARKETED",
      "id": 31226,
      "drug_code": 93430,
      "updated_date": "2025-12-03T00:32:56-05:00",
      "company": {
        "id": 254,
        "created_date": "2017-03-09T13:22:38-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 7005,
        "mfr_code": "LIL08",
        "name": "ELI LILLY CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "SUITE 900",
        "street_name": "EXCHANGE TOWER, 130 KING STREET WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M5X 1B1",
        "post_office_box": "PO BOX 73",
        "contact_information": "Lilly Canada’s Customer Response Centre 1-888-545-5972."
      },
      "drug_ingredients": [
        {
          "id": 8261568,
          "ingredient": {
            "id": 4114,
            "ingredient_code": 22660,
            "en_name": "DULAGLUTIDE",
            "fr_name": "Dulaglutide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02448599",
      "brand_name": "TRULICITY",
      "brand_name_fr": "TRULICITY",
      "descriptor": "0.5ML SINGLE-USE PEN",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0157570001"
    },
    "created_date": "2021-09-17T20:09:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02448599",
    "company_name": "ELI LILLY CANADA INC",
    "atc_number": "A10BJ",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "anticipated_start_date": "2021-10-07T00:00:00-04:00",
    "actual_end_date": "2021-10-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-10-06T21:00:49-04:00",
    "status": "avoided_shortage",
    "en_comments": "For any questions, please contact our Customer Response Center at  1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays)",
    "fr_comments": "Si vous avez des questions, veuillez contacter le service à la clientèle de Eli Lilly Canada au 1-888-545-5972 (du lundi au vendredi, de 9 h à 17 h, heure de l’Est, sauf les jours fériés)",
    "en_drug_brand_name": "TRULICITY",
    "en_drug_common_name": "DULAGLUTIDE",
    "fr_drug_brand_name": "Trulicity",
    "fr_drug_common_name": "Dulaglutide",
    "en_ingredients": "DULAGLUTIDE",
    "fr_ingredients": "Dulaglutide",
    "drug_strength": "0.75MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "4 x 0.5 ml single-use prefilled pen",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145857,
    "drug": {
      "current_status": "MARKETED",
      "id": 31228,
      "drug_code": 93431,
      "updated_date": "2025-12-03T00:32:57-05:00",
      "company": {
        "id": 254,
        "created_date": "2017-03-09T13:22:38-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 7005,
        "mfr_code": "LIL08",
        "name": "ELI LILLY CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "SUITE 900",
        "street_name": "EXCHANGE TOWER, 130 KING STREET WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M5X 1B1",
        "post_office_box": "PO BOX 73",
        "contact_information": "Lilly Canada’s Customer Response Centre 1-888-545-5972."
      },
      "drug_ingredients": [
        {
          "id": 8261569,
          "ingredient": {
            "id": 4114,
            "ingredient_code": 22660,
            "en_name": "DULAGLUTIDE",
            "fr_name": "Dulaglutide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02448602",
      "brand_name": "TRULICITY",
      "brand_name_fr": "TRULICITY",
      "descriptor": "0.5ML SINGLE-USE PEN",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0157570002"
    },
    "created_date": "2021-09-17T20:15:31-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02448602",
    "company_name": "ELI LILLY CANADA INC",
    "atc_number": "A10BJ",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "anticipated_start_date": "2021-10-07T00:00:00-04:00",
    "actual_end_date": "2021-10-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-10-06T21:01:38-04:00",
    "status": "avoided_shortage",
    "en_comments": "Please contact Eli Lilly Canada's Response Centre 1-888-545-5972 should you have any questions (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays)",
    "fr_comments": "Si vous avez des questions, veuillez contacter le service à la clientèle de Eli Lilly Canada au 1-888-545-5972 (du lundi au vendredi, de 9 h à 17 h, heure de l’Est, sauf les jours fériés)",
    "en_drug_brand_name": "TRULICITY",
    "en_drug_common_name": "DULAGLUTIDE",
    "fr_drug_brand_name": "Trulicity",
    "fr_drug_common_name": "Dulaglutide",
    "en_ingredients": "DULAGLUTIDE",
    "fr_ingredients": "Dulaglutide",
    "drug_strength": "1.5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "4 x 0.5 ml single-use prefilled pen",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145888,
    "drug": {
      "current_status": "MARKETED",
      "id": 24926,
      "drug_code": 87443,
      "updated_date": "2025-05-15T02:33:36-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259017,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02388898",
      "brand_name": "LOSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127971002"
    },
    "created_date": "2021-09-20T18:17:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02388898",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2024-09-20T00:00:00-04:00",
    "actual_start_date": "2024-04-22T00:00:00-04:00",
    "actual_end_date": "2024-09-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-09-17T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LOSARTAN",
    "en_drug_common_name": "LOSARTAN",
    "fr_drug_brand_name": "LOSARTAN",
    "fr_drug_common_name": "LOSARTAN",
    "en_ingredients": "LOSARTAN POTASSIUM",
    "fr_ingredients": "Losartan potassique",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145904,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 17142,
      "drug_code": 78175,
      "updated_date": "2025-12-03T01:25:00-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8344220,
          "ingredient": {
            "id": 1598,
            "ingredient_code": 1250,
            "en_name": "OMEPRAZOLE",
            "fr_name": "Oméprazole (Oméprazole magnésium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02296438",
      "brand_name": "SANDOZ OMEPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121643003"
    },
    "created_date": "2021-09-20T19:59:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02296438",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2021-12-03T00:00:00-05:00",
    "actual_start_date": "2021-09-20T00:00:00-04:00",
    "actual_end_date": "2021-12-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-12-07T01:37:58-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ OMEPRAZOLE",
    "en_drug_common_name": "OMEPRAZOLE",
    "fr_drug_brand_name": "SANDOZ OMEPRAZOLE",
    "fr_drug_common_name": "OMEPRAZOLE",
    "en_ingredients": "OMEPRAZOLE",
    "fr_ingredients": "Oméprazole",
    "drug_strength": "10MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30GRC BO",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145907,
    "drug": {
      "current_status": "MARKETED",
      "id": 18048,
      "drug_code": 79242,
      "updated_date": "2025-05-15T02:32:07-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256348,
          "ingredient": {
            "id": 2294,
            "ingredient_code": 11086,
            "en_name": "PANTOPRAZOLE",
            "fr_name": "Pantoprazole (Pantoprazole sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02306727",
      "brand_name": "PANTOPRAZOLE SODIUM FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133229001"
    },
    "created_date": "2021-09-20T20:01:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02306727",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2021-09-24T00:00:00-04:00",
    "actual_start_date": "2021-09-20T00:00:00-04:00",
    "actual_end_date": "2021-09-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-09-28T19:51:42-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PANTOPRAZOLE SODIUM FOR INJECTION",
    "en_drug_common_name": "PANTOPRAZOLE SODIUM FOR INJECTION",
    "fr_drug_brand_name": "PANTOPRAZOLE SODIUM FOR INJECTION",
    "fr_drug_common_name": "PANTOPRAZOLE SODIUM FOR INJECTION",
    "en_ingredients": "PANTOPRAZOLE",
    "fr_ingredients": "PANTOPRAZOLE",
    "drug_strength": "40MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 LYVI",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145911,
    "drug": {
      "current_status": "MARKETED",
      "id": 55898,
      "drug_code": 95941,
      "updated_date": "2025-05-15T02:36:11-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8262902,
          "ingredient": {
            "id": 1366,
            "ingredient_code": 1960,
            "en_name": "INDAPAMIDE",
            "fr_name": "Indapamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8262901,
          "ingredient": {
            "id": 1286,
            "ingredient_code": 232,
            "en_name": "PERINDOPRIL ERBUMINE",
            "fr_name": "Périndopril erbumine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02470446",
      "brand_name": "SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE HD",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0248401003"
    },
    "created_date": "2021-09-20T20:03:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02470446",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09BA",
    "atc_description": "ACE INHIBITORS, COMBINATIONS",
    "estimated_end_date": "2021-10-15T00:00:00-04:00",
    "actual_start_date": "2021-09-20T00:00:00-04:00",
    "actual_end_date": "2021-10-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-16T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE HD",
    "en_drug_common_name": "PERINDOPRIL ERBUMINE/ INDAPAMIDE",
    "fr_drug_brand_name": "SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE HD",
    "fr_drug_common_name": "PERINDOPRIL ERBUMINE/ INDAPAMIDE",
    "en_ingredients": "INDAPAMIDE\r\nPERINDOPRIL ERBUMINE",
    "fr_ingredients": "Indapamide\r\nPérindopril erbumine",
    "drug_strength": "2.5MG\r\n8MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100TAB BO",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145918,
    "drug": {
      "current_status": "MARKETED",
      "id": 552,
      "drug_code": 11196,
      "updated_date": "2025-12-03T00:30:30-05:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8251477,
          "ingredient": {
            "id": 348,
            "ingredient_code": 7504,
            "en_name": "MOMETASONE FUROATE",
            "fr_name": "Furoate de mométasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00851744",
      "brand_name": "ELOCOM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "71699",
      "number_of_ais": "1",
      "ai_group_no": "0121732001"
    },
    "created_date": "2021-09-20T22:07:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00851744",
    "company_name": "ORGANON CANADA INC.",
    "atc_number": "D07AC",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "anticipated_start_date": "2021-10-20T00:00:00-04:00",
    "estimated_end_date": "2021-12-20T00:00:00-05:00",
    "actual_start_date": "2021-10-12T00:00:00-04:00",
    "actual_end_date": "2021-12-20T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-12-21T13:58:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ELOCOM",
    "en_drug_common_name": "mometasone furoate cream",
    "fr_drug_brand_name": "ELOCOM CRÈME",
    "fr_drug_common_name": "crème de furoate de mométasone",
    "en_ingredients": "MOMETASONE FUROATE",
    "fr_ingredients": "Furoate de mométasone",
    "drug_strength": "0.1%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "15",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145937,
    "drug": {
      "current_status": "MARKETED",
      "id": 22474,
      "drug_code": 84908,
      "updated_date": "2025-05-15T02:32:56-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8258071,
          "ingredient": {
            "id": 74,
            "ingredient_code": 20280,
            "en_name": "HYDROMORPHONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydromorphone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02364158",
      "brand_name": "APO-HYDROMORPHONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108698005"
    },
    "created_date": "2021-09-21T19:15:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02364158",
    "company_name": "APOTEX INC",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2021-11-26T00:00:00-05:00",
    "actual_start_date": "2021-09-21T00:00:00-04:00",
    "actual_end_date": "2021-10-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-25T12:05:26-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-HYDROMORPHONE",
    "en_drug_common_name": "HYDROMORPHONE",
    "fr_drug_brand_name": "APO-HYDROMORPHONE",
    "fr_drug_common_name": "HYDROMORPHONE",
    "en_ingredients": "HYDROMORPHONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydromorphone",
    "drug_strength": "8MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145949,
    "drug": {
      "current_status": "MARKETED",
      "id": 31600,
      "drug_code": 93916,
      "updated_date": "2025-05-15T02:35:18-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261827,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "36",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02452766",
      "brand_name": "APO-METHYLPHENIDATE ER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548005"
    },
    "created_date": "2021-09-21T19:21:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02452766",
    "company_name": "APOTEX INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2021-10-28T00:00:00-04:00",
    "actual_start_date": "2021-09-21T00:00:00-04:00",
    "actual_end_date": "2021-10-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-28T13:54:12-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-METHYLPHENIDATE ER",
    "en_drug_common_name": "METHYLPHENIDATE",
    "fr_drug_brand_name": "APO METHYLPHENIDATE",
    "fr_drug_common_name": "METHYLPHENIDATE",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "36MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145955,
    "drug": {
      "current_status": "MARKETED",
      "id": 3382,
      "drug_code": 18558,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 32,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7054,
        "mfr_code": "PFR08",
        "name": "PURDUE PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252340,
          "ingredient": {
            "id": 74,
            "ingredient_code": 20280,
            "en_name": "HYDROMORPHONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydromorphone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02125331",
      "brand_name": "HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 6MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80818",
      "number_of_ais": "1",
      "ai_group_no": "0108698010"
    },
    "created_date": "2021-09-21T19:25:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02125331",
    "company_name": "PURDUE PHARMA",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2021-09-21T00:00:00-04:00",
    "estimated_end_date": "2021-11-05T00:00:00-04:00",
    "actual_start_date": "2021-09-21T00:00:00-04:00",
    "actual_end_date": "2021-10-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-10-30T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 6MG",
    "en_drug_common_name": "hydrochloride Controlled Release Capsules",
    "fr_drug_brand_name": "HYDROMORPH CONTIN",
    "fr_drug_common_name": "Capsules de chlorhydrate d’HYDROmorphone* à libération contrôlée",
    "en_ingredients": "HYDROMORPHONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydromorphone",
    "drug_strength": "6MG",
    "drug_dosage_form": "CAPSULE (SUSTAINED-RELEASE)",
    "drug_dosage_form_fr": "Capsule (à action soutenue)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145961,
    "drug": {
      "current_status": "MARKETED",
      "id": 2674,
      "drug_code": 16480,
      "updated_date": "2025-05-15T02:30:56-04:00",
      "company": {
        "id": 32,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7054,
        "mfr_code": "PFR08",
        "name": "PURDUE PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252128,
          "ingredient": {
            "id": 142,
            "ingredient_code": 9117,
            "en_name": "MORPHINE SULFATE",
            "fr_name": "Sulfate de morphine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02014238",
      "brand_name": "MS.IR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "78371",
      "number_of_ais": "1",
      "ai_group_no": "0104545002"
    },
    "created_date": "2021-09-21T19:31:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02014238",
    "company_name": "PURDUE PHARMA",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2021-09-21T00:00:00-04:00",
    "estimated_end_date": "2021-12-24T00:00:00-05:00",
    "actual_start_date": "2021-09-21T00:00:00-04:00",
    "actual_end_date": "2021-12-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-12-18T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MS.IR",
    "en_drug_common_name": "Morphine Sulfate Immediate Release Tablets",
    "fr_drug_brand_name": "MS•IR",
    "fr_drug_common_name": "Comprimés de sulfate de morphine à libération immédiate",
    "en_ingredients": "MORPHINE SULFATE",
    "fr_ingredients": "Sulfate de morphine",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET (IMMEDIATE RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération immédiate)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145966,
    "drug": {
      "current_status": "MARKETED",
      "id": 3870,
      "drug_code": 19443,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252490,
          "ingredient": {
            "id": 1560,
            "ingredient_code": 5881,
            "en_name": "PROTAMINE SULFATE",
            "fr_name": "Sulfate de protamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02139537",
      "brand_name": "PROTAMINE SULFATE INJECTION, USP",
      "brand_name_fr": "SULFATE DE PROTAMINE INJECTABLE, USP",
      "descriptor": "SINGLE-DOSE VIAL",
      "pediatric_flag": false,
      "accession_number": "81740",
      "number_of_ais": "1",
      "ai_group_no": "0107652001"
    },
    "created_date": "2021-09-21T19:45:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02139537",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "V03AB",
    "atc_description": "ALL OTHER THERAPEUTIC PRODUCTS",
    "anticipated_start_date": "2021-09-24T00:00:00-04:00",
    "estimated_end_date": "2021-12-13T00:00:00-05:00",
    "actual_start_date": "2021-09-24T00:00:00-04:00",
    "actual_end_date": "2021-11-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-12-01T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PROTAMINE SULFATE INJECTION, USP",
    "en_drug_common_name": "Protamine Sulfate Injection, USP 10 mg/mL SD Vial 25 mL",
    "fr_drug_brand_name": "Sulfate de protamine injectable, USP",
    "fr_drug_common_name": "Sulfate de protamine injectable, USP à 10 mg/mL, fioles DU, 25 mL",
    "en_ingredients": "PROTAMINE SULFATE",
    "fr_ingredients": "Sulfate de protamine",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "25 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145975,
    "drug": {
      "current_status": "MARKETED",
      "id": 23766,
      "drug_code": 86424,
      "updated_date": "2025-05-15T02:33:10-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8258563,
          "ingredient": {
            "id": 1012,
            "ingredient_code": 763,
            "en_name": "ENOXAPARIN SODIUM",
            "fr_name": "Énoxaparine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02378442",
      "brand_name": "LOVENOX",
      "brand_name_fr": "",
      "descriptor": "SINGLE DOSE PRE-FILLED SYRINGE 100MG/ML",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131860001"
    },
    "created_date": "2021-09-21T21:08:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02378442",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "B01AB",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "anticipated_start_date": "2022-02-15T00:00:00-05:00",
    "estimated_end_date": "2022-03-24T00:00:00-04:00",
    "actual_end_date": "2021-12-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2021-12-02T19:38:08-05:00",
    "status": "avoided_shortage",
    "en_comments": "Transportation delay and overselling is leading to a limited supply of product. Allocation will be kept in place to mitigate the anticipated shortage.",
    "fr_comments": "Le délai de transport et la survente entraîne une approvisionnement limitée de produits. L’allocation sera maintenue en place pour atténuer la pénurie anticipée",
    "en_drug_brand_name": "LOVENOX",
    "en_drug_common_name": "Lovenox 100mg",
    "fr_drug_brand_name": "LOVENOX",
    "fr_drug_common_name": "LOVENOX 100MG",
    "en_ingredients": "ENOXAPARIN SODIUM",
    "fr_ingredients": "Énoxaparine sodique",
    "drug_strength": "100MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "10",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 145995,
    "drug": {
      "current_status": "MARKETED",
      "id": 11318,
      "drug_code": 67764,
      "updated_date": "2025-05-15T02:31:15-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8254231,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02243825",
      "brand_name": "PRO-PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563002"
    },
    "created_date": "2021-09-22T13:00:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243825",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2021-10-07T00:00:00-04:00",
    "actual_start_date": "2021-09-22T00:00:00-04:00",
    "actual_end_date": "2021-10-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-10-06T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PRAVASTATIN-20",
    "en_drug_common_name": "PRAVASTATIN 20",
    "fr_drug_brand_name": "PRAVASTATIN-20",
    "fr_drug_common_name": "PRAVASTATIN 20",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30, 100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146019,
    "drug": {
      "current_status": "MARKETED",
      "id": 2944,
      "drug_code": 17227,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8252194,
          "ingredient": {
            "id": 170,
            "ingredient_code": 9060,
            "en_name": "HEPARIN SODIUM",
            "fr_name": "Héparine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "01990748",
      "brand_name": "HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "79380",
      "number_of_ais": "1",
      "ai_group_no": "0104596011"
    },
    "created_date": "2021-09-22T17:32:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01990748",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "B01AB",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "actual_start_date": "2021-09-27T00:00:00-04:00",
    "actual_end_date": "2021-11-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-11-04T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION",
    "en_drug_common_name": "Heparin Sodium In Sodium Chloride Injection",
    "fr_drug_brand_name": "Héparine sodique dans du chlorure de sodium à 0,9 % injectable",
    "fr_drug_common_name": "Héparine sodique dans du chlorure de sodium à 0,9 % injectable",
    "en_ingredients": "HEPARIN SODIUM",
    "fr_ingredients": "Héparine sodique",
    "drug_strength": "2UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "12 x 1L bag",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146024,
    "drug": {
      "current_status": "MARKETED",
      "id": 1522,
      "drug_code": 13302,
      "updated_date": "2025-05-15T02:30:53-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251750,
          "ingredient": {
            "id": 572,
            "ingredient_code": 649,
            "en_name": "LIPASE",
            "fr_name": "Lipase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8251749,
          "ingredient": {
            "id": 570,
            "ingredient_code": 648,
            "en_name": "PROTEASE",
            "fr_name": "Protéase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1600",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8251748,
          "ingredient": {
            "id": 568,
            "ingredient_code": 253,
            "en_name": "AMYLASE",
            "fr_name": "Amylase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25500",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01985205",
      "brand_name": "CREON MINIMICROSPHERES 25",
      "brand_name_fr": "CREON MINIMICROSPHERES 25",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74650",
      "number_of_ais": "3",
      "ai_group_no": "0302964041"
    },
    "created_date": "2021-09-22T17:59:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01985205",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "A09AA",
    "atc_description": "DIGESTIVES, INCL ENZYMES",
    "estimated_end_date": "2021-09-23T00:00:00-04:00",
    "actual_start_date": "2021-09-14T00:00:00-04:00",
    "actual_end_date": "2021-09-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2021-09-28T11:54:22-04:00",
    "status": "resolved",
    "en_comments": "Globally Allocated Product",
    "fr_comments": "Globally Allocated Product",
    "en_drug_brand_name": "CREON MINIMICROSPHERES 25",
    "en_drug_common_name": "CREON MINIMICROSPHERES 25",
    "fr_drug_brand_name": "CREON MINIMICROSPHERES 25",
    "fr_drug_common_name": "CREON MINIMICROSPHERES 25",
    "en_ingredients": "PROTEASE\r\nAMYLASE\r\nLIPASE",
    "fr_ingredients": "Protéase\r\nAmylase\r\nLipase",
    "drug_strength": "1600UNIT\r\n25500UNIT\r\n25000UNIT",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146027,
    "drug": {
      "current_status": "MARKETED",
      "id": 30350,
      "drug_code": 92401,
      "updated_date": "2025-12-03T00:32:47-05:00",
      "company": {
        "id": 678,
        "created_date": "2017-03-09T13:23:04-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 14108,
        "mfr_code": "",
        "name": "TAKEDA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "3800",
        "street_name": "22 ADELAIDE STREET WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M5H 4E3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261091,
          "ingredient": {
            "id": 3532,
            "ingredient_code": 20437,
            "en_name": "LISDEXAMFETAMINE DIMESYLATE",
            "fr_name": "Dimésylate de lisdexamfétamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02439603",
      "brand_name": "VYVANSE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152536006"
    },
    "created_date": "2021-09-22T20:05:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02439603",
    "company_name": "TAKEDA CANADA INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2021-09-22T00:00:00-04:00",
    "estimated_end_date": "2021-10-15T00:00:00-04:00",
    "actual_start_date": "2021-09-22T00:00:00-04:00",
    "actual_end_date": "2021-10-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-10-07T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "VYVANSE",
    "en_drug_common_name": "Lisdexamfetamine dimesylate capsules",
    "fr_drug_brand_name": "VYVANSE",
    "fr_drug_common_name": "Gélules de dimésylate de lisdexamfétamine",
    "en_ingredients": "LISDEXAMFETAMINE DIMESYLATE",
    "fr_ingredients": "Dimésylate de lisdexamfétamine",
    "drug_strength": "10MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "Bottles of 100's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146031,
    "drug": {
      "current_status": "MARKETED",
      "id": 21028,
      "drug_code": 83255,
      "updated_date": "2025-12-03T00:31:35-05:00",
      "company": {
        "id": 678,
        "created_date": "2017-03-09T13:23:04-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 14108,
        "mfr_code": "",
        "name": "TAKEDA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "3800",
        "street_name": "22 ADELAIDE STREET WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M5H 4E3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257459,
          "ingredient": {
            "id": 3532,
            "ingredient_code": 20437,
            "en_name": "LISDEXAMFETAMINE DIMESYLATE",
            "fr_name": "Dimésylate de lisdexamfétamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02347164",
      "brand_name": "VYVANSE",
      "brand_name_fr": "VYVANSE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152536004"
    },
    "created_date": "2021-09-22T20:13:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02347164",
    "company_name": "TAKEDA CANADA INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2021-09-22T00:00:00-04:00",
    "estimated_end_date": "2021-10-15T00:00:00-04:00",
    "actual_start_date": "2021-09-22T00:00:00-04:00",
    "actual_end_date": "2021-10-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-10-07T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "VYVANSE",
    "en_drug_common_name": "Lisdexamfetamine dimesylate capsules",
    "fr_drug_brand_name": "VYVANSE",
    "fr_drug_common_name": "Gélules de dimésylate de lisdexamfétamine",
    "en_ingredients": "LISDEXAMFETAMINE DIMESYLATE",
    "fr_ingredients": "Dimésylate de lisdexamfétamine",
    "drug_strength": "40MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "Bottles of 100's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146048,
    "drug": {
      "current_status": "MARKETED",
      "id": 6724,
      "drug_code": 44185,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 458,
        "created_date": "2017-03-09T13:22:47-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 12573,
        "mfr_code": "",
        "name": "GE HEALTHCARE CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1919 MINNESOTA COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C9",
        "post_office_box": "",
        "contact_information": "800-387-7146   \r\n\r\ncanadainfo@gehealthcare.com"
      },
      "drug_ingredients": [
        {
          "id": 8253159,
          "ingredient": {
            "id": 2234,
            "ingredient_code": 8092,
            "en_name": "IOHEXOL",
            "fr_name": "Iohexol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "518",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02172739",
      "brand_name": "OMNIPAQUE 240",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "T9819",
      "number_of_ais": "1",
      "ai_group_no": "0116846003"
    },
    "created_date": "2021-09-23T14:25:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02172739",
    "company_name": "GE HEALTHCARE CANADA INC",
    "atc_number": "V08AB",
    "atc_description": "X-RAY CONTRAST MEDIA, IODINATED",
    "estimated_end_date": "2021-10-27T00:00:00-04:00",
    "actual_start_date": "2021-09-23T00:00:00-04:00",
    "actual_end_date": "2021-10-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-27T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "OMNIPAQUE 240",
    "en_drug_common_name": "iohexol injection USP",
    "fr_drug_brand_name": "Omnipaque 240",
    "fr_drug_common_name": "injection d'iohexol USP",
    "en_ingredients": "IOHEXOL",
    "fr_ingredients": "Iohexol",
    "drug_strength": "518MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVASCULAR\r\nSUBARACHNOIDAL\r\nINTRAVASCULAR\r\nSUBARACHNOIDAL",
    "drug_route_fr": "Intravasculaire\r\nSous-arachnoÏdienne\r\nIntravasculaire\r\nSous-arachnoÏdienne",
    "drug_package_quantity": "20 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146061,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 7898,
      "drug_code": 51346,
      "updated_date": "2025-12-03T01:14:37-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8317575,
          "ingredient": {
            "id": 368,
            "ingredient_code": 7626,
            "en_name": "METHYLPREDNISOLONE",
            "fr_name": "Méthylprednisolone (Succinate sodique de méthylprednisolone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02231893",
      "brand_name": "METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106290002"
    },
    "created_date": "2021-09-23T17:25:58-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02231893",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "H02AB",
    "atc_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
    "discontinuation_date": "2021-09-10T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-09-23T17:26:15-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION",
    "en_drug_common_name": "METHYLPREDNISOLONE SOD SUCC 40MG",
    "fr_drug_brand_name": "METHYLPREDNISOLONE SOD SUCC 40MG",
    "fr_drug_common_name": "METHYLPREDNISOLONE SOD SUCC 40MG",
    "en_ingredients": "METHYLPREDNISOLONE",
    "fr_ingredients": "Méthylprednisolone",
    "drug_strength": "40MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "10",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146066,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 25440,
      "drug_code": 87880,
      "updated_date": "2025-05-15T04:20:34-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8352045,
          "ingredient": {
            "id": 2350,
            "ingredient_code": 2071,
            "en_name": "NABILONE",
            "fr_name": "Nabilone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02393581",
      "brand_name": "ACT NABILONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115009002"
    },
    "created_date": "2021-09-23T17:31:50-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02393581",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "A04AD",
    "atc_description": "ANTIEMETICS AND ANTINAUSEANTS",
    "discontinuation_date": "2021-09-10T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-09-23T17:32:10-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "ACT NABILONE",
    "en_drug_common_name": "NABILONE 0.5MG CAPSULES",
    "fr_drug_brand_name": "ACT-NABILONE 0.5MG CAPSULES",
    "fr_drug_common_name": "NABILONE 0.5MG CAPSULES",
    "en_ingredients": "NABILONE",
    "fr_ingredients": "Nabilone",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "50",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146089,
    "drug": {
      "current_status": "MARKETED",
      "id": 25048,
      "drug_code": 87564,
      "updated_date": "2025-05-15T02:33:37-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259077,
          "ingredient": {
            "id": 2818,
            "ingredient_code": 12019,
            "en_name": "EXEMESTANE",
            "fr_name": "Exémestane"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02390183",
      "brand_name": "ACT EXEMESTANE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0141702001"
    },
    "created_date": "2021-09-23T18:08:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02390183",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "L02BG",
    "atc_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
    "estimated_end_date": "2021-12-31T00:00:00-05:00",
    "actual_start_date": "2021-09-22T00:00:00-04:00",
    "actual_end_date": "2021-11-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-11-18T18:55:52-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT EXEMESTANE",
    "en_drug_common_name": "ACT-EXEMESTANE 25MG FC TAB",
    "fr_drug_brand_name": "ACT-EXEMESTANE 25MG FC TAB",
    "fr_drug_common_name": "EXEMESTANE 25MG FC TAB",
    "en_ingredients": "EXEMESTANE",
    "fr_ingredients": "Exémestane",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30UD",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146092,
    "drug": {
      "current_status": "MARKETED",
      "id": 30314,
      "drug_code": 92365,
      "updated_date": "2025-12-03T00:32:46-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261074,
          "ingredient": {
            "id": 20953,
            "ingredient_code": 23170,
            "en_name": "MIXED SALTS AMPHETAMINE",
            "fr_name": "Sels mixtes d'amphétamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02439263",
      "brand_name": "TEVA-AMPHETAMINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0161310004"
    },
    "created_date": "2021-09-23T18:10:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02439263",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2021-10-31T00:00:00-04:00",
    "actual_start_date": "2021-09-22T00:00:00-04:00",
    "actual_end_date": "2021-10-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2021-10-14T14:56:50-04:00",
    "status": "resolved",
    "en_comments": "Item is short-dated and about to expire.",
    "fr_comments": "Item is short-dated and about to expire.",
    "en_drug_brand_name": "ACT AMPHETAMINE XR",
    "en_drug_common_name": "AMPHETAMINE XR 20MG CAPS",
    "fr_drug_brand_name": "ACT-AMPHETAMINE XR 20MG CAPS",
    "fr_drug_common_name": "AMPHETAMINE XR 20MG CAPS",
    "en_ingredients": "MIXED SALTS AMPHETAMINE",
    "fr_ingredients": "AMPHETAMINE",
    "drug_strength": "20MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146095,
    "drug": {
      "current_status": "MARKETED",
      "id": 13092,
      "drug_code": 72459,
      "updated_date": "2025-05-15T02:31:28-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254769,
          "ingredient": {
            "id": 348,
            "ingredient_code": 7504,
            "en_name": "MOMETASONE FUROATE",
            "fr_name": "Furoate de mométasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02248130",
      "brand_name": "TEVA-MOMETASONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121732001"
    },
    "created_date": "2021-09-23T18:12:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248130",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "D07AC",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2021-10-31T00:00:00-04:00",
    "actual_start_date": "2021-09-22T00:00:00-04:00",
    "actual_end_date": "2021-10-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-28T15:27:38-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-MOMETASONE",
    "en_drug_common_name": "MOMETASONE 0.1% OINT",
    "fr_drug_brand_name": "TEVA-MOMETASONE 0.1% OINT",
    "fr_drug_common_name": "MOMETASONE 0.1% OINT",
    "en_ingredients": "MOMETASONE FUROATE",
    "fr_ingredients": "Furoate de mométasone",
    "drug_strength": "0.1%",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "15g",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146098,
    "drug": {
      "current_status": "MARKETED",
      "id": 9798,
      "drug_code": 63873,
      "updated_date": "2025-05-15T02:31:07-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253763,
          "ingredient": {
            "id": 380,
            "ingredient_code": 10238,
            "en_name": "TRYPTOPHAN",
            "fr_name": "Tryptophane"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02240334",
      "brand_name": "TEVA-TRYPTOPHAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0111038003"
    },
    "created_date": "2021-09-23T18:28:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02240334",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2022-05-20T00:00:00-04:00",
    "actual_start_date": "2021-09-22T00:00:00-04:00",
    "actual_end_date": "2022-05-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-05-19T17:28:52-04:00",
    "status": "resolved",
    "en_comments": "Item is short-dated and about to expire.",
    "fr_comments": "Item is short-dated and about to expire.",
    "en_drug_brand_name": "TEVA-TRYPTOPHAN",
    "en_drug_common_name": "TRYPTOPHAN 500MG CAPS",
    "fr_drug_brand_name": "TEVA-TRYPTOPHAN 500MG CAPS",
    "fr_drug_common_name": "TRYPTOPHAN 500MG CAPS",
    "en_ingredients": "TRYPTOPHAN",
    "fr_ingredients": "Tryptophane",
    "drug_strength": "500MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146101,
    "drug": {
      "current_status": "MARKETED",
      "id": 14886,
      "drug_code": 75289,
      "updated_date": "2025-05-15T02:31:40-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255333,
          "ingredient": {
            "id": 3044,
            "ingredient_code": 1218,
            "en_name": "BISOPROLOL FUMARATE",
            "fr_name": "Fumarate de bisoprolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02267489",
      "brand_name": "TEVA-BISOPROLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122418002"
    },
    "created_date": "2021-09-23T18:44:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02267489",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C07AB",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2022-01-31T00:00:00-05:00",
    "actual_start_date": "2021-09-22T00:00:00-04:00",
    "actual_end_date": "2021-11-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2021-11-11T19:26:07-05:00",
    "status": "resolved",
    "en_comments": "Item is short-dated/expiring",
    "fr_comments": "Item is ehort-dated/expiring",
    "en_drug_brand_name": "TEVA-BISOPROLOL",
    "en_drug_common_name": "BISOPROLOL FUMARATE 10MG TAB",
    "fr_drug_brand_name": "TEVA-BISOPROLOL FUMARATE 10MG TAB",
    "fr_drug_common_name": "BISOPROLOL FUMARATE 10MG TAB",
    "en_ingredients": "BISOPROLOL FUMARATE",
    "fr_ingredients": "Fumarate de bisoprolol",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146106,
    "drug": {
      "current_status": "MARKETED",
      "id": 602,
      "drug_code": 11329,
      "updated_date": "2025-05-15T02:30:51-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251507,
          "ingredient": {
            "id": 400,
            "ingredient_code": 9928,
            "en_name": "VALINE",
            "fr_name": "Valine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "580",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251506,
          "ingredient": {
            "id": 376,
            "ingredient_code": 10223,
            "en_name": "PHENYLALANINE",
            "fr_name": "Phénylalanine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "560",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251505,
          "ingredient": {
            "id": 394,
            "ingredient_code": 9396,
            "en_name": "PROLINE",
            "fr_name": "Proline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "680",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251504,
          "ingredient": {
            "id": 386,
            "ingredient_code": 10243,
            "en_name": "THREONINE",
            "fr_name": "Thréonine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "420",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251503,
          "ingredient": {
            "id": 382,
            "ingredient_code": 10239,
            "en_name": "LEUCINE",
            "fr_name": "Leucine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "730",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251502,
          "ingredient": {
            "id": 384,
            "ingredient_code": 10242,
            "en_name": "ARGININE",
            "fr_name": "Arginine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.15",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251501,
          "ingredient": {
            "id": 380,
            "ingredient_code": 10238,
            "en_name": "TRYPTOPHAN",
            "fr_name": "Tryptophane"
          },
          "ingredient_supplied_ind": "I",
          "strength": "180",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251500,
          "ingredient": {
            "id": 392,
            "ingredient_code": 7217,
            "en_name": "METHIONINE",
            "fr_name": "Méhionine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251499,
          "ingredient": {
            "id": 388,
            "ingredient_code": 193,
            "en_name": "L-LYSINE",
            "fr_name": "L-lysine (Acétate de L-lysine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "580",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": true
        },
        {
          "id": 8251498,
          "ingredient": {
            "id": 398,
            "ingredient_code": 9927,
            "en_name": "SERINE",
            "fr_name": "Sérine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251497,
          "ingredient": {
            "id": 396,
            "ingredient_code": 9750,
            "en_name": "TYROSINE",
            "fr_name": "Tyrosine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251496,
          "ingredient": {
            "id": 378,
            "ingredient_code": 10237,
            "en_name": "HISTIDINE",
            "fr_name": "Histidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "480",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251495,
          "ingredient": {
            "id": 390,
            "ingredient_code": 2959,
            "en_name": "L-ALANINE",
            "fr_name": "L-ALANINE"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.07",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251494,
          "ingredient": {
            "id": 224,
            "ingredient_code": 8865,
            "en_name": "GLYCINE",
            "fr_name": "Glycine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.03",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251493,
          "ingredient": {
            "id": 402,
            "ingredient_code": 9929,
            "en_name": "ISOLEUCINE",
            "fr_name": "Isoleucine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "600",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00872296",
      "brand_name": "TRAVASOL",
      "brand_name_fr": "",
      "descriptor": "BLEND C",
      "pediatric_flag": false,
      "accession_number": "71962",
      "number_of_ais": "15",
      "ai_group_no": "1517080002"
    },
    "created_date": "2021-09-23T19:00:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00872296",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05BA",
    "atc_description": "I.V. SOLUTIONS",
    "estimated_end_date": "2021-10-01T00:00:00-04:00",
    "actual_start_date": "2021-09-23T00:00:00-04:00",
    "actual_end_date": "2021-10-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-10-02T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Baxter is experiencing supply constraints due to the shortage of Travasol 10% 3000mL (DIN 00872296).  As a result this product has been placed on allocation at 100% of historical usage.",
    "fr_comments": "Baxter connaît des contraintes d'approvisionnement en raison de la pénurie de Travasol à 10 % 3 000 mL (DIN 00872296). Par conséquent, le produit a été mis sous allocation à 100 % de l’utilisation historique.",
    "en_drug_brand_name": "TRAVASOL",
    "en_drug_common_name": "Amino Acids (Blend C) Injection",
    "fr_drug_brand_name": "TrRAVASOL",
    "fr_drug_common_name": "Amino Acids (Blend C) Injection",
    "en_ingredients": "LEUCINE\r\nSERINE\r\nTYROSINE\r\nPROLINE\r\nARGININE\r\nGLYCINE\r\nL-ALANINE\r\nTRYPTOPHAN\r\nTHREONINE\r\nHISTIDINE\r\nVALINE\r\nISOLEUCINE\r\nL-LYSINE\r\nMETHIONINE\r\nPHENYLALANINE",
    "fr_ingredients": "Leucine\r\nSérine\r\nTyrosine\r\nProline\r\nArginine\r\nGlycine\r\nTryptophane\r\nThréonine\r\nHistidine\r\nValine\r\nIsoleucine\r\nL-lysine\r\nMéhionine\r\nPhénylalanine",
    "drug_strength": "730MG\r\n500MG\r\n40MG\r\n680MG\r\n1.15G\r\n1.03G\r\n2.07G\r\n180MG\r\n420MG\r\n480MG\r\n580MG\r\n600MG\r\n580MG\r\n400MG\r\n560MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "1000 mL (JB6584)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146109,
    "drug": {
      "current_status": "MARKETED",
      "id": 6642,
      "drug_code": 43947,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253137,
          "ingredient": {
            "id": 1450,
            "ingredient_code": 8872,
            "en_name": "GLUTAMIC ACID",
            "fr_name": "Acide glutamique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.02",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253136,
          "ingredient": {
            "id": 1452,
            "ingredient_code": 9397,
            "en_name": "L-ASPARTIC ACID",
            "fr_name": "Acide L-aspartique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.6",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253135,
          "ingredient": {
            "id": 398,
            "ingredient_code": 9927,
            "en_name": "SERINE",
            "fr_name": "Sérine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.02",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253134,
          "ingredient": {
            "id": 376,
            "ingredient_code": 10223,
            "en_name": "PHENYLALANINE",
            "fr_name": "Phénylalanine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253133,
          "ingredient": {
            "id": 224,
            "ingredient_code": 8865,
            "en_name": "GLYCINE",
            "fr_name": "Glycine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.06",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253132,
          "ingredient": {
            "id": 402,
            "ingredient_code": 9929,
            "en_name": "ISOLEUCINE",
            "fr_name": "Isoleucine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.08",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253131,
          "ingredient": {
            "id": 400,
            "ingredient_code": 9928,
            "en_name": "VALINE",
            "fr_name": "Valine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.44",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253130,
          "ingredient": {
            "id": 1494,
            "ingredient_code": 2963,
            "en_name": "ALANINE",
            "fr_name": "Alanine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.76",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253129,
          "ingredient": {
            "id": 382,
            "ingredient_code": 10239,
            "en_name": "LEUCINE",
            "fr_name": "Leucine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.08",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253128,
          "ingredient": {
            "id": 394,
            "ingredient_code": 9396,
            "en_name": "PROLINE",
            "fr_name": "Proline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.34",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253127,
          "ingredient": {
            "id": 384,
            "ingredient_code": 10242,
            "en_name": "ARGININE",
            "fr_name": "Arginine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.96",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253126,
          "ingredient": {
            "id": 396,
            "ingredient_code": 9750,
            "en_name": "TYROSINE",
            "fr_name": "Tyrosine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253125,
          "ingredient": {
            "id": 378,
            "ingredient_code": 10237,
            "en_name": "HISTIDINE",
            "fr_name": "Histidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.18",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253124,
          "ingredient": {
            "id": 440,
            "ingredient_code": 7216,
            "en_name": "DL-METHIONINE",
            "fr_name": "DL-méthionine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.76",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253123,
          "ingredient": {
            "id": 380,
            "ingredient_code": 10238,
            "en_name": "TRYPTOPHAN",
            "fr_name": "Tryptophane"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.32",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253122,
          "ingredient": {
            "id": 386,
            "ingredient_code": 10243,
            "en_name": "THREONINE",
            "fr_name": "Thréonine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.98",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253121,
          "ingredient": {
            "id": 1142,
            "ingredient_code": 9806,
            "en_name": "LYSINE",
            "fr_name": "Lysine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.35",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": true
        }
      ],
      "din": "02141450",
      "brand_name": "20% PROSOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "T9160",
      "number_of_ais": "17",
      "ai_group_no": "1727121002"
    },
    "created_date": "2021-09-23T19:02:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02141450",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05BA",
    "atc_description": "I.V. SOLUTIONS",
    "estimated_end_date": "2021-10-01T00:00:00-04:00",
    "actual_start_date": "2021-09-23T00:00:00-04:00",
    "actual_end_date": "2021-10-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-10-02T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "Baxter is experiencing supply constraints due to the shortage of Travasol 10% 3000mL (DIN 00872296).  As a result this product has been placed on allocation at 100% of historical usage.",
    "fr_comments": "Baxter connaît des contraintes d'approvisionnement en raison de la pénurie de Travasol à 10 % 3 000 mL (DIN 00872296). Par conséquent, le produit a été mis sous allocation à 100 % de l’utilisation historique",
    "en_drug_brand_name": "20% PROSOL",
    "en_drug_common_name": "Amino Acid Injection 20% w/v",
    "fr_drug_brand_name": "20% Prosol",
    "fr_drug_common_name": "Amino Acid Injection 20% w/v",
    "en_ingredients": "VALINE\r\nTYROSINE\r\nL-ASPARTIC ACID\r\nSERINE\r\nGLUTAMIC ACID\r\nPROLINE\r\nARGININE\r\nGLYCINE\r\nALANINE\r\nTRYPTOPHAN\r\nDL-METHIONINE\r\nTHREONINE\r\nPHENYLALANINE\r\nLEUCINE\r\nISOLEUCINE\r\nHISTIDINE\r\nLYSINE",
    "fr_ingredients": "Valine\r\nTyrosine\r\nAcide L-aspartique\r\nSérine\r\nAcide glutamique\r\nProline\r\nArginine\r\nGlycine\r\nAlanine\r\nTryptophane\r\nDL-méthionine\r\nThréonine\r\nPhénylalanine\r\nLeucine\r\nIsoleucine\r\nHistidine\r\nLysine",
    "drug_strength": "1.44G\r\n0.05G\r\n0.6G\r\n1.02G\r\n1.02G\r\n1.34G\r\n1.96G\r\n2.06G\r\n2.76G\r\n0.32G\r\n0.76G\r\n0.98G\r\n1G\r\n1.08G\r\n1.08G\r\n1.18G\r\n1.35G",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "2000mL (JB6186)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146112,
    "drug": {
      "current_status": "MARKETED",
      "id": 18382,
      "drug_code": 79652,
      "updated_date": "2025-05-15T02:32:10-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256440,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02310902",
      "brand_name": "TEVA-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055002"
    },
    "created_date": "2021-09-23T19:10:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02310902",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2021-10-31T00:00:00-04:00",
    "actual_start_date": "2021-09-22T00:00:00-04:00",
    "actual_end_date": "2021-11-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2021-11-18T18:56:19-05:00",
    "status": "resolved",
    "en_comments": "Item is short-dated-expiring",
    "fr_comments": "Item is short-dated/expiring.",
    "en_drug_brand_name": "TEVA-ATORVASTATIN",
    "en_drug_common_name": "ATORVASTATIN 20MG FC TAB",
    "fr_drug_brand_name": "TEVA-ATORVASTATIN 20MG FC TAB",
    "fr_drug_common_name": "ATORVASTATIN 20MG FC TAB",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "ATORVASTATIN",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30PP",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146115,
    "drug": {
      "current_status": "MARKETED",
      "id": 27028,
      "drug_code": 89272,
      "updated_date": "2025-05-15T02:33:59-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259731,
          "ingredient": {
            "id": 670,
            "ingredient_code": 10075,
            "en_name": "FENTANYL",
            "fr_name": "Fentanyl (Citrate de fentanyl)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02408023",
      "brand_name": "FENTORA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123302018"
    },
    "created_date": "2021-09-23T19:16:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02408023",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02AB",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2021-10-31T00:00:00-04:00",
    "actual_start_date": "2021-09-22T00:00:00-04:00",
    "actual_end_date": "2021-10-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2021-10-28T15:28:16-04:00",
    "status": "resolved",
    "en_comments": "Item is Short-dated/expiring",
    "fr_comments": "Item is short-dated/expiring",
    "en_drug_brand_name": "FENTORA",
    "en_drug_common_name": "FENTORA 400MCG BUCCAL TAB",
    "fr_drug_brand_name": "FENTORA 400MCG BUCCAL TAB",
    "fr_drug_common_name": "FENTORA 400MCG BUCCAL TAB",
    "en_ingredients": "FENTANYL",
    "fr_ingredients": "Fentanyl",
    "drug_strength": "400MCG",
    "drug_dosage_form": "TABLET (EFFERVESCENT)",
    "drug_dosage_form_fr": "Comprimé (effervescent)",
    "drug_route": "SUBLINGUAL\r\nBUCCAL\r\nSUBLINGUAL\r\nBUCCAL",
    "drug_route_fr": "Sublinguale\r\nBuccale\r\nSublinguale\r\nBuccale",
    "drug_package_quantity": "28PP",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146118,
    "drug": {
      "current_status": "MARKETED",
      "id": 11566,
      "drug_code": 68490,
      "updated_date": "2025-05-15T02:31:16-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254312,
          "ingredient": {
            "id": 1190,
            "ingredient_code": 470,
            "en_name": "GABAPENTIN",
            "fr_name": "Gabapentine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02244513",
      "brand_name": "TEVA-GABAPENTIN",
      "brand_name_fr": "",
      "descriptor": "100MG",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125929001"
    },
    "created_date": "2021-09-23T19:17:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02244513",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2021-10-31T00:00:00-04:00",
    "actual_start_date": "2021-09-22T00:00:00-04:00",
    "actual_end_date": "2021-10-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-10-07T15:02:15-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-GABAPENTIN",
    "en_drug_common_name": "GABAPENTIN 100MG CAPS",
    "fr_drug_brand_name": "TEVA-GABAPENTIN 100MG CAPS",
    "fr_drug_common_name": "GABAPENTIN 100MG CAPS",
    "en_ingredients": "GABAPENTIN",
    "fr_ingredients": "Gabapentine",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146122,
    "drug": {
      "current_status": "MARKETED",
      "id": 22354,
      "drug_code": 84752,
      "updated_date": "2025-05-15T02:32:52-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258004,
          "ingredient": {
            "id": 3196,
            "ingredient_code": 13584,
            "en_name": "ATOMOXETINE",
            "fr_name": "Atomoxétine (Chlorhydrate d'atomoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02362511",
      "brand_name": "TEVA-ATOMOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150434006"
    },
    "created_date": "2021-09-23T19:19:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02362511",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2022-03-31T00:00:00-04:00",
    "actual_start_date": "2021-09-22T00:00:00-04:00",
    "actual_end_date": "2022-03-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-03-24T14:45:55-04:00",
    "status": "resolved",
    "en_comments": "Item is short-dated/expiring",
    "fr_comments": "Item is short-dated/expiring",
    "en_drug_brand_name": "TEVA-ATOMOXETINE",
    "en_drug_common_name": "ATOMOXETINE 80MG CAPS",
    "fr_drug_brand_name": "TEVA-ATOMOXETINE 80MG CAPS",
    "fr_drug_common_name": "ATOMOXETINE 80MG CAPS",
    "en_ingredients": "ATOMOXETINE",
    "fr_ingredients": "ATOMOXETINE",
    "drug_strength": "80MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146125,
    "drug": {
      "current_status": "MARKETED",
      "id": 27032,
      "drug_code": 89274,
      "updated_date": "2025-05-15T02:33:59-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259733,
          "ingredient": {
            "id": 670,
            "ingredient_code": 10075,
            "en_name": "FENTANYL",
            "fr_name": "Fentanyl (Citrate de fentanyl)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "800",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02408058",
      "brand_name": "FENTORA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123302020"
    },
    "created_date": "2021-09-23T19:21:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02408058",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02AB",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2021-10-31T00:00:00-04:00",
    "actual_start_date": "2021-09-22T00:00:00-04:00",
    "actual_end_date": "2021-10-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2021-10-28T15:28:40-04:00",
    "status": "resolved",
    "en_comments": "Item is short-dated/expiring",
    "fr_comments": "Item is short-dated/expiring",
    "en_drug_brand_name": "FENTORA",
    "en_drug_common_name": "FENTORA 800MCG BUCCAL TAB",
    "fr_drug_brand_name": "FENTORA 800MCG BUCCAL TAB",
    "fr_drug_common_name": "FENTORA 800MCG BUCCAL TAB",
    "en_ingredients": "FENTANYL",
    "fr_ingredients": "Fentanyl",
    "drug_strength": "800MCG",
    "drug_dosage_form": "TABLET (EFFERVESCENT)",
    "drug_dosage_form_fr": "Comprimé (effervescent)",
    "drug_route": "SUBLINGUAL\r\nBUCCAL\r\nSUBLINGUAL\r\nBUCCAL",
    "drug_route_fr": "Sublinguale\r\nBuccale\r\nSublinguale\r\nBuccale",
    "drug_package_quantity": "PP28",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146128,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 65754,
      "drug_code": 95837,
      "updated_date": "2025-12-03T01:33:34-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8357588,
          "ingredient": {
            "id": 3710,
            "ingredient_code": 20671,
            "en_name": "FINGOLIMOD",
            "fr_name": "Fingolimod (Chlorhydrate de Fingolimod)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02469561",
      "brand_name": "TEVA-FINGOLIMOD",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152886001"
    },
    "created_date": "2021-09-23T19:23:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02469561",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "L04AA",
    "atc_description": "IMMUNOSUPPRESSANTS",
    "estimated_end_date": "2022-01-31T00:00:00-05:00",
    "actual_start_date": "2021-09-22T00:00:00-04:00",
    "actual_end_date": "2021-11-24T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2021-11-25T19:43:36-05:00",
    "status": "resolved",
    "en_comments": "Item is short-dated/expiring",
    "fr_comments": "Item is short-dated/expiring",
    "en_drug_brand_name": "TEVA-FINGOLIMOD",
    "en_drug_common_name": "FINGOLIMOD 0.5MG CAPS",
    "fr_drug_brand_name": "TEVA-FINGOLIMOD 0.5MG CAPS",
    "fr_drug_common_name": "FINGOLIMOD 0.5MG CAPS",
    "en_ingredients": "FINGOLIMOD",
    "fr_ingredients": "FINGOLIMOD",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30UD",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146133,
    "drug": {
      "current_status": "MARKETED",
      "id": 6792,
      "drug_code": 44270,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8253185,
          "ingredient": {
            "id": 2248,
            "ingredient_code": 9407,
            "en_name": "VINBLASTINE SULFATE",
            "fr_name": "Sulfate de vinblastine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02183056",
      "brand_name": "VINBLASTINE SULFATE INJECTION",
      "brand_name_fr": "SULFATE DE VINBLASTINE INJECTABLE",
      "descriptor": "SINGLE USE",
      "pediatric_flag": false,
      "accession_number": "T9994",
      "number_of_ais": "1",
      "ai_group_no": "0103625001"
    },
    "created_date": "2021-09-23T19:45:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02183056",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "L01CA",
    "atc_description": "PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS",
    "actual_start_date": "2021-10-31T00:00:00-04:00",
    "actual_end_date": "2021-12-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-12-18T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "VINBLASTINE SULFATE INJECTION",
    "en_drug_common_name": "VINBLASTINE SULFATE INJECTION",
    "fr_drug_brand_name": "Sulfate de Vinblastine injectable",
    "fr_drug_common_name": "Sulfate de Vinblastine injectable",
    "en_ingredients": "VINBLASTINE SULFATE",
    "fr_ingredients": "Sulfate de vinblastine",
    "drug_strength": "1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "1 x 10mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146151,
    "drug": {
      "current_status": "MARKETED",
      "id": 6972,
      "drug_code": 4733,
      "updated_date": "2025-05-15T02:30:31-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8250674,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "325",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00544981",
      "brand_name": "APO-ACETAMINOPHEN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "58590",
      "number_of_ais": "1",
      "ai_group_no": "0102009001"
    },
    "created_date": "2021-09-24T13:32:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00544981",
    "company_name": "APOTEX INC",
    "atc_number": "N02BE",
    "atc_description": "OTHER ANALGESICS AND ANTIPYRETICS",
    "estimated_end_date": "2021-09-27T00:00:00-04:00",
    "actual_start_date": "2021-09-21T00:00:00-04:00",
    "actual_end_date": "2021-09-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-09-28T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ACETAMINOPHEN",
    "en_drug_common_name": "ACETAMINOPHEN",
    "fr_drug_brand_name": "APO-ACETAMINOPHEN",
    "fr_drug_common_name": "ACETAMINOPHEN",
    "en_ingredients": "ACETAMINOPHEN",
    "fr_ingredients": "Acétaminophène",
    "drug_strength": "325MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 UD",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146154,
    "drug": {
      "current_status": "MARKETED",
      "id": 66442,
      "drug_code": 97193,
      "updated_date": "2025-05-15T02:36:46-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8263628,
          "ingredient": {
            "id": 3370,
            "ingredient_code": 20122,
            "en_name": "DASATINIB",
            "fr_name": "Dasatinib (Monohydrate de dasatinib)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "70",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02481499",
      "brand_name": "APO-DASATINIB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152198003"
    },
    "created_date": "2021-09-24T13:36:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02481499",
    "company_name": "APOTEX INC",
    "atc_number": "L01EA",
    "estimated_end_date": "2021-11-19T00:00:00-05:00",
    "actual_start_date": "2021-09-21T00:00:00-04:00",
    "actual_end_date": "2021-11-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-11-19T22:09:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DASATINIB",
    "en_drug_common_name": "DASATINIB",
    "fr_drug_brand_name": "APO-DASATINIB",
    "fr_drug_common_name": "DASATINIB",
    "en_ingredients": "DASATINIB",
    "fr_ingredients": "DASATINIB",
    "drug_strength": "70MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146157,
    "drug": {
      "current_status": "MARKETED",
      "id": 12400,
      "drug_code": 70895,
      "updated_date": "2025-05-15T02:31:23-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254566,
          "ingredient": {
            "id": 1090,
            "ingredient_code": 2414,
            "en_name": "NAPROXEN",
            "fr_name": "Naproxène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "375",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02246700",
      "brand_name": "APO-NAPROXEN EC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0109634004"
    },
    "created_date": "2021-09-24T13:39:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02246700",
    "company_name": "APOTEX INC",
    "atc_number": "M01AE",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2021-10-01T00:00:00-04:00",
    "actual_start_date": "2021-09-21T00:00:00-04:00",
    "actual_end_date": "2021-10-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-05T12:36:22-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-NAPROXEN EC",
    "en_drug_common_name": "NAPROXEN",
    "fr_drug_brand_name": "APO-NAPROXEN",
    "fr_drug_common_name": "NAPROXEN",
    "en_ingredients": "NAPROXEN",
    "fr_ingredients": "Naproxène",
    "drug_strength": "375MG",
    "drug_dosage_form": "TABLET (ENTERIC-COATED)",
    "drug_dosage_form_fr": "Comprimé (entérosoluble)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146160,
    "drug": {
      "current_status": "MARKETED",
      "id": 55786,
      "drug_code": 77467,
      "updated_date": "2025-05-15T02:31:51-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255890,
          "ingredient": {
            "id": 1286,
            "ingredient_code": 232,
            "en_name": "PERINDOPRIL ERBUMINE",
            "fr_name": "Périndopril erbumine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02289296",
      "brand_name": "APO-PERINDOPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127178003"
    },
    "created_date": "2021-09-24T13:42:23-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02289296",
    "company_name": "APOTEX INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2021-09-24T00:00:00-04:00",
    "actual_start_date": "2021-09-21T00:00:00-04:00",
    "actual_end_date": "2021-09-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-09-27T17:18:09-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-PERINDOPRIL",
    "en_drug_common_name": "PERINDOPRIL",
    "fr_drug_brand_name": "APO-PERINDOPRIL",
    "fr_drug_common_name": "PERINDOPRIL",
    "en_ingredients": "PERINDOPRIL ERBUMINE",
    "fr_ingredients": "Périndopril erbumine",
    "drug_strength": "8MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146163,
    "drug": {
      "current_status": "MARKETED",
      "id": 24690,
      "drug_code": 87266,
      "updated_date": "2025-05-15T02:33:31-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8258914,
          "ingredient": {
            "id": 790,
            "ingredient_code": 7426,
            "en_name": "ETHINYL ESTRADIOL",
            "fr_name": "Éthinylestradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8258913,
          "ingredient": {
            "id": 1472,
            "ingredient_code": 7490,
            "en_name": "LEVONORGESTREL",
            "fr_name": "Lévonorgestrel"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02387093",
      "brand_name": "OVIMA 28",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0220415004"
    },
    "created_date": "2021-09-24T13:44:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02387093",
    "company_name": "APOTEX INC",
    "atc_number": "G03AA",
    "atc_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
    "estimated_end_date": "2021-11-19T00:00:00-05:00",
    "actual_start_date": "2021-09-21T00:00:00-04:00",
    "actual_end_date": "2021-11-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-11-15T19:27:43-05:00",
    "status": "resolved",
    "en_comments": "21s pack size is available",
    "fr_comments": "21s pack size is available",
    "en_drug_brand_name": "OVIMA 28",
    "en_drug_common_name": "OVIMA",
    "fr_drug_brand_name": "OVIMA 28",
    "fr_drug_common_name": "OVIMA",
    "en_ingredients": "ETHINYL ESTRADIOL\r\nLEVONORGESTREL",
    "fr_ingredients": "Éthinylestradiol\r\nLévonorgestrel",
    "drug_strength": "30MCG\r\n150MCG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "28 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146170,
    "drug": {
      "current_status": "MARKETED",
      "id": 1878,
      "drug_code": 14007,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8251848,
          "ingredient": {
            "id": 1004,
            "ingredient_code": 11340,
            "en_name": "PAROXETINE",
            "fr_name": "Paroxétine (Chlorhydrate de paroxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "01940481",
      "brand_name": "PAXIL TAB 20MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "75504",
      "number_of_ais": "1",
      "ai_group_no": "0123131002"
    },
    "created_date": "2021-09-24T15:39:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01940481",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2021-10-15T00:00:00-04:00",
    "actual_start_date": "2021-09-29T00:00:00-04:00",
    "actual_end_date": "2021-10-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-06T17:25:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PAXIL TAB 20MG",
    "en_drug_common_name": "Paroxetine Tablets",
    "fr_drug_brand_name": "PAXIL",
    "fr_drug_common_name": "Comprimés de paroxétine",
    "en_ingredients": "PAROXETINE",
    "fr_ingredients": "Paroxétine (Chlorhydrate de paroxétine)",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146183,
    "drug": {
      "current_status": "MARKETED",
      "id": 29038,
      "drug_code": 91086,
      "updated_date": "2025-12-03T00:32:35-05:00",
      "company": {
        "id": 16915,
        "created_date": "2020-07-07T01:47:04-04:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 9360,
        "mfr_code": "",
        "name": "LABORATOIRE AGUETTANT",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1, RUE ALEXANDER FLEMING",
        "province": "RHÔNE",
        "country": "FRANCE",
        "city": "LYON",
        "postal_code": "69007",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260538,
          "ingredient": {
            "id": 558,
            "ingredient_code": 8970,
            "en_name": "ATROPINE SULFATE",
            "fr_name": "Sulfate d'atropine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02426269",
      "brand_name": "ATROPINE SULFATE INJECTION",
      "brand_name_fr": "SULFATE D'ATROPINE INJECTABLE",
      "descriptor": "SINGLE-USE PREFILLED SYRINGE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104748003"
    },
    "created_date": "2021-09-24T17:51:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02426269",
    "company_name": "BIOSYENT PHARMA INC",
    "atc_number": "A03BA",
    "atc_description": "BELLADONNAAND DERIVATIVES, PLAIN",
    "anticipated_start_date": "2021-10-08T00:00:00-04:00",
    "estimated_end_date": "2021-10-22T00:00:00-04:00",
    "actual_end_date": "2021-10-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2021-10-19T00:58:26-04:00",
    "status": "resolved",
    "en_comments": "Unanticipated heavy demand increase for drug.",
    "fr_comments": "Unanticipated heavy demand increase for drug",
    "en_drug_brand_name": "ATROPINE SULFATE INJECTION",
    "en_drug_common_name": "Atropine Sulfate Injection",
    "fr_drug_brand_name": "ATROPINE SULFATE INJECTION",
    "fr_drug_common_name": "Atropine Sulfate Injection",
    "en_ingredients": "ATROPINE SULFATE",
    "fr_ingredients": "Sulfate d'atropine",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nIntramusculaire\r\nSous-cutanée\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "0.5 mg/5mL pre-filled syringe. 10 syringes per carton.",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146191,
    "drug": {
      "current_status": "MARKETED",
      "id": 26198,
      "drug_code": 88535,
      "updated_date": "2025-05-15T02:33:47-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259437,
          "ingredient": {
            "id": 2616,
            "ingredient_code": 11795,
            "en_name": "CLOPIDOGREL",
            "fr_name": "Clopidogrel (Bisulfate de clopidogrel)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02400553",
      "brand_name": "CLOPIDOGREL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134440001"
    },
    "created_date": "2021-09-24T19:07:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02400553",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "B01AC",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "estimated_end_date": "2021-12-12T00:00:00-05:00",
    "actual_start_date": "2021-09-24T00:00:00-04:00",
    "actual_end_date": "2021-12-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2021-12-13T02:39:09-05:00",
    "status": "resolved",
    "en_drug_brand_name": "CLOPIDOGREL",
    "en_drug_common_name": "CLOPIDOGREL",
    "fr_drug_brand_name": "CLOPIDOGREL",
    "fr_drug_common_name": "CLOPIDOGREL",
    "en_ingredients": "CLOPIDOGREL",
    "fr_ingredients": "CLOPIDOGREL (CLOPIDOGREL BISULFATE)",
    "drug_strength": "75MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146195,
    "drug": {
      "current_status": "MARKETED",
      "id": 66448,
      "drug_code": 97311,
      "updated_date": "2025-05-15T02:37:04-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8263718,
          "ingredient": {
            "id": 142,
            "ingredient_code": 9117,
            "en_name": "MORPHINE SULFATE",
            "fr_name": "Sulfate de morphine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "1",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02482681",
      "brand_name": "MORPHINE SULFATE INJECTION, USP",
      "brand_name_fr": "SULFATE DE MORPHINE INJECTABLE, USP",
      "descriptor": "SINGLE USE VIAL, PRESERVATIVE FREE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104545008"
    },
    "created_date": "2021-09-24T19:10:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02482681",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2021-10-05T00:00:00-04:00",
    "actual_start_date": "2021-09-24T00:00:00-04:00",
    "actual_end_date": "2021-10-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-06T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MORPHINE SULFATE INJECTION, USP",
    "en_drug_common_name": "Morphine Sulfate Injection, USP 2 mg / mL Vial 1 mL",
    "fr_drug_brand_name": "Sulfate de morphine injectable, USP",
    "fr_drug_common_name": "Sulfate de morphine injectable, USP 2 mg/mL, fiole, 1 mL",
    "en_ingredients": "MORPHINE SULFATE",
    "fr_ingredients": "Sulfate de morphine",
    "drug_strength": "2MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nIntramusculaire\r\nSous-cutanée\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "1 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146199,
    "drug": {
      "current_status": "DORMANT",
      "id": 21440,
      "drug_code": 83828,
      "updated_date": "2025-05-15T06:55:41-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368460,
          "ingredient": {
            "id": 2442,
            "ingredient_code": 11516,
            "en_name": "ROPINIROLE",
            "fr_name": "Ropinirole (Chlorhydrate de ropinirole)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02353059",
      "brand_name": "ROPINIROLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132618003"
    },
    "created_date": "2021-09-24T19:26:31-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02353059",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N04BC",
    "atc_description": "DOPAMINERGIC AGENTS",
    "hc_updated_date": "2024-02-15T13:26:21-05:00",
    "estimated_end_date": "2022-12-21T00:00:00-05:00",
    "actual_start_date": "2021-09-24T00:00:00-04:00",
    "actual_end_date": "2021-09-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-15T13:26:23-05:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "ROPINIROLE",
    "en_drug_common_name": "ROPINIROLE",
    "fr_drug_brand_name": "ROPINIROLE",
    "fr_drug_common_name": "ROPINIROLE",
    "en_ingredients": "ROPINIROLE",
    "fr_ingredients": "ROPINIROLE (ROPINIROLE HYDROCHLORIDE)",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146256,
    "drug": {
      "current_status": "MARKETED",
      "id": 26390,
      "drug_code": 88731,
      "updated_date": "2025-05-15T02:33:50-04:00",
      "company": {
        "id": 74,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3798,
        "mfr_code": "BQC07",
        "name": "BRISTOL-MYERS SQUIBB CANADA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2344 BOUL. ALFRED-NOBEL, SUITE 300",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "ST-LAURENT",
        "postal_code": "H4S 0A4",
        "post_office_box": "",
        "contact_information": "For more information please contact the Customer Service Desk at 1-800-267-0005"
      },
      "drug_ingredients": [
        {
          "id": 8259532,
          "ingredient": {
            "id": 3308,
            "ingredient_code": 15233,
            "en_name": "ABATACEPT",
            "fr_name": "Abatacept"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02402475",
      "brand_name": "ORENCIA",
      "brand_name_fr": "",
      "descriptor": "PRE-FILLED SYRINGE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151647002"
    },
    "created_date": "2021-09-27T18:40:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02402475",
    "company_name": "BRISTOL-MYERS SQUIBB CANADA",
    "atc_number": "L04AA",
    "atc_description": "IMMUNOSUPPRESSANTS",
    "anticipated_start_date": "2021-09-27T00:00:00-04:00",
    "estimated_end_date": "2021-10-31T00:00:00-04:00",
    "actual_start_date": "2021-09-27T00:00:00-04:00",
    "actual_end_date": "2021-10-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-10-14T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "Allocation will be based on historical demand.",
    "fr_comments": "Allocation basée sur l'historique des commandes.",
    "en_drug_brand_name": "ORENCIA",
    "en_drug_common_name": "Abatacept",
    "fr_drug_brand_name": "Orencia SC",
    "fr_drug_common_name": "Abatacept",
    "en_ingredients": "ABATACEPT",
    "fr_ingredients": "Abatacept",
    "drug_strength": "125MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "4 x 1mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146277,
    "drug": {
      "current_status": "MARKETED",
      "id": 16052,
      "drug_code": 76846,
      "updated_date": "2025-05-15T02:31:46-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255730,
          "ingredient": {
            "id": 1004,
            "ingredient_code": 11340,
            "en_name": "PAROXETINE",
            "fr_name": "Paroxétine (Chlorhydrate de paroxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02282844",
      "brand_name": "PAROXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123131003"
    },
    "created_date": "2021-09-28T17:28:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02282844",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2021-05-08T00:00:00-04:00",
    "actual_end_date": "2021-09-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-09-29T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PAROXETINE",
    "en_drug_common_name": "PAROXETINE",
    "fr_drug_brand_name": "PAROXETINE",
    "fr_drug_common_name": "PAROXETINE",
    "en_ingredients": "PAROXETINE",
    "fr_ingredients": "PAROXETINE (PAROXETINE HYDROCHLORIDE)",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146280,
    "drug": {
      "id": 9172,
      "drug_code": 62021,
      "updated_date": "2025-12-03T02:32:18-05:00",
      "company": {
        "id": 1700,
        "created_date": "2017-03-09T13:25:18-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17140,
        "mfr_code": "",
        "name": "ENDO OPERATIONS LTD.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD",
        "province": "DUBLIN",
        "country": "IRELAND",
        "city": "BALLSBRIDGE",
        "postal_code": "D04 H9P8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8367347,
          "ingredient": {
            "id": 1658,
            "ingredient_code": 7335,
            "en_name": "ALPROSTADIL",
            "fr_name": "Alprostadil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02238593",
      "brand_name": "MUSE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115288010"
    },
    "created_date": "2021-09-28T17:59:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238593",
    "company_name": "PALADIN LABS INC.",
    "atc_number": "G04BE",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "estimated_end_date": "2022-02-28T00:00:00-05:00",
    "actual_start_date": "2021-09-08T00:00:00-04:00",
    "actual_end_date": "2022-03-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-03-23T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Product on allocation",
    "fr_comments": "Produit en allocation",
    "en_drug_brand_name": "MUSE",
    "en_drug_common_name": "ALPROSTADIL",
    "fr_drug_brand_name": "MUSE",
    "fr_drug_common_name": "ALPROSTADIL",
    "en_ingredients": "ALPROSTADIL",
    "fr_ingredients": "Alprostadil",
    "drug_strength": "250MCG",
    "drug_dosage_form": "SUPPOSITORY",
    "drug_dosage_form_fr": "Suppositoire",
    "drug_route": "URETHRAL\r\nURETHRAL",
    "drug_route_fr": "Urétrale\r\nUrétrale",
    "drug_package_quantity": "1 Micro-suppository",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146289,
    "drug": {
      "current_status": "MARKETED",
      "id": 16054,
      "drug_code": 76847,
      "updated_date": "2025-05-15T02:31:46-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255731,
          "ingredient": {
            "id": 1004,
            "ingredient_code": 11340,
            "en_name": "PAROXETINE",
            "fr_name": "Paroxétine (Chlorhydrate de paroxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02282852",
      "brand_name": "PAROXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123131002"
    },
    "created_date": "2021-09-28T18:18:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02282852",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2019-05-08T00:00:00-04:00",
    "estimated_end_date": "2021-09-10T00:00:00-04:00",
    "actual_end_date": "2021-09-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-09-29T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PAROXETINE",
    "en_drug_common_name": "PAROXETINE",
    "fr_drug_brand_name": "PAROXETINE",
    "fr_drug_common_name": "PAROXETINE",
    "en_ingredients": "PAROXETINE",
    "fr_ingredients": "PAROXETINE (PAROXETINE HYDROCHLORIDE)",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146304,
    "drug": {
      "current_status": "MARKETED",
      "id": 16056,
      "drug_code": 76848,
      "updated_date": "2025-05-15T02:31:46-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255732,
          "ingredient": {
            "id": 1004,
            "ingredient_code": 11340,
            "en_name": "PAROXETINE",
            "fr_name": "Paroxétine (Chlorhydrate de paroxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02282860",
      "brand_name": "PAROXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123131001"
    },
    "created_date": "2021-09-28T18:30:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02282860",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2019-05-08T00:00:00-04:00",
    "actual_end_date": "2021-09-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-09-29T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PAROXETINE",
    "en_drug_common_name": "PAROXETINE",
    "fr_drug_brand_name": "PAROXETINE",
    "fr_drug_common_name": "PAROXETINE",
    "en_ingredients": "PAROXETINE",
    "fr_ingredients": "PAROXETINE (PAROXETINE HYDROCHLORIDE)",
    "drug_strength": "30MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146307,
    "drug": {
      "current_status": "MARKETED",
      "id": 2594,
      "drug_code": 1620,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8250282,
          "ingredient": {
            "id": 138,
            "ingredient_code": 8551,
            "en_name": "CLINDAMYCIN",
            "fr_name": "Clindamycine (Chlorhydrate de clindamycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00260436",
      "brand_name": "DALACIN C PHOSPHATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "42067",
      "number_of_ais": "1",
      "ai_group_no": "0105830002"
    },
    "created_date": "2021-09-28T18:59:23-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00260436",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "J01FF",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "actual_start_date": "2021-10-01T00:00:00-04:00",
    "actual_end_date": "2021-10-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-10-14T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DALACIN C PHOSPHATE",
    "en_drug_common_name": "DALACIN C PHOSPHATE",
    "fr_drug_brand_name": "Dalacin C Phosphate",
    "fr_drug_common_name": "Dalacin C Phosphate",
    "en_ingredients": "CLINDAMYCIN",
    "fr_ingredients": "Clindamycin",
    "drug_strength": "150MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "1 x 60mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146310,
    "drug": {
      "current_status": "MARKETED",
      "id": 22754,
      "drug_code": 85280,
      "updated_date": "2025-12-03T00:31:47-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8258200,
          "ingredient": {
            "id": 368,
            "ingredient_code": 7626,
            "en_name": "METHYLPREDNISOLONE",
            "fr_name": "Méthylprednisolone (Succinate sodique de méthylprednisolone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02367971",
      "brand_name": "SOLU-MEDROL",
      "brand_name_fr": "",
      "descriptor": "ACT-O-VIAL. SINGLE-DOSE.  WITHOUT PRESERVATIVE. SUPPLIED WITH DILUENT.",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106290009"
    },
    "created_date": "2021-09-28T19:13:47-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02367971",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "H02AB",
    "atc_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
    "actual_start_date": "2021-10-01T00:00:00-04:00",
    "actual_end_date": "2021-10-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-14T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SOLU-MEDROL",
    "en_drug_common_name": "SOLU-MEDROL",
    "fr_drug_brand_name": "SOLU-MEDROL",
    "fr_drug_common_name": "SOLU-MEDROL",
    "en_ingredients": "METHYLPREDNISOLONE",
    "fr_ingredients": "Méthylprednisolone",
    "drug_strength": "1G",
    "drug_dosage_form": "POWDER FOR SOLUTION\r\nKIT",
    "drug_dosage_form_fr": "Poudre pour solution\r\nTrousse",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "8mL act-o-vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146330,
    "drug": {
      "current_status": "MARKETED",
      "id": 15806,
      "drug_code": 76541,
      "updated_date": "2025-05-15T02:31:45-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8255660,
          "ingredient": {
            "id": 986,
            "ingredient_code": 723,
            "en_name": "RISPERIDONE",
            "fr_name": "Rispéridone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02279827",
      "brand_name": "SANDOZ RISPERIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124332002"
    },
    "created_date": "2021-09-28T20:08:50-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02279827",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N05AX",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2021-10-08T00:00:00-04:00",
    "actual_start_date": "2021-09-27T00:00:00-04:00",
    "actual_end_date": "2021-10-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-10-16T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ RISPERIDONE",
    "en_drug_common_name": "RISPERIDONE",
    "fr_drug_brand_name": "SANDOZ RISPERIDONE",
    "fr_drug_common_name": "RISPERIDONE",
    "en_ingredients": "RISPERIDONE",
    "fr_ingredients": "Rispéridone",
    "drug_strength": "3.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100FCT BO",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146335,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 64678,
      "drug_code": 97248,
      "updated_date": "2025-12-03T01:33:48-05:00",
      "company": {
        "id": 1952,
        "created_date": "2017-03-09T13:26:33-05:00",
        "updated_date": "2025-05-15T02:30:24-04:00",
        "company_code": 15890,
        "mfr_code": "",
        "name": "STERINOVA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3005 AVENUE JOSE-MARIA ROSELL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HYACINTHE",
        "postal_code": "J2S 0J9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8358074,
          "ingredient": {
            "id": 2756,
            "ingredient_code": 6417,
            "en_name": "METHADONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthadone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02481979",
      "brand_name": "METHADONE HYDROCHLORIDE ORAL CONCENTRATE USP",
      "brand_name_fr": "CONCENTRÉ ORAL DE CHLORHYDRATE DE MÉTHADONE USP",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0144621001"
    },
    "created_date": "2021-09-28T20:20:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02481979",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N07BC",
    "atc_description": "DRUGS USED IN ADDICTIVE DISORDERS",
    "actual_start_date": "2021-09-28T00:00:00-04:00",
    "actual_end_date": "2021-10-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-05T01:56:40-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ METHADONE",
    "en_drug_common_name": "METHADONE",
    "fr_drug_brand_name": "SANDOZ METHADONE",
    "fr_drug_common_name": "METHADONE",
    "en_ingredients": "METHADONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthadone",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1000ML SOL BO",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146338,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 64678,
      "drug_code": 97248,
      "updated_date": "2025-12-03T01:33:48-05:00",
      "company": {
        "id": 1952,
        "created_date": "2017-03-09T13:26:33-05:00",
        "updated_date": "2025-05-15T02:30:24-04:00",
        "company_code": 15890,
        "mfr_code": "",
        "name": "STERINOVA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3005 AVENUE JOSE-MARIA ROSELL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HYACINTHE",
        "postal_code": "J2S 0J9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8358074,
          "ingredient": {
            "id": 2756,
            "ingredient_code": 6417,
            "en_name": "METHADONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthadone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02481979",
      "brand_name": "METHADONE HYDROCHLORIDE ORAL CONCENTRATE USP",
      "brand_name_fr": "CONCENTRÉ ORAL DE CHLORHYDRATE DE MÉTHADONE USP",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0144621001"
    },
    "created_date": "2021-09-28T20:25:05-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02481979",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N07BC",
    "atc_description": "DRUGS USED IN ADDICTIVE DISORDERS",
    "discontinuation_date": "2021-10-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-10-05T01:55:54-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "SANDOZ METHADONE",
    "en_drug_common_name": "METHADONE",
    "fr_drug_brand_name": "SANDOZ METHADONE",
    "fr_drug_common_name": "METHADONE",
    "en_ingredients": "METHADONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthadone",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1000ML SOL BO",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146362,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 6464,
      "drug_code": 43386,
      "updated_date": "2025-12-03T01:13:06-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8312949,
          "ingredient": {
            "id": 2130,
            "ingredient_code": 424,
            "en_name": "AZITHROMYCIN",
            "fr_name": "Azithromycine (Monohydrate d'azithromycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02223716",
      "brand_name": "ZITHROMAX - PWS ORL 100MG/5ML",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9717",
      "number_of_ais": "1",
      "ai_group_no": "0126072002"
    },
    "created_date": "2021-09-29T15:06:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02223716",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "J01FA",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "actual_start_date": "2021-09-30T00:00:00-04:00",
    "actual_end_date": "2022-01-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-01-13T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ZITHROMAX - PWS ORL 100MG/5ML",
    "en_drug_common_name": "ZITHROMAX - PWS ORL 100MG/5ML",
    "fr_drug_brand_name": "ZITHROMAX - PWS ORL 100MG/5ML",
    "fr_drug_common_name": "ZITHROMAX - PWS ORL 100MG/5ML",
    "en_ingredients": "AZITHROMYCIN",
    "fr_ingredients": "Azithromycine",
    "drug_strength": "100MG",
    "drug_dosage_form": "POWDER FOR SUSPENSION",
    "drug_dosage_form_fr": "Poudre pour suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "15mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146367,
    "drug": {
      "current_status": "MARKETED",
      "id": 6140,
      "drug_code": 42848,
      "updated_date": "2025-12-03T00:30:36-05:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252986,
          "ingredient": {
            "id": 142,
            "ingredient_code": 9117,
            "en_name": "MORPHINE SULFATE",
            "fr_name": "Sulfate de morphine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02184451",
      "brand_name": "KADIAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9015",
      "number_of_ais": "1",
      "ai_group_no": "0104545012"
    },
    "created_date": "2021-09-29T17:17:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02184451",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "hc_updated_date": "2021-10-26T19:32:40-04:00",
    "anticipated_start_date": "2021-10-20T00:00:00-04:00",
    "estimated_end_date": "2021-11-02T00:00:00-04:00",
    "actual_start_date": "2021-10-15T00:00:00-04:00",
    "actual_end_date": "2021-11-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-11-03T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "KADIAN",
    "en_drug_common_name": "MORPHINE SULFATE",
    "fr_drug_brand_name": "KADIAN",
    "fr_drug_common_name": "MORPHINE SULFATE",
    "en_ingredients": "MORPHINE SULFATE",
    "fr_ingredients": "Sulfate de morphine",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE (SUSTAINED-RELEASE)",
    "drug_dosage_form_fr": "Capsule (à action soutenue)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "50BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146370,
    "drug": {
      "current_status": "MARKETED",
      "id": 22070,
      "drug_code": 84453,
      "updated_date": "2025-05-15T02:32:51-04:00",
      "company": {
        "id": 32,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7054,
        "mfr_code": "PFR08",
        "name": "PURDUE PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257904,
          "ingredient": {
            "id": 74,
            "ingredient_code": 20280,
            "en_name": "HYDROMORPHONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydromorphone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "9",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02359510",
      "brand_name": "HYDROMORPH CONTIN",
      "brand_name_fr": "",
      "descriptor": "CONTROLLED RELEASE CAPSULE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108698019"
    },
    "created_date": "2021-09-29T20:41:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02359510",
    "company_name": "PURDUE PHARMA",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2021-09-29T00:00:00-04:00",
    "estimated_end_date": "2021-11-12T00:00:00-05:00",
    "actual_start_date": "2021-09-29T00:00:00-04:00",
    "actual_end_date": "2021-11-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-11-04T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "HYDROMORPH CONTIN",
    "en_drug_common_name": "HYDROmorphone hydrochloride Controlled Release Capsules",
    "fr_drug_brand_name": "HYDROMORPH CONTIN",
    "fr_drug_common_name": "Capsules de chlorhydrate d’HYDROmorphone* à libération contrôlée",
    "en_ingredients": "HYDROMORPHONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydromorphone",
    "drug_strength": "9MG",
    "drug_dosage_form": "CAPSULE (SUSTAINED-RELEASE)",
    "drug_dosage_form_fr": "Capsule (à action soutenue)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146373,
    "drug": {
      "current_status": "MARKETED",
      "id": 16396,
      "drug_code": 77190,
      "updated_date": "2025-12-03T00:31:10-05:00",
      "company": {
        "id": 32,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7054,
        "mfr_code": "PFR08",
        "name": "PURDUE PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255846,
          "ingredient": {
            "id": 3208,
            "ingredient_code": 13904,
            "en_name": "TRAMADOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de tramadol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02286440",
      "brand_name": "ZYTRAM XL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151694001"
    },
    "created_date": "2021-09-29T20:46:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02286440",
    "company_name": "PURDUE PHARMA",
    "atc_number": "N02AX",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2021-09-29T00:00:00-04:00",
    "estimated_end_date": "2021-10-22T00:00:00-04:00",
    "actual_start_date": "2021-09-29T00:00:00-04:00",
    "actual_end_date": "2021-10-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-10-15T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ZYTRAM XL",
    "en_drug_common_name": "Tramadol Hydrochloride Controlled Release Tablets",
    "fr_drug_brand_name": "ZYTRAM XL",
    "fr_drug_common_name": "Comprimés de chlorhydrate de tramadol à libération contrôlée",
    "en_ingredients": "TRAMADOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de tramadol",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146385,
    "drug": {
      "current_status": "MARKETED",
      "id": 962,
      "drug_code": 12256,
      "updated_date": "2025-05-15T02:30:52-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251604,
          "ingredient": {
            "id": 466,
            "ingredient_code": 2322,
            "en_name": "DOPAMINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de dopamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251603,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00761850",
      "brand_name": "DOPAMINE HCL 0.8MG/ML DEXTROSE 5% INJ USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "73323",
      "number_of_ais": "2",
      "ai_group_no": "0217918001"
    },
    "created_date": "2021-09-30T14:18:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00761850",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "C01CA",
    "atc_description": "CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES",
    "anticipated_start_date": "2021-09-30T00:00:00-04:00",
    "estimated_end_date": "2021-12-08T00:00:00-05:00",
    "actual_start_date": "2021-09-30T00:00:00-04:00",
    "actual_end_date": "2021-12-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-12-09T06:00:02-05:00",
    "status": "resolved",
    "en_comments": "Baxter products Dopamine Hydrochloride and 5% Dextrose USP – 400mg/250mL bags (DIN 00761826) and 800mg/250mL bags (DIN 00761834) are available as alternatives if they align with clinical practice.",
    "fr_comments": "Les produits Baxter, Dopamine Hydrochloride et 5% Dextrose USP – 400mg/250mL (DIN 00761826) et 800mg/250mL (DIN 00761834)  peut être utilisé comme alternatives s'ils correspondent à la pratique clinique.",
    "en_drug_brand_name": "DOPAMINE HCL 0.8MG/ML DEXTROSE 5% INJ USP",
    "en_drug_common_name": "Dopamine",
    "fr_drug_brand_name": "DOPAMINE HCL 0.8MG/ML DEXTROSE 5% INJ USP",
    "fr_drug_common_name": "DOPAMINE",
    "en_ingredients": "DEXTROSE\r\nDOPAMINE HYDROCHLORIDE",
    "fr_ingredients": "Dextrose\r\nChlorhydrate de dopamine",
    "drug_strength": "50MG\r\n.8MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "250mL (18 bags per case)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146434,
    "drug": {
      "current_status": "MARKETED",
      "id": 25630,
      "drug_code": 88042,
      "updated_date": "2025-05-15T02:33:42-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259257,
          "ingredient": {
            "id": 2740,
            "ingredient_code": 11923,
            "en_name": "TEMOZOLOMIDE",
            "fr_name": "Témozolomide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02395312",
      "brand_name": "TEVA-TEMOZOLOMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0138781004"
    },
    "created_date": "2021-09-30T18:06:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02395312",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "L01AX",
    "atc_description": "ALKYLATINGAGENTS",
    "estimated_end_date": "2021-10-31T00:00:00-04:00",
    "actual_start_date": "2021-09-29T00:00:00-04:00",
    "actual_end_date": "2021-10-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-10-21T15:38:57-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT TEMOZOLOMIDE",
    "en_drug_common_name": "TEMOZOLOMIDE 250MG CAPS",
    "fr_drug_brand_name": "ACT-TEMOZOLOMIDE 250MG CAPS",
    "fr_drug_common_name": "TEMOZOLOMIDE 250MG CAPS",
    "en_ingredients": "TEMOZOLOMIDE",
    "fr_ingredients": "Témozolomide",
    "drug_strength": "250MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "5",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146437,
    "drug": {
      "current_status": "MARKETED",
      "id": 64616,
      "drug_code": 94375,
      "updated_date": "2025-05-15T02:35:29-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262061,
          "ingredient": {
            "id": 3432,
            "ingredient_code": 20171,
            "en_name": "DULOXETINE",
            "fr_name": "Duloxétine (Chlorhydrate de duloxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02456761",
      "brand_name": "TEVA-DULOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152350002"
    },
    "created_date": "2021-09-30T18:07:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02456761",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2021-10-31T00:00:00-04:00",
    "actual_start_date": "2021-09-29T00:00:00-04:00",
    "actual_end_date": "2021-10-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-21T15:39:23-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-DULOXETINE",
    "en_drug_common_name": "DULOXETINE HCL 60MG CAPS",
    "fr_drug_brand_name": "TEVA-DULOXETINE HCL 60MG CAPS",
    "fr_drug_common_name": "DULOXETINE HCL 60MG CAPS",
    "en_ingredients": "DULOXETINE",
    "fr_ingredients": "DULOXETINE HCL",
    "drug_strength": "60MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146440,
    "drug": {
      "current_status": "MARKETED",
      "id": 3712,
      "drug_code": 19201,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252460,
          "ingredient": {
            "id": 1536,
            "ingredient_code": 11254,
            "en_name": "CEFOXITIN",
            "fr_name": "Céfoxitine (Céfoxitine sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": true
        }
      ],
      "din": "02128195",
      "brand_name": "CEFOXITIN FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81492",
      "number_of_ais": "1",
      "ai_group_no": "0113134001"
    },
    "created_date": "2021-09-30T18:08:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02128195",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01DC",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "estimated_end_date": "2021-10-31T00:00:00-04:00",
    "actual_start_date": "2021-09-29T00:00:00-04:00",
    "actual_end_date": "2021-10-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-10-07T15:02:43-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CEFOXITIN FOR INJECTION",
    "en_drug_common_name": "CEFOXITIN INJECTION 2 GRAM",
    "fr_drug_brand_name": "CEFOXITIN INJECTION 2 GRAM",
    "fr_drug_common_name": "CEFOXITIN INJECTION 2 GRAM",
    "en_ingredients": "CEFOXITIN",
    "fr_ingredients": "CEFOXITIN",
    "drug_strength": "2G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "10pk",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146443,
    "drug": {
      "current_status": "MARKETED",
      "id": 17236,
      "drug_code": 78284,
      "updated_date": "2025-12-03T00:31:14-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256080,
          "ingredient": {
            "id": 782,
            "ingredient_code": 11344,
            "en_name": "AMLODIPINE",
            "fr_name": "Amlodipine (Bésylate d'amlodipine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02297493",
      "brand_name": "TEVA-AMLODIPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131437001"
    },
    "created_date": "2021-09-30T18:09:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02297493",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C08CA",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.",
    "estimated_end_date": "2021-10-31T00:00:00-04:00",
    "actual_start_date": "2021-09-29T00:00:00-04:00",
    "actual_end_date": "2021-10-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-07T15:03:45-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT AMLODIPINE",
    "en_drug_common_name": "AMLODIPINE 10MG TAB",
    "fr_drug_brand_name": "ACT-AMLODIPINE 10MG TAB",
    "fr_drug_common_name": "AMLODIPINE 10MG TAB",
    "en_ingredients": "AMLODIPINE",
    "fr_ingredients": "AMLODIPINE",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146446,
    "drug": {
      "current_status": "MARKETED",
      "id": 16866,
      "drug_code": 77854,
      "updated_date": "2025-05-15T02:31:55-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255956,
          "ingredient": {
            "id": 2616,
            "ingredient_code": 11795,
            "en_name": "CLOPIDOGREL",
            "fr_name": "Clopidogrel (Bisulfate de clopidogrel)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02293161",
      "brand_name": "TEVA-CLOPIDOGREL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134440001"
    },
    "created_date": "2021-09-30T18:11:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02293161",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "B01AC",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "estimated_end_date": "2022-01-31T00:00:00-05:00",
    "actual_start_date": "2021-09-29T00:00:00-04:00",
    "actual_end_date": "2022-01-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-01-20T14:39:50-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-CLOPIDOGREL",
    "en_drug_common_name": "CLOPIDOGREL 75MG TAB",
    "fr_drug_brand_name": "TEVA-CLOPIDOGREL 75MG TAB",
    "fr_drug_common_name": "CLOPIDOGREL 75MG TAB",
    "en_ingredients": "CLOPIDOGREL",
    "fr_ingredients": "CLOPIDOGREL",
    "drug_strength": "75MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500's  PP 30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146449,
    "drug": {
      "current_status": "MARKETED",
      "id": 18380,
      "drug_code": 79651,
      "updated_date": "2025-05-15T02:32:10-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256439,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02310899",
      "brand_name": "TEVA-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055001"
    },
    "created_date": "2021-09-30T18:13:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02310899",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2021-11-30T00:00:00-05:00",
    "actual_start_date": "2021-09-29T00:00:00-04:00",
    "actual_end_date": "2021-11-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-11-11T19:26:35-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-ATORVASTATIN",
    "en_drug_common_name": "ATORVASTATIN 10 MG FC TAB",
    "fr_drug_brand_name": "TEVA-ATORVASTATIN 10 MG FC TAB",
    "fr_drug_common_name": "ATORVASTATIN 10 MG FC TAB",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "ATORVASTATIN",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146456,
    "drug": {
      "current_status": "MARKETED",
      "id": 18382,
      "drug_code": 79652,
      "updated_date": "2025-05-15T02:32:10-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256440,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02310902",
      "brand_name": "TEVA-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055002"
    },
    "created_date": "2021-09-30T18:20:22-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02310902",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2021-11-30T00:00:00-05:00",
    "actual_start_date": "2021-09-29T00:00:00-04:00",
    "actual_end_date": "2021-11-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-11-11T19:26:59-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-ATORVASTATIN",
    "en_drug_common_name": "ATORVASTATIN 10 MG FC TAB",
    "fr_drug_brand_name": "TEVA-ATORVASTATIN 10 MG FC TAB",
    "fr_drug_common_name": "ATORVASTATIN 10 MG FC TAB",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "ATORVASTATIN",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146459,
    "drug": {
      "current_status": "MARKETED",
      "id": 21090,
      "drug_code": 83386,
      "updated_date": "2025-12-03T00:31:35-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257488,
          "ingredient": {
            "id": 862,
            "ingredient_code": 768,
            "en_name": "FINASTERIDE",
            "fr_name": "Finastéride"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02348500",
      "brand_name": "TEVA-FINASTERIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124110001"
    },
    "created_date": "2021-09-30T18:29:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02348500",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "G04CB",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "estimated_end_date": "2021-10-31T00:00:00-04:00",
    "actual_start_date": "2021-09-29T00:00:00-04:00",
    "actual_end_date": "2021-10-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-07T15:04:15-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-FINASTERIDE",
    "en_drug_common_name": "FINASTERIDE 5MG TAB",
    "fr_drug_brand_name": "TEVA-FINASTERIDE 5MG TAB",
    "fr_drug_common_name": "FINASTERIDE 5MG TAB",
    "en_ingredients": "FINASTERIDE",
    "fr_ingredients": "Finastéride",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146462,
    "drug": {
      "current_status": "MARKETED",
      "id": 14418,
      "drug_code": 74666,
      "updated_date": "2025-12-03T00:31:02-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255198,
          "ingredient": {
            "id": 2776,
            "ingredient_code": 11980,
            "en_name": "LEFLUNOMIDE",
            "fr_name": "Léflunomide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02261278",
      "brand_name": "TEVA-LEFLUNOMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0140182002"
    },
    "created_date": "2021-09-30T18:31:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02261278",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "L04AA",
    "atc_description": "IMMUNOSUPPRESSANTS",
    "estimated_end_date": "2021-10-31T00:00:00-04:00",
    "actual_start_date": "2021-09-29T00:00:00-04:00",
    "actual_end_date": "2021-10-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-21T15:39:49-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-LEFLUNOMIDE",
    "en_drug_common_name": "LEFLUNOMIDE 20MG TAB",
    "fr_drug_brand_name": "TEVA-LEFLUNOMIDE 20MG TAB",
    "fr_drug_common_name": "LEFLUNOMIDE 20MG TAB",
    "en_ingredients": "LEFLUNOMIDE",
    "fr_ingredients": "Léflunomide",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146466,
    "drug": {
      "current_status": "MARKETED",
      "id": 7970,
      "drug_code": 5181,
      "updated_date": "2025-05-15T02:30:32-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250710,
          "ingredient": {
            "id": 496,
            "ingredient_code": 8376,
            "en_name": "CEPHALEXIN",
            "fr_name": "Céphalexine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00583413",
      "brand_name": "TEVA-CEPHALEXIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "59856",
      "number_of_ais": "1",
      "ai_group_no": "0105911004"
    },
    "created_date": "2021-09-30T18:34:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00583413",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01DB",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "estimated_end_date": "2022-01-31T00:00:00-05:00",
    "actual_start_date": "2021-09-29T00:00:00-04:00",
    "actual_end_date": "2021-10-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-07T15:05:57-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-CEPHALEXIN",
    "en_drug_common_name": "CEPHALEXIN 250MG TAB",
    "fr_drug_brand_name": "TEVA-CEPHALEXIN 250MG TAB",
    "fr_drug_common_name": "CEPHALEXIN 250MG TAB",
    "en_ingredients": "CEPHALEXIN",
    "fr_ingredients": "Céphalexine",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146469,
    "drug": {
      "current_status": "MARKETED",
      "id": 2124,
      "drug_code": 14504,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251972,
          "ingredient": {
            "id": 1080,
            "ingredient_code": 2023,
            "en_name": "SUCRALFATE",
            "fr_name": "Sucralfate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02045702",
      "brand_name": "TEVA-SUCRALFATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "76137",
      "number_of_ais": "1",
      "ai_group_no": "0114237002"
    },
    "created_date": "2021-09-30T18:35:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02045702",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "A02BX",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2021-10-31T00:00:00-04:00",
    "actual_start_date": "2021-09-29T00:00:00-04:00",
    "actual_end_date": "2021-11-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-11-05T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-SUCRALFATE",
    "en_drug_common_name": "SUCRALFATE 1GM TAB",
    "fr_drug_brand_name": "TEVA-SUCRALFATE 1GM TAB",
    "fr_drug_common_name": "SUCRALFATE 1GM TAB",
    "en_ingredients": "SUCRALFATE",
    "fr_ingredients": "Sucralfate",
    "drug_strength": "1G",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146472,
    "drug": {
      "current_status": "MARKETED",
      "id": 20876,
      "drug_code": 82803,
      "updated_date": "2025-05-15T02:32:36-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257385,
          "ingredient": {
            "id": 2614,
            "ingredient_code": 11793,
            "en_name": "ZOLMITRIPTAN",
            "fr_name": "Zolmitriptan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02342545",
      "brand_name": "TEVA-ZOLMITRIPTAN OD",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134381001"
    },
    "created_date": "2021-09-30T18:37:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02342545",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2021-10-31T00:00:00-04:00",
    "actual_start_date": "2021-09-29T00:00:00-04:00",
    "actual_end_date": "2021-10-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-10-07T15:06:26-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-ZOLMITRIPTAN OD",
    "en_drug_common_name": "ZOLMITRIPTAN 2.5MG OD TAB",
    "fr_drug_brand_name": "TEVA-ZOLMITRIPTAN 2.5MG OD TAB",
    "fr_drug_common_name": "ZOLMITRIPTAN 2.5MG OD TAB",
    "en_ingredients": "ZOLMITRIPTAN",
    "fr_ingredients": "Zolmitriptan",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "pp 6",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146477,
    "drug": {
      "current_status": "DORMANT",
      "id": 21472,
      "drug_code": 83851,
      "updated_date": "2025-05-15T06:55:41-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368462,
          "ingredient": {
            "id": 786,
            "ingredient_code": 93,
            "en_name": "CIPROFLOXACIN",
            "fr_name": "Ciprofloxacine (Chlorhydrate de ciprofloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02353318",
      "brand_name": "CIPROFLOXACIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123207006"
    },
    "created_date": "2021-09-30T20:05:15-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02353318",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "J01MA",
    "atc_description": "QUINOLONE ANTIBACTERIALS",
    "anticipated_start_date": "2021-09-30T00:00:00-04:00",
    "estimated_end_date": "2021-12-06T00:00:00-05:00",
    "actual_start_date": "2021-09-30T00:00:00-04:00",
    "actual_end_date": "2021-12-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-12-07T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "CIPROFLOXACIN",
    "en_drug_common_name": "CIPROFLOXACIN",
    "fr_drug_brand_name": "CIPROFLOXACIN",
    "fr_drug_common_name": "CIPROFLOXACIN",
    "en_ingredients": "CIPROFLOXACIN",
    "fr_ingredients": "CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE)",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146482,
    "drug": {
      "current_status": "DORMANT",
      "id": 21438,
      "drug_code": 83827,
      "updated_date": "2025-05-15T06:55:41-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368459,
          "ingredient": {
            "id": 2442,
            "ingredient_code": 11516,
            "en_name": "ROPINIROLE",
            "fr_name": "Ropinirole (Chlorhydrate de ropinirole)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02353040",
      "brand_name": "ROPINIROLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132618001"
    },
    "created_date": "2021-09-30T20:12:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02353040",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N04BC",
    "atc_description": "DOPAMINERGIC AGENTS",
    "actual_start_date": "2021-09-30T00:00:00-04:00",
    "actual_end_date": "2021-03-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-08T20:48:13-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "ROPINIROLE",
    "en_drug_common_name": "ROPINIROLE",
    "fr_drug_brand_name": "ROPINIROLE",
    "fr_drug_common_name": "ROPINIROLE",
    "en_ingredients": "ROPINIROLE",
    "fr_ingredients": "ROPINIROLE (ROPINIROLE HYDROCHLORIDE)",
    "drug_strength": "0.25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  }
]